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Abstract 
In the field of drug addiction, relapse back to drug seeking and taking is the major 
unmet clinical need. The rate of relapse back to drug-taking is ~70-80% within a 
year of drug abstinence. Gaining a better understanding of the prolonged neuronal 
changes that have taken place during drug addiction may lead to the design of 
better anti-relapse therapies. It is now widely believed that one component of drug 
addiction is by aberrant learning and memory processes. To study this, we 
investigated synaptic changes caused by the development of drug-seeking 
behaviour in C57BL/6J mice. Mice were treated either with non-contingent 
morphine or trained to exhibit drug-seeking behaviour following morphine-induced 
conditioned place preference (CPP) training, hippocampal slices were taken from 
these animals and synaptic changes examined at the CA3-CA1 synapse using 
electrophysiological methods. Mice that underwent morphine CPP were 
demonstrated to exhibit a significant preference for the morphine paired 
compartment before ex vivo electrophysiological analysis. Using field recordings, 
both non-contingent morphine and morphine CPP treatments resulted in a reduced 
ability to undergo stimulus-induced LTP compared to their respective controls. 
Whole cell patch clamp was then utilised to further investigate these effects. Non-
contingent morphine treatment resulted in both pre- and post-synaptic changes 
with an increased AMPA:NMDA receptor ratio, concurrent increases in cell size, 
and reductions in the release probability of both glutamate and GABA. Morphine 
CPP treatment resulted in a more variable increase in AMPA:NMDA receptor ratio 
(presumably by the same mechanism but in a more specific group of neurones) 
and GABA release probability was also decreased. There were no detected 
increases in cell size however, or any detected changes in glutamate release 
probability. These findings therefore reveal a set of synaptic adaptations in the 
hippocampus unique to morphine-induced behavioural change, and may provide 
targets for future intervention in drug addiction.  
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1.1  Introduction 
Drug addiction represents a major socioeconomic burden on society not only in 
the UK but worldwide. It has effects not only on the health of individuals, but also 
on social cohesion and crime. In the year 2000, WHO estimated that 12% of 
deaths annually were due to non-medicinal drug use (www.who.int). In the UK the 
estimated socioeconomic cost of drug addiction is £15.4 billion per annum 
(Gordon et al. 2006). There is currently an unmet need for the treatment of drug 
addiction with 70% of 'recovered' addicts relapsing within one year (Nutt and 
Lingford-Hughes, 2004). The dogma of modern addiction theory is the idea that 
addictive substances somehow usurp the brain’s natural control of behaviour, and 
so induce a pathological behavioural state. In order to identify rational targets for 
pharmacological intervention in drug addiction it is first necessary to elucidate the 
mechanism that leads to the addictive state.  
In this work, addiction is defined as a pathological change in behaviour, centred 
around the search for and consumption of a particular substance. Examples of this 
pathological change in behaviour range from the continued consumption of a drug 
despite detrimental effects on health or well being, to acts such as burglary in 
order to obtain money to buy more of the drug.   
This study focuses on one particular brain structure within the mesocorticolimbic 
system (often called the reward system) known as the hippocampus. Specifically, 
this study investigates the effects of behavioural adaptations induced by morphine 
on hippocampal synaptic transmission.  
In this introduction the idea of drug addiction as a pathological alteration in the 
brains natural learning and memory processes will be presented. First by 
introducing key brain areas thought to be involved in reward, giving a hypothesis 
of how reward can drive behaviour. Then the concept of synaptic plasticity as the 
cellular correlate of learning and memory will be introduced and the effects of 
addictive substances discussed. Finally this introduction will concentrate on the 
hippocampus, giving an up to date overview of present ideas surrounding the role 
of this much studied brain structure in addiction.  
24 
1.2  The reward system 
Modern biology states that the behaviour of all living organisms is directed toward 
survival of their genetic code. Many mobile organisms are capable of responding 
behaviourally to environmental changes in a manner that is dependent on previous 
experience. Fundamental to this behavioural plasticity is the brain and its ability to 
integrate large amounts of environmental information with information stored from 
previous experience. In order to survive and reproduce these organisms depend 
on their ability to decide when to perform certain 'goal directed behaviours' such as 
chasing food, seeking water or attempting to mate. By making rational decisions 
based on previous similar experiences they are able to expend the minimum 
amount of required energy to obtain nutrition and sex, and so gain a survival 
advantage. Similar to natural rewards, animals will rapidly learn predictive cues 
and complex behavioural responses in order to obtain addictive substances. 
Anecdotally, addictive substances share many of the same subjective sensations 
of natural rewards such as 'wanting' and 'liking'. This suggests the brain systems 
usurped by addictive substances could include some of those involved in the 
seeking of survival relevant goals (Kelley and Berridge, 2002).  
This decision to expend valuable energy in the pursuit of a survival orientated goal 
is dependent on many factors, such as - the perceived value of the goal, the likely 
energetic cost of the planned behaviour, any current internal state such as thirst or 
hunger, and the predicted probability of a successful outcome. It seems likely that 
alterations in any of these calculations could lead to inappropriate (or even 
pathological) behaviour (Robinson and Berridge, 2008; Beeler, 2012). The 
selection of behaviours relevant to survival is likely to be attributable to entire 
neural networks if not the whole brain rather than any one particular structure, and 
is far from understood. One system that is thought by many to be central to the 
detection of reward and/or the selection of behaviour is known as the 
mesocorticolimbic system (Figure 1.1).  
The mesocorticolimbic reward system comprises of dopaminergic neurones arising 
in the ventral tegmental area (VTA) and projecting to various cortical and limbic 
regions including the nucleus accumbens (NAc), medial prefrontal cortex (mPFC), 
amygdala and hippocampus. Each of these regions receives dopaminergic input 
25 
from the VTA but are also functionally connected with each other by direct and 
indirect glutamatergic and GABAergic connections. The early observations that 
animals would self administer electrical stimulation into the VTA (Olds and Milner, 
1954) combined with experiments in human subjects (Heath, 1964) led to the idea 
that activity in this region could mediate some aspect of pleasure. Direct activation 
of this brain region causes such a strong behavioural response in laboratory 
animals that they will impose self starvation if given the choice between food and 
water or electrical stimulation (Routtenberg and Lindy, 1965). This feature along 
with a lack of satiation (>6,000 lever presses per hour; Bozarth, 1994) are a 
cardinal feature of direct stimulation of these mid brain dopamine neurones. All 
addictive substances are capable of causing the release of dopamine from these 
midbrain neurones, despite their varying mechanisms of action (Di Chiara and 
Imperato, 1988).  
The exact information encoded by these VTA dopamine neurones has been the 
subject of intense debate for over half a century now. While ever more 
sophisticated imaging, behavioural, and electrophysiological experiments are 
being performed, these arguments can still essentially be split in to two classes - 
those that argue VTA activation mediates the desire to act in order to acquire a 
reward (motivational theories), and those that argue VTA activation mediates 




Figure 1.1 A highly simplified diagram of some important neural connections 
in the mesocorticolimbic reward system.  
The dopaminergic projections from the VTA are drawn in red, whilst the black 
arrows represent glutamatergic projections (some lines are dashed for clarity). 
This is a highly simplified diagram and other direct and indirect connections exist 
between these brain regions. The general function of this network is thought to be 
the initiation of goal-directed behaviour. The nucleus accumbens can be thought of 
as the final output structure of this system where signals coming from the 
prefrontal cortex (PFC), the amygdala (AMG) and the hippocampus (HPC) are 
integrated under modulation by the ventral tegmental area (VTA). The nucleus 
accumbens projects to a variety of brain regions associated with motor function in 
the basal forebrain and hypothalamus.  
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One popular idea concerning the precise role played by the firing of midbrain 
dopamine neurones is that it detects a reward prediction error. In monkeys VTA 
dopamine neurones fire in response to the receipt of an unexpected reward 
(Mirenowicz and Schultz, 1994; Schultz et al. 1993) consistent with their role 
encoding reward. The activation of these neurones is even proportional to the size 
of the reward (Tobler et al. 2005). This supports the idea that VTA dopamine 
neurones are heavily implicated (in some way) in reinforcement/reward related 
learning. However the role of dopamine release is likely to be more complex than 
simply encoding a reward or its size. If the reward is correctly predicted by a cue 
VTA dopamine neurones do not fire, and if the reward occurs earlier or later than 
expected then again these neurones increase in their firing rate (Tobler et al. 
2005). These properties of VTA dopamine neurones are consistent with the 
properties of reward prediction error encoding as predicted by the machine 
learning hypothesis (Schultz, 2002). This reward prediction error model of 
dopamine function is probably the most influential hypothesis presently, but is not 
without its problems. For example the pause in tonic activity predicted in the 
absence of an expected reward is not consistently shown (Bayer and Glimcher, 
2005; Satoh et al. 2003) and some studies find dopamine neurones that continue 
to increase their firing rate upon receipt of a fully expected reward (Pan et al. 
2005). The reward prediction error model also fails to explain a phenomenon 
known as behavioral priming. Behavioral priming describes the effect giving a free 
reward has in intensifying a behavioral response to a reward related cue (Gallistel 
et al. 1974). This priming effect has been demonstrated for both drug (Phillips et 
al. 2002) and natural rewards (Roitman et al. 2004).  
The nucleus accumbens forms part of the striatum whose function (in a very broad 
sense) is thought to be the conversion of thought into action. For this reason the 
output from the nucleus accumbens is thought to be the final output from a system 
that drives goal directed behaviours. As stated before the selection of behaviours 
depends on many factors other than those directly related to reward, such as the 
context the animal is in, or internal emotional states. So while the predicted value 
of the reward or the motivation to get a reward may depend on signals from the 
VTA; various other brain regions provide important information such as previously 
learnt reward-cue associations (thought to be mediated by the amygdala), the 
identification of drug predictive contexts (thought to be mediated by the 
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hippocampus) or other higher cognitive information related to the situation such as 
conscious desires, often called executive control (possibly mediated by the 
prefrontal cortex). Each of these inputs to the nucleus accumbens is required for 
the normal physiological function of the reward system and therefore each is 
required for the appropriate selection of behaviours. It is easy to imagine a 
situation where dysfunction of any of these brain regions could lead to the 
pathological selection of behaviours.   
All addictive substances (despite their varied mechanisms of action) can cause the 
release of dopamine in the nucleus accumbens from VTA neurones (Wise and 
Bozarth 1987, Koob and Bloom 1988, Di Chiara 1998, Wise 1998). This 
convergence of the actions of addictive substances led to the idea that a 
generalised theory of addiction could be developed. In order to further develop this 
common theory of addiction, researchers have attempted to model certain aspects 
of human behaviour in laboratory animals.  
1.3  Animal models used to study drugs of abuse 
In the design of any animal model there will always be two contradictory 
requirements; the requirement to closely model the human condition and thereby 
maximise validity, and the requirement to simplify the model to increase 
reproducibility and make drawing conclusions easier. This problem is particularly 
acute when attempting to model a complex behavioural disorder such as drug 
addiction, although through careful interpretation of the models appropriate 
conclusions can be drawn.  
Designing models with high face validity, that is, to model the human condition as 
closely as possible; is always going to be extremely difficult given the vast 
difference in normal behaviour exhibited between humans and rodents. A different 
approach to designing models is to aim for high construct validity; that is, to model 
as closely as possible one specific construct of addictive behaviour - such as 
impulse control, incentive sensitisation, or habit formation. This construct validity 
method has gained popularity in studies of drug addiction as it allows for the 
design of reasonably valid models with simple, reproducible outcomes.  
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The most simple aspect of drug abuse to model is the reinforcement of behaviour 
by addictive substances. Reinforcement is a concept developed by Skinner (1938) 
and describes the effect that a salient stimulus can have when given in a manner 
that is contingent on a specific behaviour. Reinforcing stimuli can either increase 
the probability of a behaviour being repeated (positive reinforcement) or decrease 
the probability of a behaviour being repeated (negative reinforcement). The term 
positive reinforcement is often used interchangeably with reward, however this can 
be unhelpful as it implies some kind of positive subjective state. It is unclear if 
animals other than humans experience such positive subjective states. Even in 
humans positive reinforcement occurs in the absence of any clear positive 
subjective state (an example would be the positive reinforcing properties of 
nicotine).  Throughout this work the term 'positive reinforcement' is shortened to 
'reinforcement', as is common in the literature. Addictive drugs can act through 
both primary and secondary reinforcement mechanisms. Primary reinforcement is 
seen in both humans and animals in that they will self administer drug and the act 
of drug taking is reinforced. Secondary reinforcement is subserved by the learning 
of drug-cue associations through Pavlovian conditioning processes. Pavlovian 
conditioning is where the presentation of a salient stimulus, called the 
unconditioned stimulus (US, in this case an addictive drug), is repeatedly paired to 
the presentation of a previously neutral stimulus (CS, such as a light or tone, for 
example). The result of this process is that the CS is learnt to predict the 
availability of the US and elicits a response - the conditioned response. Eventually 
the CS can take on motivational properties of its own, helping to prolong behaviour 
even in the absence of the US (Everitt and Robbins, 2005).  
Primary reinforcement can be modelled using the self administration paradigm. 
Self-administration models have perhaps the most immediately obvious validity to 
the human condition. These models are classified as either operant or non-
operant, depending on whether the animal has to perform a specific action in order 
to receive a drug. The non-operant model is really only commonly used to study 
alcohol use, mostly due to the fact that rodents hardly consume alcohol by any 
other route of administration other than orally (Sanchis-Segura and Spanagel, 
2006). The operant model commonly makes use of a so called 'Skinner-box' where 
the animal is placed and one or more manipulandi are present. These manipulandi 
(commonly levers, but can be places to poke with a nose or disks to peck) are 
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activated in order to gain delivery of the drug, this is often via intravenous or 
intracranial cannulation and therefore requires the disadvantage of having to 
perform surgery on the animal prior to training. Once set-up however this 
procedure has the advantage of near complete automation, increasing 
reproducibility. The number of actions required to gain the drug delivery can be 
altered, known as the schedule of reinforcement and so allows investigation of the 
motivational properties of the drug. However, the use of interventions to prevent 
'drug seeking behaviour' (lever presses) must be treated with caution as 
reductions in motor function can cause complications in interpreting these kind of 
results. Another confounding factor in self administration protocols is due to the 
instrumental learning required to perform the task. It is often not clear what 
adaptations have occurred in response to the learning of the task rather than the 
drug-task associations (Gardner, 2000). In the case of the present study there 
were a number of factors that indicated against the use of this model. The 
requirement for young animals for brain slice electrophysiology meant that surgery 
and recovery before training would have been performed on extremely young 
animals. Also self-administration requires large numbers of trials and drug doses, 
and therefore the effects of tolerance and withdrawal are likely to complicate 
interpretation.  
The conditioned place preference (CPP) model is extensively used to study the 
reinforcing effects of drugs of abuse. This model is widely presumed to depend on 
a type of contextual Pavlovian conditioning (second order reinforcement) whereby 
non-contingent administration of the drug is repeatedly paired with one particular 
distinct environment. Briefly, this involves exposing the animal to one distinct 
environment (context) immediately after administration of the drug under study. 
Then after sufficient time has elapsed to allow for the drug's effects to dissipate, 
the animal is exposed to the second context immediately after administration of 
the drug vehicle. These two contexts can be distinguishable by visual, tactile or 
olfactory cues (Tzschentke, 2007). Preference for a particular environment is then 
tested for during a drug free phase where the animal is allowed access to both 
compartments, and the time spent in each compartment is measured. Conditioned 
place preference is defined as an increase in the amount of time spent in the drug-
paired context, or the development of a preference where previously there was 
none. CPP can be induced by nearly all substances with abuse potential in 
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humans. Notable exceptions include pentobarbital and phencyclidine, although the 
failure of studies using these drugs to induce CPP probably represents a failure to 
find the correct conditions (Bardo and Bevins, 2000). The CPP model is often 
referred to as a model of Pavlovian conditioning and the temporal contiguity 
required for both Pavlovian conditioning and CPP supports this idea. For example 
cocaine induced CPP occurs when a rat is given cocaine immediately or 5 minutes 
before being placed in the specific context, whereas a conditioned place aversion 
is induced if cocaine is given 15 minutes before being placed in to the context 
(Ettenberg et al. 1999).  
CPP has the advantages that it is relatively inexpensive, requires no surgery, is 
measured when the animal is free of any acute effects of the drug, is sensitive to 
low drug doses and relatively few training sessions are required compared to other 
models. The interpretation of the results however is more complex than with some 
other models. For example, the demonstration of CPP is variously reported as an 
increase in time spent in the drug-paired compartment after training compared to 
before; a significantly greater amount of time spent in the drug-paired 
compartment compared to the vehicle-paired compartment on the test day; and an 
increased preference for a drug-paired compartment compared to double vehicle 
controls. To date few studies seem to have addressed this question surrounding 
the handling and analysis of such data. There is also a more general problem in 
determining what aspect of drug seeking behaviour in humans CPP actually 
represents (Bardo and Bevins, 2000). Of interest to this study however was not 
particularly what CPP was a measure of, but a demonstration of the formation of 
drug-environment associations. In the case of CPP, these associations must be 
learnt for CPP to be expressed. A further advantage of CPP is that it can be 
demonstrated in animals that have received relatively small amounts of the drug. 
This is a particularly important factor (in the context of this study) as when using a 
drug that induces tolerance and physical dependence very quickly (such as 
morphine), the effects of learning could easily be confounded by the effects of 
tolerance and withdrawal.   
Another commonly used behavioural model in the study of drug addiction is 
behavioural sensitization. The major advantage of this model appears to be its 
ease of use - upon repeated intermittent non-contingent administration of a drug 
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the motor-stimulant effect of the drug increases. As with CPP there is some debate 
as to what aspect of addiction it actually models (Steketee and Kalivas, 2011). 
Similar processes in humans have proved hard to observe. Although its longevity 
and its ability to augment subsequent self-administration has lead to the 
suggestion that the mechanisms involved may at least partially overlap. While 
behavioural sensitization can be context-dependent (and therefore require 
associative learning processes) it requires the animal to be presented with drug 
during the test session. This complicates subsequent immediate 
electrophysiological analysis when using drugs such as morphine due to short 
term withdrawal effects.  
1.4  Drug addiction as a pathology of learning and memory 
The observation that both drug-taking and relapse to drug seeking are often 
controlled by environmental cues hints at the importance of associative learning 
processes in addiction. The receipt of a natural reinforcer as a consequence of 
behaviour results in the release of dopamine in VTA target sites (Schultz, 1997) 
increasing the animals ability to learn through either enhancing memory directly or 
increasing the motivation to learn (Taylor and Horger, 1999). The receipt of 
addictive drug reinforcement as a consequence of behaviour results in a 
dopaminergic signal that is both greater in magnitude and duration than that of a 
natural reward (Einhorn et al. 1998) and therefore could be expected to greatly 
increase the learning of drug predictive cues in the environment. Over time the 
chronic over-activation of the dopaminergic system can lead to lasting changes in 
the way an organism responds to reward associated cues, as well as adaptations 
in natural learning and memory processes. While this idea had been suspected for 
some time, the first really strong evidence that addictive substances usurp natural 
learning processes came in 1999, when Taylor and Horger (1999) demonstrated 
that chronic cocaine exposure could potentiate learning about a non-drug 
predictive cue. This effect has since been demonstrated for other 
psychostimulants, and also using different learning paradigms. These studies 
demonstrated that chronic exposure to drugs of abuse could enhance learning of 
subsequent reward predictive cues. 
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Addictive drugs can enhance other forms of learning as well as discrete cue-
reward associations. Prior exposure to environments associated with either 
morphine or cocaine can enhance subsequent performance in a spatial learning 
task (the Morris water maze). This effect was not seen if the environment was 
associated with either a natural reward (sucrose) or stress (Zhai et al. 2008). 
Chronic exposure to cocaine can also enhance performance in a more difficult 
version of the Morris water maze (Del Olmo et al. 2006). These kind of spatial 
tasks are well documented to require hippocampal processing, and so these 
results suggest the possibility that hippocampal function may be enhanced. There 
is also a wealth of evidence suggesting that addictive substances can enhance the 
learning of new habits. Habit formation in drug seeking and taking behaviours are 
particularly damaging as habits are relatively insensitive to goal devaluation. This 
means that even when the outcome of a habit no longer results in a reward (or 
even results in a punishment) the animal may continue to respond, whereas goal 
directed behaviours rapidly change dependent on outcomes (for a review on the 
subject see Everitt and Robbins, 2005).The switching of learnt behaviours is 
thought to be mediated by the prefrontal cortex, and therefore perhaps this is one 
region where addictive substances may inhibit learning.   
The above observations suggest that addictive substances may fundamentally 
alter learning and memory processes, by enhancing associative learning 
processes, speeding up habit formation and/or decreasing executive control. Over 
the many years that a person may take a drug, chronic over-activation of these 
learning and memory mechanisms, combined with habit formation may help 
induce the compulsive drug seeking behaviour often seen in long term addicts. 
While over learning and habit formation may help explain compulsive drug use, it 
provides little explanation of perhaps the largest problem with the treatment of 
drug addiction - relapse. It is possible that during the often long periods (perhaps 
10 years or more) of drug consumption that occur before an addict attempts to 
abstain from their drug, many features of their environment will become associated 
with drug use. Upon attempting to abstain from the drug an addict may experience 
powerful cravings brought on through 'over learnt' environmental cues predicting 
drug availability.  
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Discrete drug-cue associations (CSs) that signal the availability of a drug (US) can 
exert a powerful hold over both human or rodent behaviour during abstinence or 
extinction respectively. Examples of this such as the sight of drug paraphernalia (in 
humans) effectively induce cravings. In rodent models the presentation of a tone 
previously paired with a drug is an effective method of reinstating drug-seeking 
behaviour. This so-called 'cue-induced reinstatement' appears to be dependent 
upon the amygdala in rodents (Meil and See, 1997). The presentation of discrete 
drug cues to detoxified humans can induce craving and increase the blood flow in 
the amygdala (amongst other limbic regions) measured by PET (Childress et al. 
1999). In rodents the repeated presentation of the CS in the absence of the US 
can reduce the conditioned response to the CS over time. This process is known 
as extinction. Attempts to extinguish drug seeking in humans based on this idea 
('exposure therapy') have largely been unsuccessful however (Marissen et al. 
2007). One possible reason for the failure of Marissen et al. (2007) to prevent 
relapse (relapse rates actually increased) could be due to the specific context in 
which the cues were presented. Crombag and Shaham (2002) used a model of 
cue-induced relapse utilising two separate contexts, A and B. Rats first were 
trained to self-administer cocaine in context  A. Each reinforcement was paired 
with the turning on of a light for 40 seconds. Drug seeking behaviour was then 
extinguished in context B although the light cue was still presented after a lever 
press. When reintroduced into context A, reinstatement of drug seeking behaviour 
could be induced by the contingent presentation of the light cue (lever press 
resulted in light but no drug, as in context B). The authors concluded that in this 
instance the context must function as an occasion setter. This suggests that 
contexts may control the ability of drug-paired cues to control behaviour. This 
result implies that exposure therapy would be only effective in the context that it 
was given. While this is not a problem in laboratory animals it represents perhaps 
an insurmountable challenge in humans. Therefore perhaps context-drug 
associations would be a better target for intervention. Again the success of 
exposure therapy here would likely be limited by the practical problem of 
recreating realistic contexts. A better understanding of the process of drug-context 
learning could provide better, more rational targets for intervention, 
pharmacological or otherwise. 
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The hippocampus is a brain structure heavily implicated in the formation of drug-
environment associations in animal models, and also context-dependent relapse 
(Vorel et al. 2001). Therefore adaptations in the hippocampus during drug use may 
lead to the 'over-learning' of these drug-environment associations, memories that 
in humans could possibly induce relapse many years after drug taking ceased. 
Before the role of the hippocampus in addiction can be fully explored, it is 
necessary to consider its normal physiological functioning.  
1.5  The hippocampus  
The hippocampus is part of the hippocampal formation, a group of brain areas 
located in the medial temporal lobe. The famous case of patient HM who had his 
medial temporal lobe removed surgically for the relief of his epilepsy, marked the 
start of a new era in the study of memory. Since HM, the hippocampal formation 
has become possibly the most widely studied area in the mammalian brain. In this 
section, the normal physiological functioning of the hippocampus is discussed. The 
section begins with the general topography of the hippocampus, and then goes on 
to discuss how patterns of neuronal activity in the hippocampus can be correlated 
with certain behaviours. In the final part of this section some attempt is made to 
define a function for the hippocampus.  
1.5.1  General anatomy of the hippocampus 
A striking feature of the mouse hippocampal formation topography is the 
unidirectional flow of information from the dentate gyrus to CA3 (see Figure 1.2). 
As can be seen from this simplified Figure the superficial layers of the entorhinal 
cortex can be thought of as the beginning of the hippocampal formation. 
Information flows from the entorhinal cortex into the dentate gyrus, hippocampus 
proper (consisting of the major regions CA3 to CA1) and the subiculum before re-
entering deeper layers of entorhinal cortex. This is of course a highly simplified 
view and many other unidirectional and reciprocal connections exist between 
various parts of the hippocampal formation and the wider brain.  
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Figure 1.2 A simplified diagram of some of the major external and internal 
connections for the hippocampus.   
A wide variety of cortical information arrives at the hippocampus via the superficial 
layers of the entorhinal cortex (Ent. Cortex). This information then enters the 
largely unidirectional hippocampal processing loop where it is further processed 
and integrated with information from the amygdala (AMG). This process is 
modulated by a wide variety of subcortical structures. An unusual feature of this 
brain region is the unidirectional flow of information from the entorhinal cortex, 
through CA3, CA1, and the subiculum (Sub.). 
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The entorhinal cortex is a multi-laminate structure that receives a wide variety of 
sensory input from areas throughout the cortex as well as various other sub-
cortical inputs, most notably from the amygdala. One interesting feature of the 
amygdala connection to the entorhinal cortex is that it appears to only be present 
in the medial portion of the entorhinal cortex. The cells of the superficial layers II 
and III provide the main input into the hippocampal processing loop, with layer II 
neurones projecting to the dentate gyrus and CA3 and the layer III neurones 
projecting to the CA1 and subiculum. The deeper layers V and VI receive their 
major input from CA1 and the subiculum (the other end of the hippocampal 
processing loop) and convey this signal to the higher multi-modal and association 
areas of the cortex. Therefore the entorhinal cortex can be thought of as a conduit 
for the information entering and leaving the hippocampal processing loop from the 
wider neocortex (Amaral and Lavenex, 2007).  
The dentate gyrus receives its major cortical input from layer II entorhinal cortex 
neurones via the perforant pathway. The perforant path terminates in the 
superficial molecular layer of the dentate gyrus (Hjorth-Simonsen and Jeune, 
1972) where it forms synapses with dendrites of the granule cells of the dentate 
gyrus. The perforant path is often further divided into medial and lateral divisions 
based on the origin and target of the constituent neurones. The lateral perforant 
path neurones originate in the lateral entorhinal area and terminate in the outer 
third of the molecular layer, whereas the medial perforant path originates in the 
medial entorhinal area and terminates in the middle third of the molecular layer 
(van Groen et al. 2003). While the dentate gyrus receives relatively few sub-
cortical inputs, a major input is the poorly understood innervation from the septal 
nuclei. This is a mixture of cholinergic and GABAergic innervation. The septal 
nuclei are a group of structures poorly understood (perhaps mediating attention or 
arousal) but known to support self-stimulation as demonstrated by Olds and Milner 
(1959) in their classic experiment. The dentate gyrus also receives input from 
various other sub-cortical structures including; a poorly defined projection from the 
hypothalamus, a noradrenergic projection from the locus coeruleus (Loughlin et al. 
1986) a dopaminergic projection from the ventral tegmental area and a 
serotinergic projection from the dorsal raphe nucleus (Conrad et al. 1974). All of 
these sub-cortical inputs are undoubtedly important in the physiological functioning 
of the hippocampal processing loop. They are however likely to play more 
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modulatory roles in controlling how the hippocampal formation processes the 
information provided by the amygdala and cortex via the entorhinal cortex. 
Unusually for the brain, the dentate gyrus does not appear to project to any brain 
structure other than the CA3 area of the hippocampus. The collection of axons that 
originate at the granule cells of the dentate gyrus and project to CA3 are known as 
the mossy fibres.  
The principal cells CA3 of the hippocampus proper are the only hippocampal 
structure to receive input from the dentate gyrus. The proximal portions of the CA3 
(those closest to the dentate gyrus) have short apical dendrites and are more 
strongly under the influence of the granule cells (of the dentate gyrus) than the 
distal portions with larger apical dendrites that reach into the stratum lacunosum-
moleculare (were the perforant path from the entorhinal cortex is situated) and 
receive direct input from layer II of the entorhinal cortex (Ishizuka et al. 1995, van 
Groen et al. 2002). The distal principal cells of CA3 therefore may receive the 
same signals transmitted to the dentate gyrus by the layer II cells of the entorhinal 
cortex, this parallel and serial connectivity is a feature of the hippocampal 
processing loop. The ventral portions of CA3 also appear to receive a significant 
input from the basolateral amygdala (Pikkarainen et al. 1999; Pitkanen et al. 2000) 
through synapses found in both the stratum radiatum and stratum oriens. The 
largest sub-cortical input to the CA3 (and CA1) comes from the septal nuclei 
(Nyakas et al. 1987; Gaykema et al. 1991) innervating both the stratum oriens as 
well as the stratum radiatum, these connections are reciprocal (as they also are in 
CA1). The CA3/CA2 region also receives a variety of modulatory influence from 
brain stem structures such as the locus coeruleus and dorsal raphe nucleus. One 
of the major differences between CA3/CA2 and CA1 is the extensive self 
association that occurs within CA3/CA2. In fact any one CA3 neurone may be 
monosynaptically connected to almost any other neurone contained in the 
ipsilateral CA3-CA1 (Li et al. 1994). The CA3 to CA1 projection (the Schaffer-
collaterals) contact the apical dendrites in the striatum radiatum and the basal 
dendrites of the striatum oriens (Li et al. 1994).  
The CA1 sub-region of the hippocampus gets the majority of its excitatory input 
from the CA3 projection as already mentioned. The entorhinal input into this area 
is different in three ways. Firstly the projection originates from layer III of the 
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entorhinal cortex rather than layer II. Second is that the transverse terminal 
location of the input depends on its medial/lateral origin in the entorhinal cortex. 
This is in contrast to the dentate gyrus/CA3 projection where the lateral portions of 
the entorhinal cortex project to the more superficial layers of the stratum 
lacunosum-moleculare whereas the medial portion terminates in more deep 
layers. Therefore a more proximal CA1 pyramidal cell (close to CA3) is more likely 
to be connected to a more medial location in the entorhinal cortex. Finally, the 
connection to the entorhinal cortex appears to be reciprocal in CA1, whereas in 
CA3 (and the dentate gyrus) the flow of information is unidirectional (Naber et al. 
2001). As already mentioned the reciprocal connection between the hippocampus 
and septal nuclei is present in CA1 also. The amygdala also has significant 
reciprocal connections with the CA1 area in the more ventral portions (Pitkänen et 
al. 2000). The dorsal raphe and locus coeruleus innervate CA1 less strongly when 
compared to CA3 (Samuels and Szabadi, 2008). A dopaminergic projection from 
the ventral tegmental area to the ventral portions of CA1 has also been described 
(Gasbarri et al., 1994 and 1997).  
As the CA1 area gives way to the subiculum the defined laminate structure of the 
hippocampus breaks down into a more diffuse organisation. The stratum 
lacunosum-moleculare of CA1 is replaced by the superficial molecular layer, with 
the deep molecular layer joining the stratum radiatum. The pyramidal cells of the 
subiculum are also more diffusely distributed and there is no stratum oriens. CA1 
projects to the deep molecular layer while the entorhinal cortex layer III neurones 
project to the more superficial layers. The CA1 to subiculum connection is 
organised in a proximal-to-distal fashion, this means that the distal portions of CA1 
project proximally to the subiculum and vice versa (Tamamaki et al., 1987). Again 
in the subiculum numerous associational connections exist. Interestingly there 
seems to be a unidirectional flow of information toward the ventral subiculum 
through these associational connections, in that each pyramidal cell projects to 
other cells ventrally but not dorsally (Harris et al. 2001). The subiculum, along with 
CA1 can be thought of as one of the major output structures of the hippocampal 
processing loop, both structures have significant outputs into layer V of the 
entorhinal cortex. The amygdala has reciprocal connections with the subiculum, 
with the projection from the amygdala terminating in the proximal molecular layer 
throughout the dorso-ventral axis. Interestingly only the ventral subiculum appears 
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to project back toward the amygdala (Pitkanen et al. 2000). As with all other parts 
mentioned above - the septal nuclei appear to have reciprocal connections with 
the subiculum, also present however is a unidirectional projection to the nucleus 
accumbens (Kelley et al. 1982). There are also a variety of hypothalamic, thalamic 
and direct cortical projections arising from the subiculum.  
The direct connection between the ventral subiculum and the nucleus accumbens 
has been suggested to play a pivotal role in the selection of goal directed 
behaviour. In their model, Sesack and Grace (2010) propose that the 
hippocampus and prefrontal cortex compete for control over the NAc. The release 
of dopamine in the NAc is proposed to shift the balance of control to favour the 
hippocampal control through actions on the D1/D2 receptors located on the 
medium spiny neurones of the NAc itself (Sesack and Grace, 2010).    
The intrinsic connections of the hippocampus are summarised in Figure 1.3. As 
can be seen from the Figure the highly ordered structures described above results 
in the topographical conservation of entorhinal inputs. Layer II neurones from the 
medial entorhinal cortex project, via the ventral hippocampal processing loop, to 
medially located entorhinal layer V neurones. This fact is significant when one 
considers that the lateral and medial entorhinal cortex receive projections from 
different brain areas. This has led to the idea that there may be a functional 
separation within the hippocampus along the dorso-ventral axis. Another striking 
feature of this structure is the serial/parallel nature of the connections. An 
individual CA3 neurone for example, may receive the same signal mono-
synaptically direct from the entorhinal cortex or di-synaptically via the dentate 
gyrus. Likewise, neurones in CA1 receive projections direct from the entorhinal 
cortex but also tri-synaptically through the dentate gyrus and CA3.   
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Figure 1.3 A diagram summarising some of the intrinsic connections in the 
hippocampus. 
For clarity some lines are dashed, this is not indicative of any difference in the 
projection as they are all glutamatergic. There is a complex transverse and 
dorsoventral organisation within the hippocampus. Studying the diagram reveals 
that it is likely that different transverse or dorsoventral locations within any 
hippocampal sub region receives a unique combination of processed information 
from different hippocampal regions. This is of relevance when combined with the 
fact that different brain regions project selectively to the lateral or medial entorhinal 
cortex (Ent. Cortex), as well as the fact that different transverse and dorsoventral 
locations in the subiculum (Sub.) project to different brain regions. DG = dentate 
gyrus  
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Not yet mentioned in any of the above descriptions of anatomical connectivity is 
the significant number of inhibitory interneurones present in all of these structures. 
Historically, the role of these GABAergic neurones was thought to be the inhibition 
of over-excitability during the integration of information by excitatory transmission. 
It is now clear however, that these interneurones play a fundamental role in many 
aspects of signal integration as well as synchronising population activity to create 
the characteristic electroencephalographic signals of the hippocampal theta wave 
(discussed below). The wide variety, as well as problems in the classification of 
these interneurones, puts a review of them outside the scope of this work, and 
they will be mentioned only where appropriate.       
1.5.3  Functions of the hippocampus 
In the following sections an attempt is made to define the role of the hippocampus. 
As will become clear, the attempt to define a specific function of any particular 
brain region belies the vastly interconnected and interdependent nature of the 
brain. This does not mean that the attempt to investigate hippocampal function is 
without use however, and by studying the physiology of the hippocampus in awake 
animals insights can be gained regarding behavioural correlates of neuronal 
activity. The hope is that one day we may be able describe the information 
integrated by a particular group of neurones. It is unlikely that the neurones 
contained within our current definition of the hippocampus are both necessary and 
sufficient for any one particular behavioural construct.    
The removal of the medial temporal lobe in patient HM in an attempt to relieve him 
of severe epilepsy marked the beginning of a new era in the study of brain 
function. The finding that HM had impaired memory for facts or faces, while 
seemingly continuing to perform normally (or even slightly better) in procedural 
memory tasks (such as learning to draw in a mirror) first suggested that multiple 
memory systems exist in the brain, and that these could be dependent on different 
structures (Milner, 1962).  
There is a temptation (as a reductionist) to therefore attempt to ascribe a particular 
function to a particular part of the brain. Upon attempting to do this, two problems 
become immediately apparent. The first problem is defining the brain region that is 
43 
both necessary and sufficient for that particular function. Take the hippocampus for 
example. It appears from the anatomy that the main excitatory connections 
through the dentate gyrus, hippocampus proper and subiculum could form the 
definition of the brain region. The normal physiological function of these brain 
regions however, depends heavily on the modulatory input from the sepal nuclei 
and other sub cortical structures. In order for the hippocampus to perform its 
function this modulation must be present and so the rest of the sub-cortical areas 
involved in the modulation of the hippocampus must be included if we are to arrive 
at a structure that is both necessary and sufficient for a particular function. So the 
problem of the extensive interconnectivity in the brain leads us rapidly to defining 
structures that encompass areas so large and diverse that the definition is of little 
use.  
The second problem is in defining a particular behavioural construct that is of 
relevance to the way the brain processes information. Behavioural constructs 
thought to be affected during addiction such as impulse control or motivation may 
not have single cellular mechanisms within the brain. Another is the measurement 
of behaviour as an output of brain processing. This is limited by the fact that 
certain areas of the brain will be necessary for the expression of the measured 
behaviour while playing little role in the process of interest. To take an extreme 
analogy - in the conditioned place preference model the motor cortex (and even 
the animal’s legs) could all be seen as necessary in the expression of preference, 
while playing little part in the real mechanism of interest (the development of 
preference for one particular environment as a result of repeated paired US and 
CS).  
So if the measurement of behavioural constructs is limited by poor definition of 
constructs and problems with expression, then defining a function based on the 
processing of information must be used. Since currently we have a very limited 
understanding of the precise information being transmitted in many brain regions, 
we are then limited to basic descriptions of their connectivity (the anatomy, already 
described). The attempt to define a specific function for one particular brain region 
therefore leads to the inclusion of unhelpfully large brain structures and/or 
unhelpfully limited descriptions of function. The solution to this problem is rather 
than attempting to define a particular structure as performing a certain function, 
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defining the structure as necessary (or involved in), but not necessarily sufficient 
for, a particular function. This approach leads to partly useful descriptions of what 
behaviours the hippocampus plays a role in, while avoiding the potential problems 
associated with defining a specific function.   
Clues from human patients with hippocampal damage 
The vast wealth of literature available on human hippocampal lesions including 
HM, gives rise to an almost indisputable view that the hippocampus is intimately 
involved in at least some forms of memory (Roy et al. 2001). Extensive study of 
individual patients has well characterised individual deficits (such as HM in Milner, 
1962), and studies involving multiple patients with hippocampal damage has 
indentified general patterns in deficits. The lesions performed in humans often vary 
with respect to their exact extent and often include damage to the adjacent cortical 
areas (the parahippocampal and perirhinal cortex). It is therefore difficult to draw 
conclusions about the function of the hippocampal formation specifically from 
these studies. As a result, although the broad effects of damage to the 
hippocampal formation and adjacent cortical areas is well characterised, very little 
is known about the role of specific hippocampal areas. The findings from studies of 
the role of the hippocampus in humans can be summarised  
 The hippocampus and adjacent cortical areas are critically involved in 
declarative, spatial and episodic memory in a time limited fashion (Milner, 
1962; Squire et al. 2004).  
 Working and implicit memory appear not to be affected by hippocampal and 
adjacent cortical area damage (Stark and Squire, 2000).  
 The hippocampus and adjacent cortical areas are not involved in non 
mnemonic aspects of cognition. A good example of this is the finding that 
spatial processing appears to be intact in patients with hippocampal 
damage. They are able to find novel routes through environments that they 
have memories of due to them being in the distant past (Teng and Squire, 
1999).    
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Clues from studying in vivo physiology in awake rodents 
The electroencephalogram (EEG) provides information about the synchronous 
activity of large populations of neurones, making no distinction between excitatory 
or inhibitory inputs. While this method has obvious limitations in the study of brain 
function, the correlation of synchronous activity with certain behavioural outputs 
does provide glimpses into the roles a particular region may have. Elegant work by 
Vanderwolf (1969) demonstrated the existence of three major classes of oscillatory 
activity in the rat hippocampal region. There was a regular, rhythmical oscillation of 
variable frequency, termed theta. This was correlated to the voluntary movement 
through an environment. There were also two forms of irregular activity, large and 
small (LIA and SIA respectively). LIA appeared to occur during behaviours that did 
not result in the animals movement through its environment (such as eating, 
grooming etc). SIA appeared to occur during transitions in behaviour such as 
waking from sleep (Vanderwolf, 1969).  
The theta wave can be further divided based on its pharmacological sensitivity into 
an atropine-sensitive component (a-theta) and an atropine-insensitive component 
(t-theta) (Kramis et al. 1975). This separation reveals that t-theta is correlated with 
movement through space, possibly increasing in frequency as movement speed 
increases (Rivas et al. 1996; Slawinska and Kasicki, 1998). The behavioural 
correlate of a-theta is less clear, but appears to be potentiated by high states of 
attention or arousal (Sainsbury et al. 1987). The theta wave is a measurement of 
the membrane potential oscillations of the pyramidal cells throughout the 
hippocampus. These oscillations may serve to synchronise population activity 
across distant brain regions, as theta waves can be observed throughout many 
limbic structures. Another function of theta waves could be to constrain when 
plasticity could occur, indeed Hyman et al. (2003) found that the same burst 
pattern delivered at either the peak or trough of theta waves would induce LTP or 
LTD respectively.  
LIA and SIA are much less studied phenomena. LIA oscillations occur during 
states of low arousal and sleep. They are thought to occur as a result of 
synchronous firing of CA3 pyramidal neurones, followed by interneurone activity 
that synchronises the resultant CA1 pyramidal cell firing (Buzsaki et al. 1992). Due 
46 
to both the behavioural correlates and the likely effect LIAs may have on 
hippocampal target structures, LIAs have been proposed as a mechanism for 
synaptic modification of these structures. Put differently, LIAs could represent the 
consolidation of information transfer from the hippocampus to its target structures. 
In support of this idea is the finding that cells that fire together during theta phase 
exploration are more likely to fire together during LIA in sleep (Skaggs and 
McNaughton, 1996). SIA occurs regularly in the rat during sleep and probably 
represents the reactivation of the place representation of the place the rat went to 
sleep (Jarosiewicz and Skaggs, 2004).  
While EEG recordings are a powerful way to investigate general functions of 
populations of cells, they are limited by their resolution. In vivo extracellular field 
recordings allow the recording of smaller populations of neurones or even single-
unit recordings if multiple electrodes are used. As early as 1971 this technique was 
identifying differences in the functioning of neurones in vivo. Immediately apparent 
was that there appeared to be at least two separate populations of neurones, 
Ranck termed these two types of neurone theta cells and complex spike cells 
(Ranck, 1973). Theta cells increase their frequency during theta and show strong 
phase locking to the EEG wave. Complex spike cells show a broader action 
potential than theta cells with a bursting pattern characterised by steadily 
increasing duration and decreasing amplitude action potentials. O’Keefe and 
Dostrovsky (1971) first noted that one of the most powerful predictors of complex 
spike cell firing was the animal's location in space. This finding led to the 
development of the cognitive map theory of hippocampal function, an idea still 
highly influential today (O’Keefe and Nadel, 1978). Other spatially correlated 
patterns of firing have been both predicted and found in other hippocampal 
structures, the most recent of which was the discovery of entorhinal grid cells 
(Hafting et al. 2005). 
The CA1 pyramidal neurones display place cell properties, meaning they have an 
increased probability of firing when an animal is in a particular location in space - 
the 'place field'. Place fields develop rapidly upon entry into a novel environment 
and are not topographically organised, meaning place cells adjacent to each other 
are not more likely to have adjacent place fields. Place fields generally increase in 
size as recordings are taken from progressively more ventral portions of CA1 
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(Maurer et al. 2005). A striking demonstration of place cell encoding was given 
recently by Ziv et al. (2013) who used somatic calcium imaging in behaving mice. 
Over the period of 45 days place cells remained remarkably stable. It was possible 
to determine accurately the animal's location in space through analysis of place 
cell behaviour and animal location on any previous visit to that arena. There is 
general widespread agreement that spatial processing intimately involves the 
hippocampus in rodents and this is at least partially supported by studies of 
humans with hippocampal damage. There is considerably more disagreement as 
to whether or not place cell firing encodes any sort of motivational signal (either 
aversive or appetitive). Hollup et al. (2001) recorded place fields during 
performance in a water maze. They found place fields tended to cluster around the 
goal platform, suggesting that the development of place fields can be modulated 
by motivational influences. Moita et al. (2004) used an aversive electrical 
stimulation of the eye as the US with either a discrete cue (a tone) or a specific 
context as the CS. They found that significantly more place fields were altered in 
the context CS group compared to the tone CS group. Taken together these 
results suggest that it is at least possible that CA1 place fields are modulated by 
the presence of salient stimuli in specific locations. 
The fact that the hippocampus seems to be involved in the processing of spatial 
information does not mean that the only function of the hippocampus is spatial 
processing. Many other theories regarding hippocampal function do exist, such as 
the role of the hippocampus in stress. While relatively well studied in rodent 
models, relatively little information regarding the emotional deficits in humans 
following hippocampal damage seems to be available. Perhaps the profound 
memory deficits in these patients prevent the expression of any emotional deficit. 
Also, any depressive like effects seen could easily be dismissed as a result of the 
profound memory loss. One of the major debates surrounding hippocampal 
function and stress currently is regarding causality. It is clear that stress can have 
profound effects on hippocampal function, but it is unclear if stress can be 
modulated by the hippocampus. A full discussion of this topic is beyond the scope 
of this work, for a review see Sheline (2011). 
The vast majority of studies on rodent hippocampal function have been centred 
around the role the hippocampus plays in spatial processing. The conclusions from 
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studies involving humans however, often define the role of the hippocampus in a 
broader sense, such as playing a role in declarative memory. There are obvious 
difficulties in studying memory that can be declared in rodents, and so perhaps it is 
for this reason that studies focus on the spatial aspect. Another possibility is that 
the human hippocampus is functionally different from that of the rodent. 
Anatomically the hippocampus is well conserved across all mammals, however the 
input structures are very different. In humans the massively increased neocortical 
association areas are likely to deal with a much wider range of complex abstract 
information than those of the rodent. As already mentioned the hippocampus 
receives information from across the neocortex via the entorhinal cortex. The 
information integrated by the hippocampus therefore is likely to reflect the 
information processed by the neocortex.  
The studies described above can give many insights into hippocampal processing 
but still do not lead us toward a definition of hippocampal function. The definition of 
hippocampal function that is unlikely to be wrong, but at the same time not 
particularly useful is that; the hippocampus combines and extends information 
processed by adjacent cortical and subcortical regions. While the exact role of the 
hippocampus remains to be defined, information flow through it will undoubtedly 
be affected by addictive substances. As will be discussed later in this work, 
morphine has direct effects on the GABAergic interneurones responsible for 
synchronising neuronal activity throughout the hippocampus (the theta rhythm). 
The dopamine signal generated in VTA target sites by all addictive substances will 
also have effects on synaptic plasticity in certain parts of the hippocampus 
(discussed later). These actions will affect both the processing and storage of 
information by the hippocampus, but this fact alone does tell what if any addiction-
related behaviours are then mediated by the hippocampus. 
1.5.4  The functions of the hippocampus of relevance to addiction-related 
behaviours 
So far in this work, the case has been made that drug addiction is a pathology of 
learning and memory, and that environmental cues can trigger these pathological 
memories and so instigate drug seeking behaviours. We have also seen that 
although defining a specific role for the hippocampus is difficult, it seems to be 
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intimately involved in the processing of sensory information along with many 
aspects of memory formation. The following paragraphs now examine evidence 
suggesting that the normal function of the hippocampus is (at least partly) 
responsible for some addiction-related behaviours.  
On a basic level, lesions of the dentate gyrus (the beginning of the hippocampal 
processing loop) have been shown to completely disrupt both the acquisition and 
expression of place preference to cocaine (Hernández-Rabaza et al. 2008). 
Temporary inactivation of the dorsal hippocampus can also prevent the expression 
of place preference behaviour (Meyers et al. 2006).   
In 2001 Vorel et al. demonstrated that patterned stimulation of the ventral 
subiculum was able to reinstate a previously extinguished cocaine seeking 
behaviour. This effect was dependent upon context as well as activation of the 
VTA. It is worth noting that this effect was not exclusively dependent upon VTA-
induced NAc dopamine as medial forebrain bundle stimulation (that supports self 
administration and causes NAc dopamine release) was not able to reinstate this 
behaviour (Vorel et al. 2001). This result suggested that signals generated in the 
hippocampus could mediate at least some forms of relapse. Ventral subiculum 
stimulation has also been used successfully to reinstate d-amphetamine self 
administration behaviour during periods of voluntary abstinence (Taepavarapruk 
and Phillips, 2003). Taken together these two results strongly suggest that the 
initiation of drug seeking behaviour can be induced by hippocampal activation. 
The role of the hippocampus in the initiation of drug seeking behaviour appears to 
translate into addicted humans, as craving inducing stimuli increased blood flow to 
the hippocampus measured using PET (Kilts et al. 2001). The ventral subiculum 
has also been implicated in other addiction-related behaviours, such as in the 
reinforcing effects of cocaine (Caine et al. 2001).  
Unilateral lesions of the hippocampus have been shown to disrupt a sucrose-
induced place preference when the only available cue was spatial (Ito et al. 2006). 
A functional connection between the hippocampus and the nucleus accumbens 
may underlie this effect. Ito et al. (2008) showed that a unilateral lesion of the 
hippocampus with contralateral lesion of the nucleus accumbens shell sub region 
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was able to disrupt a conditioned place preference to sucrose. This connection 
from the hippocampus to the nucleus accumbens appears to be enhanced by 
phasic dopamine release in the nucleus accumbens (Gotto and Grace, 2005). As 
mentioned earlier nucleus accumbens dopamine release is thought to play a 
central role in goal directed behaviour. This dopamine release therefore may 
represent a mechanism to allow the hippocampus control over nucleus 
accumbens output.  
The hippocampus, or more specifically the ventral subiculum, may also play a role 
in controlling the activity of dopamine neurones in the VTA through a complex loop 
formed by the ventral subiculum, NAc, ventral pallidum (a basal ganglia nucleus) 
and the VTA (Lodge and Grace, 2006). This system may be the way in which the 
hippocampus regulates responses to drug predictive cues dependent on 
recognition of environmental contexts (Grace et al. 2007). More recently, an 
alternative pathway between the dorsal CA3 and the VTA via the lateral septum 
has been proposed to modulate the same process.  Luo et al. (2011) showed that 
injections of GABA agonists bilaterally in CA3 (or contralateral injections into the 
lateral septum and VTA) blocked context-induced reinstatement of lever pressing.  
Summarising the evidence presented in this section, addiction-related behaviours 
such as place preference or self administration are clearly modulated by the 
hippocampus. These facts alone do not suggest that the hippocampus would be a 
good target for intervention however, as these studies do not demonstrate that 
changes in hippocampal processing underlie these behavioural changes. 
Evidence that addictive substances can alter hippocampal processing does exist 
however, but before these studies can be explained, a more in depth look at how 
information is transmitted through the hippocampus is necessary. 
1.6  Synaptic transmission in CA1 
The synapse is a specialised area of the neurone where signals in one neurone 
are passed to another in a process known as synaptic transmission. In synaptic 
transmission an electrical signal is first transduced into a chemical signal by the 
first neurone, called the pre-synaptic neurone. This chemical signal is released into 
a very tight space (2Å) between the cells (the synaptic cleft) where specialised 
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receptors on the second cell (the post-synaptic cell) convert this chemical signal 
back into an electrical one. Figure 1.4 (next page) shows a typical glutamatergic 
synapse such as those found at the synapses formed between the hippocampal 
CA3 and CA1 neurones. When an electrical signal (known as an action potential) 
arrives at the pre-synaptic membrane, voltage-gated calcium channels (VGCCs) 
open and allow the influx of calcium into the pre-synaptic cell. This can trigger a 
calcium dependent exocytosis of neurotransmitter (in this case glutamate) into the 
synaptic cleft. This neurotransmitter is then free to diffuse across the synaptic cleft 
where it can bind with ionotropic and metabotropic receptors on the post-synaptic 
membrane. The opening of ionotropic receptors allows the movement of ions 
down their electrochemical gradient. The result of this flow of ions can either be a 
depolarisation or a hyperpolarisation of the post-synaptic membrane, dependent 
on the electrochemical potential of the ion conducted. At the glutamatergic 
hippocampal CA3-CA1 synapse, the opening of ligand-gated cation channels 
depolarises the membrane. If the depolarisation of the post-synaptic membrane is 
great enough then voltage-gated sodium channels open and an action potential 
may be triggered along the axon causing the release of neurotransmitter from the 
axon terminals (Stuart et al. 1997).   
The presynaptic specialisation can be identified in electron micrographs as a 
thickening in the membrane with vesicles of similar size clustered behind it. The 
membrane thickening is thought to represent the 'active zone' containing voltage-
gated calcium channels and all the necessary proteins for SNARE mediated 
exocytosis. Postsynaptic specialisations for so called 'asymmetrical synapses' 
include a thickening of the membrane and a electron dense area known as the 
postsynaptic density (PSD). 'Symmetrical synapses' lack this PSD and are often 
found around the soma and axon hillock of the pyramidal cells of CA1. It is 
generally thought that asymmetrical synapses are excitatory while symmetrical 
synapses are inhibitory. The principal excitatory and inhibitory neurotransmitters in 
CA1 are glutamate and GABA respectively. The exocytosis of neurotransmitter into 
the synaptic cleft may occur via one of two mechanisms, 'full fusion' and 'kiss and 
run'. Identifying what type of exocytosis occurs at a synapse is technically 
challenging and very little specific information regarding CA1 is available. There is 
evidence from cultured hippocampal cells that this mode of vesicle release can be 
regulated however (Regner et al. 2001). The changes in kinetics of 
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neurotransmitter release can have a significant impact on neurotransmission due 
to rapid diffusion and re-uptake of neurotransmitter from the synaptic cleft 
(discussed later).  
 
 
Figure 1.4 Synaptic transmission at a glutamatergic synapse.  
1. Depolarisation of the presynaptic membrane (top) causes the opening of 
voltage-gated calcium channels. 2. The rise in intracellular calcium triggers 
SNARE mediated endocytosis and the release of glutamate into the synaptic cleft. 
3. Glutamate can bind to ionotropic AMPA (red) and NMDA channels (blue). 4. 
AMPA channels are permeable to Na+ ions which flow down their electrochemical 
gradient and depolarise the postsynaptic membrane (bottom). 5. Also present on 
both pre– and postsynaptic membranes are GPCRs that regulate cell excitability 
and transmitter release.  
Neurotransmitter released into the synaptic cleft can act on two principal types of 
receptors. Ionotropic receptors couple ligand binding to the opening of ion 
permeable channels. Metabotropic receptors (GPCRs) couple ligand binding to 
intracellular signalling cascades through the dissociation of GTP-binding proteins 
(G-proteins).  
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There are three major classes of ionotropic glutamate receptors, classified 
according to their sensitivity to experimental compounds. They are named AMPA, 
NMDA and kainate receptors. Kainate receptors are the least studied class of 
receptors and have complex physiological roles, mainly in the modulation of 
synaptic transmission rather than being involved directly in synaptic transmission 
itself (Jane et al. 2009). In the hippocampal CA1 area the highest expression of 
kainate receptors is in pre-synaptic CA3 nerve terminals and on GABAergic 
interneurones (Jane et al. 2009). Due to their poorly understood role in synaptic 
plasticity and limited evidence for their involvement in drug addiction they are not 
discussed further. AMPA receptors are hetero or homotetrameric assemblies of 
highly homologous sub-units named GluR1-4 (Anggono and Huganir, 2012). The 
trafficking of AMPA receptors is highly dynamic and regulated by sub-unit specific 
interacting proteins as well as post-translational modifications to the c-terminal 
domain. NMDA receptors are heterotetrameric assemblies of diverse sub-units 
named NR1-3. While historically seen as a less dynamic population of receptors 
(Wenthold et al. 2003), it is now apparent that NMDA receptor function and 
trafficking is also dynamically regulated (for a review see Hunt and Castillo, 2012).  
The generation of an action potential is dependent on the depolarisation of the 
membrane around an area called the axon hillock. Therefore the depolarisation at 
the post-synaptic membrane must spread up the dendrite and through the soma to 
reach this area. In fact the probability of a single synaptic event triggering an 
action potential in the post synaptic membrane is actually very small, and many 
synaptic events must occur in quick succession if the depolarisation is to reach the 
axon hillock. As mentioned earlier, synaptic transmission can result in either an 
excitatory depolarisation or inhibitory hyperpolarisation and it is therefore the sum 
of these events that can increase or decrease the chances of the action potential 
being transmitted - for this reason this process is called summation (Piskorowski 
and Chevaleyre, 2012). As well as depolarising and hyperpolarising influences, 
pre-synaptic activity can control action potential transmission from second to 
second  through second messenger systems. These can have effects on the 
ligand-gated ion channels as well as voltage-gated channels (Betke et al. 2012). It 
is worth noting that these excitatory and inhibitory currents do not summate in a 
linear fashion. Voltage-gated conductances on the dendritic membrane are more 
likely to be triggered by local summation of EPSCs than by EPSCs occurring 
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distally from one another. The action of inhibitory IPSCs is also dependent on 
location. IPSCs not only hyperpolarise the membrane but also decrease the 
membrane resistance. IPSCs can therefore shunt generated EPSCs out of the 
dendrites preventing the spread of depolarisation reaching the soma from where 
action potentials are generated (Stuart et al. 1997). 
Longer-term modifications to synaptic efficacy also occur via a plethora of 
mechanisms, and are referred to collectively as synaptic plasticity. These changes 
can last from seconds to months and possibly longer in vivo (Abraham, 2003) and 
are the focus of the following section.  
1.7  Mechanisms of synaptic plasticity in CA1 
Synaptic plasticity describes the process by which the efficiency of signal 
transduction between pre- and post-synaptic cells is either increased or 
decreased. The term, first coined by Konorski (1948) has long been postulated as 
a cellular basis for information storage. The first complete theory of how synaptic 
plasticity could be utilised by the brain to store information was presented by Hebb 
(1949). In his theory, coincident activation of the pre- and postsynaptic neurone led 
to the connection between these two neurones being strengthened. The startling 
similarities between his model and the type of long-term synaptic plasticity 
discovered nearly 25 years later (Bliss and Lomo, 1973), has led to the coining of 
term Hebbian-synaptic plasticity. Hebbian, as well as some other forms of synaptic 
plasticity, are now thought by many to be a cellular correlate of memory (Bliss and 
Collingridge, 1993). The study of synaptic plasticity has become such a large field 
in the intervening 40 years that a comprehensive review of the literature is beyond 
the scope of any single work. Given that the majority of investigations into synaptic 
plasticity have taken place in the hippocampal CA1-CA3 synapse, and that this is 
also the target of the current investigation, only those studies involving CA3-CA1 
are mentioned here. Changes in synaptic transmission that result from specific 
patterns of stimulation have been studied now for 40 years, but despite this 
several fundamental questions regarding the nature of this change remain 
unanswered. One such debate revolves around the locus of the change, it being 
either pre- or postsynaptic. Evidence in favour of both arguments is presented 
here.  
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1.7.1  NMDAR-LTP 
The CA3-CA1 synapse is a glutamatergic synapse expressing two major types of 
ionotropic receptor, AMPAR and NMDAR. The process begins with activity in the 
presynaptic terminal causing the release of glutamate. The ligand bound AMPAR 
in its open state is permeable to cations (mostly sodium and potassium) and so the 
net result is a flow of sodium ions into the cell. The ligand bound NMDAR is 
blocked in a voltage-dependent manner by extracellular magnesium ions and so at 
the resting membrane potential no current flows through these. If the postsynaptic 
membrane becomes depolarised enough then the magnesium block is relieved 
and current flows through the ligand bound NMDAR. The NMDAR is also a non-
specific cation channel but it has a much higher permeability to calcium, and so 
the intracellular concentration of calcium then rises. This calcium signal may 
induce a series of complex and sometimes parallel signalling cascades that 
ultimately result in an increase (or sometimes a decrease) in synaptic efficacy 
(Lisman and Raghavachari, 2006). Initially these signalling cascades are 
dependent on the activity of various kinases (probably most significantly CaMKII) 
but then over a period of hours the mechanism also becomes dependent on 
protein synthesis. NMDAR-LTP can therefore be split into two major processes 
based on its pharmacological sensitivity. The long lasting form known as late-LTP 
(L-LTP) can be blocked by the use of protein synthesis inhibitors. CA1 neurones in 
hippocampal slices will revert back to baseline EPSC measurements in around 5 
to 6 hours under these conditions (Frey et al. 1988). Early-LTP (E-LTP) is sensitive 
to the inhibition of protein kinases and seems to maintain LTP up until L-LTP is 
apparent. Weak stimulations can sometimes produce E-LTP without inducing L-
LTP. No stimulus protocol has yet been found that induces L-LTP without inducing 
E-LTP first, although application of certain compounds can. It appears therefore 
that E-LTP is a prerequisite of L-LTP during activity dependent plasticity. One last 
important note is that E-LTP and L-LTP are not necessarily temporally distinct, in 
that the protein synthesis phase of L-LTP can occur immediately after the LTP 
inducing stimulus (Lisman and Raghavachari, 2006).   
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Induction Protocols  
There are a number of ways to induce long lasting changes in synaptic efficacy in 
an NMDAR-dependent manner, but it appears that not all of them do so by the 
same mechanism. With extracellular recordings there are two general categories 
of induction protocol, the high intensity methods and the theta-type methods. The 
high intensity methods vary from brief 400 Hz stimulation (Douglas and Goddard, 
1975) to extended periods of 1 Hz stimulation at a very high intensity in the 
presence of picrotoxin (Abraham et al. 1986). The most widely used of these 
methods is probably a train of 100 pulses delivered at 100 Hz. It is difficult to 
imagine an activity pattern of 100 Hz for 1 second occurring during the normal 
physiological function of the hippocampus, certainly no patterns of activity like this 
have ever been observed in healthy animals. Two of the more physiologically 
relevant protocols (the theta type methods) are known as primed burst stimulation 
(PBS) and theta burst stimulation. The common principle behind these methods is 
a gap of around 200 ms between stimulations. This idea is based on the 
observation that the first stimulation of the efferent fibre results in both the release 
of glutamate and GABA, GABAB auto-receptors on the GABAergic inter-neurones 
act to reduce transmitter release with a maximal effect at around 200ms post-
stimulation (Davies et al. 1991). The role of GABA receptors, both ionotropic 
(GABAA) and metabotropic (GABAB) has been well documented in CA1. The IPSC 
generated coincidently with the EPSC serves to shorten the amount of time the 
post-synaptic membrane remains depolarised. The effect of this is the decreased 
sensitivity to temporal summation as shown by the effects of GABAA inhibition 
(Dingledine et al. 1986). The second train of impulses arrives at this peak of GABA 
auto-inhibition. This protocol therefore makes use of the hippocampal theta 
generation mechanisms to increase the temporal summation of the presynaptic 
signal and can therefore be thought of as more physiologically relevant. The 
induction protocol used is relevant as different mechanisms may be activated by 
different patterns of activity. At the extreme end of this argument is the fact that 
certain activity patterns can depress instead of potentiate synaptic efficacy, but 
different mechanisms may also be responsible for NMDAR-LTP depending on 
stimulation protocol as will be shown in the following sections.  
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Factors influencing the generation of the calcium signal 
The activation of the NMDAR and entry of calcium ions through its pore is the 
defining mechanism of NMDAR-LTP. The NMDA receptor displays a strong 
voltage-dependence due to pore-block by extracellular magnesium ions. These 
ions are driven away from the pore at depolarised membrane potentials, allowing 
the influx of both sodium and calcium into the neurone (Mayer et al. 1984; Nowak 
et al. 1984). As these channels are also ligand-gated, the conditions necessary for 
current to flow through the NMDA receptor are; a sufficiently depolarised post-
synaptic membrane, and the presence of glutamate in the synaptic cleft. Therefore 
the NMDAR requires coincident pre- and postsynaptic activity. Hebb's coincidence 
detector.  
As mentioned above, the NMDA receptor is unusual amongst the ligand-gated ion 
channels in that it is permeable to calcium. Since intracellular calcium is required 
for the induction of NMDAR-LTP in the hippocampus (Lynch et al., 1983) it seems 
reasonable to assume that the entry of calcium through the NMDA receptor could 
be the trigger for LTP. There are other sources of intracellular calcium however. A 
second major source of intracellular calcium is from intracellular stores, through 
the actions of IP3 on IP3 receptors, or through calcium-induced calcium release 
mediated by ryanodine receptors. Depletion of these intracellular stores has been 
shown to inhibit NMDAR-LTP (Harvey and Collingridge, 1992) and augment the 
NMDA receptor dependent calcium signal in post-synaptic neurones after tetanic 
stimulation (Alford et al. 1993). The relevance of this alternative source of calcium 
in physiological changes in synaptic strength is unclear, however its dependence 
on NMDA receptor activation means that it does not detract from the critical role of 
the NMDA receptor. A third major source of intracellular calcium could be through 
depolarisation-induced activation of voltage-gated calcium channels. If entry of 
calcium through these voltage-gated channels was an alternative method of 
induction of LTP, then depolarisation (through voltage-clamp) in the absence of 
pre-synaptic activity would be expected to induce widespread LTP across many 
synapses independent of pre-synaptic activation. It appears that stable LTP can 
only be produced when protein-phosphatases are also introduced into the 
intracellular medium, suggesting that under physiological conditions voltage-gated 
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calcium entry does not play a significant role in the induction of LTP (Wyllie and 
Nicoll, 1994).  
The role of metabotropic glutamate receptors (mGluRs) in the induction of 
NMDAR-LTP is complex and incompletely understood. Group I mGluRs are 
expressed post-synaptically and couple to Gq proteins that activate phospholipase 
C (PLC). PLC activity produces IP3 that can act to release intracellular calcium, 
therefore mGluR activation targets a mechanism common to NMDAR-LTP. The 
activation of mGluRs during NMDAR-LTP has been reported to be a requirement 
for the induction of LTP (Bashir et al. 1993). In other studies however the same 
antagonist (MCPG) appears to have no effect (Manzoni et al. 1994; Martin and 
Morris, 1997). These conflicts can be reconciled by the finding that activation of 
mGluRs can occur minutes before the LTP induction protocol rendering NMDAR-
LTP independent of mGluR activation (Bortolotto et al. 1994). One study found that 
activation of mGluRs alone (with ACPD) was sufficient to trigger NMDAR-LTP 
independent of pre-synaptic stimulation or NMDAR activation (Bortolotto and 
Collingridge, 1993). There have also been reports that the selective mGluR 
agonist DHPG can induce a form of synaptic depression (Naie and Manahan-
Vaughan, 2005; Palmer et al. 1997). So while NMDAR-LTP may be dependent on 
mGluR activation, pharmacological activation of mGluR can result in LTP or LTD 
depending on the experimental conditions. These findings may be reconciled by 
the observation that pairing weak pre- and post-synaptic activity with application of 
DHPG can switch the depression into a potentiation (Kwag and Paulson, 2012). 
Therefore mGluR activation could result in a weak calcium signal that under the 
correct conditions could produce LTD, whereas the small additional rises in 
intracellular calcium as a result of weak stimulation could be sufficient to induce 
LTP. The role of mGluR activation in NMDAR-LTP therefore is complex and may 
depend on the history of activation at that particular synapse as well as the 
strength of the presynaptic signal.  
Induction involves the activation of multiple kinases 
The postsynaptic intracellular signalling cascade that follows LTP induction is 
extremely complex with numerous kinases implicated in both early and late LTP. 
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This section will briefly review the evidence for the role of CaMKII, PKA, PKC, 
MAPK, tyrosine kinase and IP3K in both early and late LTP.  
Perhaps of all the kinases involved, CaMKII could be seen as playing a central 
role. CaMKII is a large holoenzyme made from twelve homo- or heteromeric 
subunits. There are two major forms of the subunit, α and β. One calmodulin 
molecule can bind each subunit in a cooperative manner, this binding removes the 
regulatory domain from the kinase domain and activates the enzyme. A relatively 
slow process of autophosphorylation also occurs between adjacent calmodulin 
bound subunits, this process greatly increases the association between CaMKII 
and calmodulin and converts the enzyme into an autonomous state. This 
autonomous state allows CaMKII activity to persist long after the calcium signal 
has been removed (Lisman et al. 2012). If a constitutively active form of CaMKII is 
introduced into CA1 neurones then an LTP-like effect is observed, and this effect 
occludes further synaptically induced LTP (Lledo et al. 1995; Pi et al. 2010). If the 
autophosphorylation site in CaMKIIα (the major subunit found in the dendrites) is 
mutated to prevent the enzyme entering its autonomous state, then the induction 
of LTP through stimulation is prevented (Giese et al. 1998). While the central role 
of CaMKII is well accepted, other CaMKII independent forms of NDMAR-LTP can 
occur, such as early in development when cAMP-dependent kinase appears to 
play the central role (Yasuda et al. 2003). Taken together, these results suggest 
that CaMKII activation is both necessary and sufficient for the induction of at least 
some forms of LTP.  
The role of cAMP-dependent kinase (PKA) is much less clear. Studies find varying 
results of PKA inhibition ranging from complete inhibition of L-LTP while sparing E-
LTP (Matthies and Reymann, 1993; Huang and Kandel, 1994; Duffy and Nguyen, 
2003), to no effect (Bortolotto and Collingridge, 2000). One study (Huang and 
Kandel, 1994) found that while some stimulation patterns resulted in PKA 
insensitive E-LTP, other stronger patterns of stimulation resulted in L-LTP that was 
dependent on PKA activation. Consistent with a role for PKA in L-LTP is the 
observation of a steadily increasing EPSP following PKA activation that occludes 
further NMDAR-LTP induction (Duffy and Nguyen, 2003). Interestingly, there 
appears to be significant strain differences among mice in the ability of PKA to 
influence L-LTP (Nguyen et al. 2000). Reviewing these studies leads to the 
60 
conclusion that PKA has varying importance in LTP induction, ranging from a 
critical role in L-LTP to apparently having no effect. This may be dependent on 
both the strain as well as the age of the animal.  
Perhaps the first kinase to be identified as playing a role in LTP was PKC 
(Lovinger et al. 1987). There are a number of PKC isoforms that can broadly be 
split into the conventional, novel and atypical forms (cPKC, nPKC and aPKC 
respectively). The activation of cPKC requires DAG and intracellular calcium ions, 
whereas nPKC can be activated independently of calcium ions. aPKCs are 
independent of both DAG and calcium (Sacktor, 2008). Therefore PKC could be 
expected to be activated by mGluR stimulation alone or through co-activation of 
NMDA and mGluR. In some studies in fact, PKC inhibition can abolish the effects 
of mGluR activation on synaptic plasticity (Bortolotto and Collingridge, 2000). In 
other studies, normal LTP is abolished in mutant mice lacking the cPKC isoform 
PKCγ. LTP can be restored in these mice if a low frequency LTD inducing protocol 
is given prior to the LTP induction, although this effect is not dependent on the 
induction of LTD (Abeliovich et al. 1993). These results are consistent with a role 
for PKC in mediating mGluR modulation of LTP. PKC has also been shown to 
induce LTP independent of any stimulation protocol when activated by phorbol 
esters, although non-specific effects on vesicle release may account for this effect 
(Kazanietz et al. 2000). There is also evidence that PKC phosphorylation of GluR1 
may control synaptic insertion of AMPARs during LTP (Boehm et al. 2006). To 
summarise these results, PKC appears to be intimately involved with many 
aspects of synaptic plasticity although further work is needed to clarify its precise 
role.  
The MAP kinase signalling cascade has also been implicated in LTP, but only 
under some stimulation protocols (Opazo et al. 2003). This finding suggests that 
the role of MAPK may be regulatory rather than directly modulating a critical 
induction mechanism. MAP kinases are part of a long signalling cascade that is 
responsible for signal transduction to the nucleus and can be regulated by both 
PKA and PKC. It would therefore be expected that the target of MAP kinases 
would be part of the L-LTP mechanism, however effects on AMPAR trafficking and 
potassium channel regulation have also been observed (for a review see Sweatt, 
2004). Another regulator of the MAP kinase cascade is PI3 kinase. PI3K has also 
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been implicated in the induction of LTP through effects on MAP kinase but also 
through more direct mechanisms (Opazo et al. 2003). 
Lastly, the non-receptor tyrosine kinases fyn and src have been shown to be 
involved NMDAR-LTP. Knockout mice are incapable of expressing LTP (O’Dell et 
al. 1991) at least under some induction protocols in mature animals (Kojima et al. 
1997). The role of these src-family tyrosine kinases could be modulation of the 
NMDAR (Li et al. 2011).   
To summarise, it appears that the activation of CaMKII plays a central role in the 
induction of NMDAR-LTP. A multitude of other kinases regulate this central 
mechanism, and some also take part in parallel signalling cascades that under 
certain conditions can induce LTP independent of CaMKII. The large amount of 
modulation and interaction between these various signalling mechanisms that 
ultimately result in the same outcome suggests that intracellular kinase cascades 
may play a role in the further integration of information. If this where true then 
accurate neural network simulations would have to take this into account, adding a 
great deal of complexity to an already complex field.  
E-LTP expression mechanisms  
There are three obvious mechanisms by which NMDAR-LTP could be expressed. 
Firstly, the amount of neurotransmitter released per presynaptic impulse could 
increase. This would obviously involve changes in the presynaptic cell such as 
changes in release probability and/or quantal size. The second way involves the 
postsynaptic cell becoming more sensitive to the neurotransmitter released by the 
presynaptic neurone. This could involve changes in the density of AMPARs in the 
postsynaptic membrane and/or alterations in the function of AMPARs. The later 
possibility is through the creation of more synapses through either pre- or 
postsynaptic mechanisms (or both). The locus of expression of NMDAR-LTP was 
the focus of intense debate for over a decade around the 1990s, and the 
arguments suffered somewhat from polarisation. While a wealth of data supports 
the view that post-synaptic changes do in fact occur, there is more limited 
evidence for changes in pre-synaptic function (Malenka and Bear, 2004). The 
amount of available evidence for a mechanism however is not correlative of the 
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relative importance of that mechanism. For instance, there are significantly greater 
technical challenges in the measurement of presynaptic changes that could be 
partly responsible for this imbalance, also the highly polarised debate has led to 
review articles selectively referencing in favour of a particular stance. The view 
taken here is one that assumes that both pre- and postsynaptic changes could 
occur, as there is evidence supporting both ideas. These mechanisms are not 
necessarily mutually exclusive.  
As mentioned above, changes in the postsynaptic cell would be expected to result 
in an increased sensitivity to neurotransmitter. Indeed this seems to be the case, 
as exogenously applied AMPA has a significantly greater effect after the induction 
of stimulus-induced LTP (Davies et al. 1989). The increased response to a crudely 
applied ligand depends on not only synaptic but also extrasynaptic receptors, and 
so it is possible that this result could be of little relevance to synaptic transmission. 
In an attempt to address this problem, Matsuzaki et al. (2004) used photolysis of 
caged glutamate to measure the responsiveness of single dendritic spines. After 
an induction protocol that involved repetitive stimulation of a dendritic spine paired 
with a solution lacking magnesium ions, an LTP-like process caused an increase in 
the AMPAR-mediated current (Matsuzaki et al. 2004). As already mentioned, there 
are two proposed mechanisms for this increased sensitivity during NMDAR-LTP; 
an increase in the amount of current conducted by individual AMPA receptors (the 
conductance) through post-translational modification or changes in the 
stoichiometry of AMPARs and/or an increase in the number of functional synaptic 
AMPA receptors through modifications in trafficking, or changes in the conduction 
of EPSPs from the dendrites to the soma.  
There have been a number of reports suggesting that post-translational 
modification of AMPARs does occur during NMDA-LTP. Alterations in the amount 
of current conducted by a single AMPAR are dependent on a number of factors 
including; the open probability of the channel in its ligand bound state (PO), the 
activation/deactivation kinetics and the single channel conductance. There are 
limited reports of changes in receptor kinetics in CA1 (Kolta et al. 1998) although 
there are conflicting reports (Rammes et al. 1999). A significant difference between 
these reports is the method of induction - whereas Rammes et al. (1999) used the 
100Hz method, the other study (Kolta et al. 1998) used theta type stimulation. As 
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already mentioned the AMPA receptor contains numerous sites for phosphorylation 
by various kinases, many of which have been implicated in NMDAR-LTP. 
Regulation of both trafficking and function by phosphorylation is a common 
mechanism among neuronal ion channels, and the AMPA receptor appears to be 
no different. Both PKC and CaMKII may phosphorylate GluR1 S831, and S845 
can be phosphorylated by PKA to increase PO (Roche et al. 1996; Kristensen et al. 
2011). These phosphorylation sites appear to be a requirement of stable LTP, as in 
double mutant mice lacking phosphorylation at either of these residues LTP is 
augmented (Lee et al. 2003; Lee et al. 2010).  
There has been considerably more interest in the role that an increase in receptor 
number plays in NMDAR-LTP and for the most part the expression mechanisms 
are reasonably well defined. AMPA receptors are quickly recycled at peri-synaptic 
sites under normal conditions, through the classical pathways of SNARE-mediated 
exocytosis and dynamin/clathrin mediated endocytosis. In fact, inhibiting 
endocytosis leads to a gradual increase in the stimulated EPSC amplitude 
(Lüscher et al. 1999). The trafficking (and function) of AMPA receptors in the post 
synaptic density is tightly controlled by a group of proteins known as 
transmembrane AMPA receptor regulatory proteins (TARPs). One such TARP, 
called stargazin has the ability modify the lateral diffusion of AMPARs by anchoring 
within the PSD and thus altar the number of receptors present at any one time 
(Bats et al. 2007). Stargazin is tightly bound to the AMPA receptor and contains a 
binding site for the synaptic scaffolding protein PSD-95, the affinity of which may 
be controlled by CaMKII or PKC phosphorylation (Tomita et al. 2005). There is also 
increasing acceptance that the NMDAR may be upregulated during NMDAR-LTP 
also (Peng et al. 2010, Hunt and Castillo, 2012).  
Evidence that a change in the stoichiometry of AMPARs may happen during 
NMDAR-LTP in the hippocampus is controversial. Under basal conditions in CA1 
neurones very few AMPARs lack the GluR2 subunit that prevents calcium from 
passing through the pore. GluR2 -lacking AMPARs display inward rectification due 
to endogenous polyamine block, an effect often used to test for the presence of 
these channels by the inclusion of spermine in the pipette solution. While there 
have been conflicting reports (Adesnik and Nicoll, 2007; Gray et al. 2007) the 
evidence is probably in favour of GluR2-lacking receptors being present after 
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induction of NMDAR-LTP (Plant et al. 2006; Moult et al. 2010; Guire et al. 2008, 
Rozov et al. 2012), at least under some conditions.  
Expression of post-synaptic NMDAR-E-LTP is therefore a result of numerous 
mechanisms that depend not only on the specific stimulation that induces it, but 
also on the developmental stage of the animal.  
L-LTP Expression/maintenance mechanisms 
Late-LTP is the phase of LTP sensitive to protein synthesis inhibition as already 
mentioned and also often involves morphological changes to the synapse. The 
depth of understanding of L-LTP is much less than for E-LTP, probably because of 
the long and stable recordings required to observe the mechanism (typically 
around 6-12 hours). Also, the fact that L-LTP is dependent on E-LTP means that 
elucidating the role of kinases that are involved in both E-LTP and L-LTP is 
challenging.  
Krug et al. (1984) were the first to demonstrate that protein synthesis inhibition 
could disrupt the late forms of LTP in vivo in the dentate gyrus. This effect also 
occurs in vitro in the CA1 area (Frey et al. 1988). This mechanism is likely to 
involve both local protein synthesis within the dendrites as well as within the soma. 
Evidence in support of local dendritic protein synthesis comes from the finding that 
a form of L-LTP induced in isolated dendrites is sensitive to protein synthesis 
inhibitors (Frey et al. 1989) and that local apical dendritic application of protein 
synthesis inhibitors can selectively inhibit L-LTP in that region whilst basal dendritic 
synapses seemed unaffected (Bradshaw et al. 2003). In support of the idea that 
dendritic protein synthesis occurs is the rough endoplasmic reticulum observed in 
electron micrographs of dendritic spines, and the finding that there are ~400 
different mRNAs estimated to be in the dendrites of cultured pyramidal cells 
(Eberwine et al. 2001). As already mentioned however, local dendritic synthesis is 
unlikely to be wholly responsible for L-LTP. For LTP to display associativity 
(strengthening of a weak input when temporally paired with a spatially separated 
strong input) some form of signal must be passed from the strongly activated 
synapse to the weakly activated one. The only logical way for this to happen would 
be via the nucleus. In support of this idea is the observation that transcriptional 
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inhibitors can block L-LTP in vitro in CA1 (Nguyen et al. 1994), and immediate 
early genes such as zif268 and arc may be upregulated in response to LTP 
inducing stimulation (Roberts et al. 1996; Granado et al. 2008). Critical to the 
induction of LTP appears to be phosphorylation of the transcription factor CREB 
(cAMP response element binding protein). CREB may be phosphorylated (either 
directly or indirectly) by the actions of a variety of kinases including CaMKIV (a 
nuclear version of CaMKII), the MAPK cascade and PKA (Lonze and Ginty, 2002).  
The products of these genes, either mRNA or plasticity-related proteins must 
somehow be targeted back to the synapse where the L-LTP stimulus originated, 
although the mechanisms controlling this process are far from understood. Frey 
and Morris (1997) first proposed the so called 'synaptic tag' hypothesis. They used 
a weak LTP induction protocol capable of inducing E-LTP but not L-LTP, and a 
strong LTP induction protocol down a separate input that induced L-LTP. They then 
went on to demonstrate that the weak input could produce L-LTP if given shortly 
(less than 3 hours) before the strong input (Frey and Morris, 1997). They proposed 
that L-LTP inducing protocols caused a cell wide somatic signal that was somehow 
captured by synapses that had been 'tagged' by prior activity. CaMKII and PKA 
have both been implicated in this process (Barco et al. 2002; Redondo et al. 
2010). Somewhat surprisingly, the molecular identities of the plasticity related 
proteins that mediate the increased synaptic efficacy are still largely undefined. As 
mentioned earlier the locus of the persistent expression is still the source of much 
debate, so perhaps it is unsurprising we know little about the mediators. PKMζ (an 
atypical form of PKC, lacking any of its regulatory domains) has been 
contentiously implicated in the maintenance of increased AMPAR number. 
Expression of PKMζ appears to require de novo protein synthesis (Hernandez et 
al. 2003). Addition of PKMζ to the pipette solution results in an LTP-like 
mechanism involving the insertion of AMPARs, and a dominant negative form of 
PKMζ blocks the synaptic induction of LTP (Ling et al. 2002).Perhaps most 
interestingly of all, PCMζ inhibition may reverse previously induced LTP, 
suggesting that continued PKMζ activity may be required for its persistence 
(Madroñal et al. 2010). However, contrasting reports come from studies in 
knockout mice lacking PKMζ (Volk et al. 2013) and the specificity of PKMζ 
inhibitors has been questioned (Wu-Zhang et al. 2012).  
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Evidence for a presynaptic locus  
As already mentioned there is sufficient evidence for presynaptic adaptations 
occurring during NMDAR-LTP to warrant consideration. Zakharenko et al. (2001) 
first used the fluorescent dye FM1-43 to measure the rate of vesicle emptying 
before and after LTP induction. They found significant increases in loss of 
fluorescence, a measure of exocytosis (suggesting increased neurotransmitter 
release) after LTP induction using 200 Hz but not after LTP induction using 50 or 
100 Hz. This dependence on stimulation protocol has been seen by other 
researchers (Bayazitov et al. 2007) using different fluorescence methods but again 
directly measuring vesicle fusion. Another approach has been to use the low 
affinity competitive NMDAR antagonist L-AP5 (Choi et al. 2000; Choi et al. 2003). 
The cooperative binding of glutamate to the NMDAR renders it insensitive possible 
changes in the kinetics of glutamate release. This means that an NMDAR-EPSC 
generated from a slow gradual release of glutamate from the presynaptic 
membrane could look very similar to a NMDAR-EPSC generated by a fast release 
of the same amount of glutamate - associated with a much higher peak 
concentration. Adding extracellular L-AP5 allows the antagonist to compete with 
glutamate for NMDAR occupancy and thus resolves differences in peak glutamate 
concentrations in the synaptic cleft. Before LTP induction at some synapses, the 
addition of L-AP5 caused a significant reduction in the NMDAR-mediated EPSC. 
This effect was abolished by prior induction of NMDAR-LTP (Choi  et al. 2000). 
This result suggests that peak glutamate concentration in the synaptic cleft is 
raised, consistent with a modification in exocytosis from kiss and run to full fusion 
(Choi et al. 2003).  
NMDAR-LTP: Summary 
So far this section has only briefly reviewed some of the myriad of biochemical 
mechanisms implicated in NMDAR-LTP. No attempt has been made to 
comprehensively cover each topic or even address all of the current questions 
regarding models of NMDAR-LTP. NMDAR-LTP is just one kind of synaptic 
plasticity displayed within the CA3-CA1 synapse. In other synapses a whole 
different set of mechanisms may control changes in synaptic strength. Even within 
the hippocampus, at the dentate gyrus-CA3 synapse a completely different 
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NMDAR-independent mechanism of LTP is observed (Bortolotto et al. 2005). 
Hopefully this has given a flavour of the complexity underlying these changes in 
synaptic strength. For two very different proposed models of NMDAR-LTP (even 
using many of the same research papers as their supporting evidence) the reader 
is directed to Lüscher and Malenka (2012), and Lisman and Raghavachari (2006).  
Modulation by subcortical afferents 
The induction of NMDAR-LTP can be modulated by the actions of prior or 
coincident synaptic activity. An example of this has already been given in the form 
of mGluR modulation of NMDAR-LTP induction. The changes in the susceptibility 
of a synapse to undergo plasticity is referred to as metaplasticity. Specifically this 
section will deal with the modulation of NMDAR-LTP induction at the CA3-CA1 
synapse by the major modulatory inputs to this area.  
The largest modulatory input in CA1 is the cholinergic input from the medial septal 
nuclei. Leung et al. (2003) investigated the role of this cholinergic drive in vivo in 
both sleeping/immobile rats as well as in walking rats. As already discussed the 
hippocampal a-theta wave is driven by the cholinergic input from the septal nuclei 
during states of arousal. The authors found that induction of LTP was enhanced if 
induction during walking was performed compared to the LTP induced during the 
sleeping/immobile states. This effect was shown to be dependent on cholinergic 
activation (Leung et al. 2003). Gu and Yakel (2011) showed that small changes in 
the timing of the cholinergic input relative to the LTP-inducing stimulus resulted in 
widely varying effects ranging from LTP dependent on nicotinic receptors 
(cholinergic input stimulated 100ms prior to LTP induction) to LTP dependent on 
muscarinic receptors (cholinergic input stimulated 100ms after LTP induction).  
The role of noradrenergic input into CA1 from the locus coeruleus is less clear, 
although numerous studies have found effects on LTP. Both the α and β subtypes 
have been implicated in lowering the threshold for synaptic induction of LTP 
(Katsuki et al. 1997; Izumi and Zorumski, 1999). A mechanism has been proposed 
where β-adrenergic activation results in phosphorylation of the GluR1 AMPAR 
subunit at residues S845 (a PKA site) and S831 (a CaMKII/PKC site) (Hu et al. 
2007).  
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The role of the serotinergic input into CA1 has been much less studied compared 
to other inputs, but probably acts to inhibit LTP induction (Arias-Cavieres et al. 
2010; West et al. 2009) although one study found that 5-HT3 receptor antagonists 
facilitate LTP induction (Staubli and Xu, 1995). The inhibitory role for 5-HT is 
further supported by the finding that re-uptake inhibition by fluvoxamine also 
reduces LTP, possibly through actions on 5-HT1A  receptors (Kojima et al. 2003). 
The mechanism for these effects is largely unclear.  
There has been considerable interest into the role of the dopaminergic input on 
LTP in the CA1 area and the mechanisms are fairly well defined. Frey et al. (1990) 
first demonstrated that dopaminergic antagonists could prevent the induction of L-
LTP while leaving E-LTP unaffected. In support of this idea is the finding that D1 
receptor knockout mice display a lack of L-LTP (Matthies et al. 1997). Also, 
facilitation of PKA activity (the major downstream target of D1 receptors) by 
phosphodiesterase inhibitors can convert E-LTP into L-LTP (Navakkode et al. 
2004), and over activation of D1/D5 receptors can induce a protein synthesis 
dependent L-LTP-like process that occludes further L-LTP (Haung and Kandel, 
1995). Together this provides strong evidence that dopamine D1 receptor 
activation is necessary for L-LTP (Stramiello and Wagner, 2008).  
In summary, the above sections have described how NMDAR-LTP is a mechanism 
through which activity in pre- and post-synaptic neurones can cause changes in 
the efficacy of the connections between them. The intracellular complexity of this 
mechanism is bewildering, possibly suggesting an as yet unappreciated role in the 
integration and storage of information. Short term changes in synaptic strength 
can arise as a result of weaker inputs, whereas longer term changes require 
stronger inputs and protein synthesis. Phosphorylation of a variety of proteins by a 
variety of kinases control many of the steps in the mechanism. Modulation of 
NMDAR-LTP can result from subcortical activation of the relevant brain areas. Of 
particular relevance to this study is the control of L-LTP by dopaminergic 
innervation, presumably from the ventral tegmental area.  
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1.7.2  NMDAR-LTD/mGluR-LTD 
NMDA receptors also play a role in the reduction of synaptic efficacy, termed long-
term depression (LTD). LTD, when compared to its counterpart LTP, is relatively 
understudied. This may be in part due to the inconsistency often seen in the 
induction of LTD. In NMDA receptor-dependent LTD (NMDAR-LTD) the depression 
of synaptic strength is thought to be achieved mainly through the clathrin- and 
dynamin-dependent endocytosis of AMPA receptors (Lüscher and Malenka, 2012). 
One other major form of LTD can be observed at the CA3-CA1 synapse, mGluR-
dependent LTD (mGluR-LTD). Again as for NMDAR-LTP there is evidence for both 
pre- and post-synaptic locations of expression (Ashby et al. 2004; Stanton et al. 
2001). These mechanisms can be induced experimentally through slower 
frequency stimulation for longer periods compared to the experimental induction of 
NMDAR-LTP. NMDAR-LTD may still be dependent on depolarisation of the post-
synaptic membrane and the influx of calcium through NMDA receptors though, 
although the differing magnitude and kinetics of the resultant calcium signal may 
determine whether LTP or LTD is triggered (Abraham et al. 2001). This may be 
due to the LTD phosphatase cascade having a higher sensitivity to calcium than 
the αCaMKII subunit. This would lead to selective activation of the phosphatase 
cascade at lower calcium concentrations than the kinase cascade associated with 
NMDAR-LTP.  NMDAR-LTD is also thought to be inhibited during LTP induction by 
the PKA-dependent activation of an inhibitor of protein phosphatases (Blitzer et al. 
1998). The processes underlying NMDAR-LTD are almost certainly as complex as 
those underlying NMDAR-LTP. Modification in the phosphorylation state of AMPAR 
subunits, control of lateral diffusion by disruption of the bond between AMPARs 
and their PSD anchoring proteins, and reductions in transmitter release have all 
been suggested. Interestingly, NMDAR-LTD may also involve the reduction of 
NMDAR-mediated current as well as the AMPAR-mediated current. The expected 
effect of this reduced NMDAR-mediated current would be to reduce the 
susceptibility of the synapse to undergo any further synaptic plasticity, a further 
example of metaplasticity. mGluR-LTP appears to work by a very different 
mechanism but ultimately resulting in the removal of AMPARs from the 
postsynaptic membrane and possibly other mechanisms such as changes in 
transmitter release (Lüscher and Huber, 2010).  
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One important distinction to make here is the difference between the reversal of 
LTP (known as depotentiation) and LTD. The fact that these two mechanisms are 
distinct suggests a role for LTD in the integration and storage of information. 
Depotentiation is the reversal of a previously induced LTP, and is generally only 
effective shortly after LTP induction in vitro (Fujii et al. 1991). This mechanism may 
represent the failure of a memory trace to consolidate into a long lasting change 
(forgetting). LTD on the other hand appears to be independent of LTP and 
therefore represents a possible alternative method of information storage (the 
formation of new memories). 
As well as all the above mechanisms which are largely considered to be synapse-
specific, neurones can also globally alter the sensitivity of all their synapses. This 
is generally thought to be a homeostatic response to long term changes in 
neuronal activity rather than any sort of information storage that the previous 
mechanisms are assumed to mediate. The mechanism may involve the insertion 
or removal of AMPA receptors as well as changes in transmitter release. A key 
feature of this sort of homeostatic response is that the relative differences in 
synaptic strength are maintained during these adaptations, suggesting perhaps 
that no loss of information has occurred. The idea that synaptic plasticity is the 
brain’s method of information storage is a popular one, and the focus of the 
following section.  
1.8  Synaptic plasticity and memory  
One of the major assumptions of this and many thousands of other pieces of work 
published over the last half a century is that synaptic plasticity represents the 
encoding of experience to influence later behaviour (memory). As alluded to earlier 
many researchers believe that synaptic plasticity is a cellular correlate of memory. 
Perhaps far fewer researchers today would go as far as to say synaptic plasticity is 
both necessary and sufficient for memory. While the full debate surrounding the 
exact function of synaptic plasticity is beyond the scope of this work, this debate 
can briefly be put into context with regard to spatial memory and the hippocampus. 
Martin et al. (2000) defined a set of certain properties a proposed memory 
mechanism should have, these were; detectability, anterograde alteration, 
retrograde alteration and mimicry. Detectability infers that changes in synaptic 
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strength should be detectable following learning. Anterograde alteration suggests 
that augmenting or attenuating the changes in synaptic strength should enhance 
or inhibit learning and memory respectively. Retrograde alteration suggests that 
reversing the changes in synaptic strength should reverse the learning or memory 
and finally mimicry infers that memories should be able to be induced by the 
artificial induction of synaptic plasticity.  
Detectability may be present in CA1 following associative learning tasks. The most 
convincing evidence for this comes from Whitlock et al. (2006). The authors 
demonstrated that high-frequency stimulation induced LTP was occluded in rats 
after learning an inhibitory avoidance task. They also found a spatially restricted 
increase in fEPSP slopes after learning, and increased phosphorylation of GluR1 
S831.  
Anterograde alteration of synaptic plasticity by inhibition of NDMARs seems to 
prevent learning. Intra-hippocampal infusions of D-AP5 (a competitive NMDAR 
antagonist) have been shown to prevent one trial learning in a spatial task (Bast et 
al. 2005). Significantly, D-AP5 did not affect memory retrieval in this model, 
whereas CNQX (an AMPAR/kainate antagonist) did. Interfering with the function of 
downstream signalling molecules can also disrupt LTP and spatial learning. Giese 
et al. (1998) introduced a point mutation into the CaMKIIα subunit at threonine 
286, the residue that undergoes autophosphorylation to prolong the action of 
CaMKII. LTP induction was disrupted, as was spatial learning in a water maze. As 
mentioned earlier anterograde alteration also predicts that enhancing LTP 
induction would enhance memory formation. Positive allosteric modulators of 
AMPARs can enhance LTP induction and enhance learning. Staubli et al. (1994a) 
demonstrated first that positive allosteric modulators could enhance LTP induction 
in vivo before going on to show that these compounds enhance learning in a 
spatial task (Staubli et al. 1994b).  
Retrograde alteration of previously induced LTP is predicted to reverse any 
learning encoded by the plasticity affected. This was clearly demonstrated by the 
recent investigations into ZIP, a (possible) inhibitor of PKMζ. The contentious role 
of PKMζ has already been discussed, regardless of ZIPs specificity it does appear 
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to be able to reverse LTP and also abolish experience/hippocampus dependent 
behavioural plasticity (Serrano et al. 2008).  
Mimicry is the last of the Martin et al. (2000) properties and by far the hardest to 
show clearly. Unfortunately demonstration of this property is critical to demonstrate 
synaptic plasticity is sufficient for memory storage, all other properties discussed 
so far merely show that plasticity is necessary for memory storage. There does not 
appear to have been any true demonstrations of mimicry for any type of memory in 
any brain region. Perhaps mimicry is just too technically challenging to show 
currently, or perhaps there is yet another layer of complexity to information storage 
in the brain. 
1.9  Addictive substances evoke synaptic plasticity  
Many molecules already implicated in synaptic plasticity have been shown to also 
be involved in animal models of drug addiction. As already discussed the NMDA 
receptor has been shown to play a critical role in perhaps the most common form 
of synaptic plasticity, and NMDA receptor antagonists can prevent the 
development of drug seeking behaviour in several animal models (Kalivas and 
Alesdatter, 1993; Harris et al. 2004; Harris and Ashton-Jones, 2003; Karler et al. 
1989; Jeziorski et al. 1994; Kim et al. 1996; Tzschentke and Schmidt, 1995). By far 
the most studied locus for drug-evoked changes in synaptic transmission are the 
glutamatergic synapses on VTA dopamine neurones. However alterations at 
numerous other sites in nearly every brain region studied have been observed. 
The following discussion will just describe functional adaptations observed in VTA 
dopamine neurones as well as their major target sites; the nucleus accumbens, 
the prefrontal cortex, the hippocampus, and the amygdala.  
1.9.1  The ventral tegmental area 
As mentioned earlier exposure to most drugs of abuse as well as reward-related 
cues causes an increase in dopamine concentrations at VTA target sites (Schultz, 
1998). This increase in dopamine release may be caused by a switch of VTA 
dopamine neurones from tonic to phasic firing (Schultz, 2007). In fact the induction 
of phasic firing in VTA dopamine neurones can be used to induce CPP (Tsai et al. 
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2009). Firing patterns of VTA dopamine neurones are thought to be controlled by 
glutamatergic inputs (White, 1996), and NMDAR-LTP at these synapses may be 
required for the formation of cue-reward associations (Stuber et al. 2008).  
The first demonstration of drug-evoked changes in synaptic transmission was by 
Ungless et al. in 2001. The now widespread method of measuring synaptic 
'strength' was developed in this paper and involved comparison of AMPAR-
mediated currents with NMDAR-mediated currents to calculate an AMPA to NMDA 
ratio. Ungless et al. (2001) used this method to show that AMPA:NMDA was 
significantly increased for more than 5 but less than 10 days following a single 
non-contingent injection of cocaine. mEPSC frequency was also shown to be 
increased while mEPSC amplitude was unaffected, they therefore proposed that 
this increase was due to an increase in AMPA receptor number through a process 
dependent on NMDA receptor activation (NMDAR-LTP). A more recent study 
however (Mameli et al. 2011) suggests that along with this increase in AMPA, 
reductions in NMDA could also influence the measured increase in AMPA:NMDA. 
This increase in AMPA:NDMA has been shown for numerous addictive substances 
with diverse mechanisms of action such as morphine, nicotine and ethanol - 
although psychoactive drugs with minimal abuse potential such as fluoxetine and 
carbamazepine do not potentiate AMPA:NMDA (Saal et al. 2003). This increased 
AMPA:NMDA can persist for up to three months if the drug is self-administered 
(Chen et al. 2008) and can also be induced by cues previously associated with 
drug use (Stuber et al. 2008) and stress (Saal et al. 2003).  
The mechanism for this increase in AMPA:NMDA in the VTA appears to be 
dependent on not only the activation of NMDA receptors (Ungless et al. 2001) but 
also the activation of D1/D5 receptors (Schilström et al. 2006) and possibly orexin 
receptors also located on VTA dopamine neurones (Borgland et al. 2006). The 
expression of increased AMPA:NMDA appears to be due to both an increase in the 
AMPAR-EPSC (Ungless et al. 2001) mediated by insertion of GluR2-lacking AMPA 
receptors (Bellone and Lüscher, 2006; Mameli et al. 2007), as well as a reduction 
in NMDAR (Mameli et al. 2011). This reduced NMDA-mediated current along with 
an increased AMPA-mediated current that contains calcium (due to the presence 
of GluR2 lacking AMPARs) can have complex effects on the subsequent further 
induction of synaptic plasticity. Mameli et al. (2011) found that LTP induction was 
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prevented in depolarised post-synaptic cells, whereas in hyperpolarised cells LTP 
induction was possible in ex vivo cocaine treated slices (an example of anti-
Hebbian synaptic plasticity).  The reversal of this increased AMPA:NMDA seen 
after 10 days in animals injected with a single dose of drug may be mediated by a 
metabotropic glutamate receptor dependent process of depotentiation, as 
disruption of mGluR1 signalling can prolong the increased AMPA:NMDA (Mameli 
et al. 2009). In fact, activation of mGluR1 directly can reverse this increase in 
AMPA:NMDA by the replacement of GluR2-lacking receptors with GluR2 
containing ones (Bellone and Lüscher, 2005; Bellone and Lüscher, 2006).  
Given the central role often given to NMDAR-LTP in VTA dopamine neurones 
during reward-related learning it is surprising that NR1 knock-out mice that lack 
NMDAR-LTP in dopamine neurones still show behavioural sensitisation and CPP 
(Engblom et al. 2008, although see Harris et al. 2004 for a conflicting report). This 
data, along with other knock-out models has led to the suggestion that 
strengthening of VTA synapses may not contribute to long or short term 
behavioural modifications, but be responsible for the initiation of long-term 
neuroadaptations that control the persistence of drug seeking behaviour (Van de 
Oever et al. 2012). The origins of the glutamatergic innervation in to the VTA that is 
potentiated in response to addictive substances remains to be identified and 
warrants further investigation.   
A much less understood adaptation within the VTA also occurs at inhibitory 
GABAergic synapses. Morphine has been shown to prevent the induction of LTP in 
GABAergic synapses (Nugent et al. 2007) with similar effects seen after 
administration of nicotine or cocaine  (Niehaus et al. 2010) and ethanol (Guan and 
Ye, 2010). Down regulation of GABAA receptors has also been observed following 
chronic administration of cocaine (Liu et al. 2005). The role of VTA GABA is much 
less understood, with the VTA receiving GABAergic projections from nucleus 
accumbens as well as the rostromedial tegmental nucleus; GABAergic 
interneurones may also be affected. Currently the behavioural consequences of 
these adaptations in GABAergic transmission are unclear. 
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1.9.2  The nucleus accumbens 
The nucleus accumbens is the major target of VTA dopamine neurones as well as 
receiving numerous glutamatergic projections from other mesocorticolimbic system 
components such as the prefrontal cortex, hippocampus, and amygdala.  
In the nucleus accumbens the effects of addictive substances are much more 
complex, likely in part due to the fact that the nucleus accumbens is really a set of 
functionally distinct neurones occupying the same physical space. Non-contingent 
administration of cocaine for 5 days was sufficient to reduce ex vivo 
measurements of AMPA:NMDA (ie. LTD). During abstinence the AMPA:NMDA then 
increases (Kourrich et al. 2007) and is reduced following a challenge dose 
(Thomas et al. 2001). This pattern of reduction of AMPA-mediated transmission 
gradually turning into potentiation is supported by biochemical expression studies 
(Boudreau et al. 2007). Prolonged self-administration of cocaine has also been 
shown to reduce excitatory transmission in the nucleus accumbens shell 
(Schramm-Sapyta et al. 2006) with a concurrent reduction in experimentally-
induced LTD (Martin et al. 2006). This reduction in experimentally induced LTD 
was observed only in animals self-administering cocaine, not those receiving 
cocaine in a yoked manner or self-administering food. This suggests that unique 
synaptic adaptations may be correlated with drug experience-dependent 
behavioural adaptations (Martin et al. 2006). As in the VTA, evidence for changes 
in the stoichiometry of AMPA receptors also exists, although interestingly this 
change (insertion of GluR2 lacking receptors) may only occur after prolonged 
withdrawal (Conrad et al. 2008), a period known to be associated with increased 
drug seeking behaviours (Grimm et al. 2001). The precise regulation of AMPAR 
expression in the nucleus accumbens following exposure to addictive substances 
is yet to be elucidated, however there is mounting evidence in support of a role for 
extracellular-signal regulated kinase (ERK). Phosphorylation of ERK during LTP 
can increase the insertion of AMPARs (Zou et al. 2002); and ERK phosphorylation 
is increased following withdrawal, something that is reversed following a challenge 
dose (Boudreau et al. 2007). In further support of a vital role of ERK 
phosphorylation in drug seeking behaviour is the observation that ERK 
phosphorylation inhibition prevents the expression of CPP (Gerdjikov et al. 2004; 
Miller and Marshall 2005).  
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As alluded to earlier, significant differences exist between changes induced by 
non-contingent administration and self-administration. In fact differences exist 
between animals self-administering cocaine. Experimentally-induced LTD is 
attenuated following withdrawal from self-administration (Martin et al. 2006) and 
both LTD and LTP are impaired during protracted withdrawal (Martin et al. 2006; 
Moussawi et al. 2009). Kasanetz et al. (2010) found that this impaired LTD only 
occurs in animals showing behavioural signs of compulsive drug use, whereas in 
animals that maintained a steady rate of drug intake this effect was absent. 
Changes in stoichiometry may also be dependent on the route of administration, 
Lu et al. (2003) found increases in the expression of GluR1 and GluR2 following 
non-contingent administration of cocaine. Self-administering animals only show 
increases in the expression of GluR1 following withdrawal (Conrad et al. 2008; Lu 
et al. 2003). In the nucleus accumbens core (a sub-region of the nucleus 
accumbens) there is evidence that extracellular glutamate levels may be reduced 
following both non-contingent and contingent administration (Baker et al. 2003; 
Miguens et al. 2008). This reduced extracellular glutamate can increase release 
probability through reduced activation of mGluRs (Moran et al. 2005; Moussawi et 
al. 2011) and may be responsible for the reduced LTP/LTD seen after withdrawal 
(Moussawi et al. 2009).  
Interestingly, there is evidence that a sub-population (2-3%) of MSNs in the 
nucleus accumbens may be differentially affected after withdrawal from chronic 
cocaine administration. Using a fluorescent form of c-fos (a neuronal activity 
marker) Koya et al. (2012) showed that whilst the majority of neurones recorded 
from showed an increase in AMPA:NMDA, selectively recording from strongly 
activated neurones revealed a decreased AMPA:NMDA; most likely due to the 
formation of new synapses containing only NMDA receptors (so called 'silent' 
synapses). These strongly activated neurones may be both necessary and 
sufficient for certain drug-induced behaviours (Koya et al. 2009). The identification 
of this sub population of neurones mediating certain drug-induced behaviours 
supports the 'currant bun' hypothesis of memory storage in the brain.  
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1.9.3  The medial prefrontal cortex 
Evidence for changes in mPFC synaptic transmission is much less substantial 
than other brain regions, which is surprising given its often stated important role in 
the development of addictive behaviours. The mPFC receives a significant 
dopaminergic innervation from the VTA that is involved in the acquisition of self-
administration (Schenk et al. 1991; Weissenborn et al. 1997). The glutamatergic 
projection from the mPFC to the nucleus accumbens appears to be necessary for 
the reinstatement of drug-seeking behaviours (Kalivas et al. 2005; LaLumiere and 
Kavilas, 2008). There is evidence however, that cue-induced reinstatement of 
heroin seeking may cause a decrease in AMPA:NMDA through the internalisation 
of AMPA receptors (Van de Oever et al. 2008). This decrease in excitatory 
transmission may be further enhanced by an increase in GABA activity (Van de 
Oever et al. 2010). Therefore cue-induced relapse may be dependent on an acute 
decrease in mPFC control of nucleus accumbens activity. There is also evidence 
of increased NMDA receptor expression following protracted cocaine withdrawal 
(Ben-Shahar et al. 2009), and a facilitation of stimulus-induced LTP in acute 
cocaine withdrawal possibly due to reductions in GABA transmission (Lu et al. 
2010). Much further work is needed on this brain region if its role in drug seeking 
behaviour is to be better understood.  
1.9.4  The amygdala 
The amygdala complex is a group of structures with distinct connectivity and 
functions, of particular interest to addiction are the basolateral amygdala (BLA) 
and the central nucleus of the amygdala (CeA). The basolateral amygdala is 
heavily implicated in the formation of drug-cue associations and is also involved in 
cue-induced and stress-induced relapse (Buffalari and See, 2010; Fuchs and See, 
2002; Gabriele and See, 2010; Kruzich et al. 2001; McLaughlin and See, 2003). 
The CeA is thought to mediate the expression of drug seeking behaviours 
(Buffalari and See, 2010; Kruzich and See, 2001; Lu et al. 2005). Despite this 
wealth of evidence implicating the amygdala in drug seeking behaviour very few 
studies have been published on the functional changes occurring in response to 
addictive substances. Non-contingent administration of cocaine reduces stimulus-
induced LTP (Goussakov et al. 2006), an effect that may be longer lasting after 
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self-administration (Lu et al. 2005b). The BLA to CeA projection expresses 
enhanced CRF-induced LTP (CRF is a stress hormone) after prolonged withdrawal 
from non-contingent cocaine (Fu et al. 2007, Pollandt et al. 2006). CRF 
antagonism can also prevent stress induced relapse (Shaham et al. 1998).  
1.9.5  The hippocampus 
The functional effects of addictive substances in the hippocampus is another 
relatively neglected area, although recently there seems to have been a growing 
interest in the role the hippocampus plays in drug seeking behaviour. The 
hippocampus is functionally connected to the VTA through a variety of indirect 
pathways and also receives a direct dopaminergic input from the VTA (Gasbarri et 
al. 1994; Gasbarri et al. 1997). There is mounting evidence that this dopaminergic 
projection may play a vital role in controlling hippocampal synaptic plasticity. The 
ventral CA1 expresses dopamine D1/D5 receptors that couple to the activation of 
PKA. PKA has been shown to be required for the persistence of LTP in the 
hippocampus (Duffy and Nguyen, 2003). Dopamine release in the hippocampus 
appears to be responsible for the facilitation of experimentally-induced LTP 
induced by a novel environment in awake rats (Li et al. 2003). It follows then that if 
activation of the VTA by the pharmacological actions of an addictive substance 
was paired with a hippocampal dependent learning task, then this learning may be 
enhanced. Indeed rats that self-administer cocaine showed increased 
experimentally-induced LTP, and perform better in an unrelated Morris water maze 
task (Del Olmo et al. 2007), and D1/D5 receptor antagonism in the hippocampus 
can reduce place preference to morphine (Rezayof et al. 2003).  
Most studies investigating the hippocampus have employed fEPSP recordings; as 
this area with its ordered topography is particularly suited to this technique. In 
contrast to many of the studies investigating other brain regions mentioned above, 
morphine is often used instead of cocaine as the test drug. There is at present 
conflict regarding the effects of non-contingent morphine on hippocampal 
transmission. This may largely be due to the effects of tolerance and withdrawal, 
processes that are particularly relevant with respect to morphine. Another reason 
for this lack of clarity may be the over-use of fEPSP recordings in the absence of 
more powerful techniques such as whole cell patch clamp. fEPSP recordings often 
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yield inconclusive results and so without concurrent patch clamp techniques data 
are often left open to different interpretations.   
Most researchers find that there is a reduction in stimulus-induced LTP after non-
contingently administered morphine (Xia et al. 2011; Pu et al. 2002; Lu et al. 2010; 
Bao et al. 2007), although there are conflicting reports (Billa et al. 2010, 
Salmandazeh et al. 2003; Mansouri et al. 1999). A reduction in stimulus-induced 
LTP is indicative of either prior LTP occurring in vivo (indicating the drug augments 
LTP) or could be due to a reduction in metaplasticity (indicating that the drug 
attenuates LTP). To date only one lab appears to be investigating this dichotomy 
using higher resolution methods such as whole cell patch clamp. Billa et al. 
(2010a) found that AMPA:NMDA was increased following morphine treatment and 
that the AMPAR-mediated current had become inwardly rectifying. Using 
biochemical data to support their argument they concluded that prior LTP had 
occurred in vivo. They did not observe any change in stimulus-induced LTP 
however and so the mechanism underlying this reduction in LTP is still not clear. 
To add to the confusion the use of repeated injections of high doses of morphine 
during their study means that it is very difficult to separate the effects of prior 
morphine experience with the effects of withdrawal. Using cocaine as a test 
substance, Guan et al. (2009) found that chronic cocaine appeared to have no 
effect on stimulus-induced LTP but that withdrawal enhanced LTP by a 
corticotrophin-releasing factor-dependent mechanism. This supports the Billa et al. 
(2010a) observation that morphine administration may not affect LTP induction, 
although using the same paradigm as Billa et al. (2010a), Xia et al. (2011) found 
that LTP induction was impaired if morphine was administered in a novel context.  
Current literature is therefore inconclusive regarding the effects of addictive 
substances in the hippocampus, although it is clear that information processing in 
this region is affected. Given the relatively numerous papers published on the 
effects of addictive substances in the hippocampus it is surprising that there still 
exists such uncertainties surrounding even the most simple questions. These 
apparent contradictions between papers likely stem from the mixed effects of 
withdrawal, contextual drug-related learning, and the pharmacological actions of 
the drug. In order for our understanding to further progress it is necessary to 
isolate these effects so that adaptations correlated to addictive behaviors can be 
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identified. Also, as was seen in the nucleus accumbens (Koya et al. 2012) 
behaviors may be dependent on sub sets of neurones and these neurones may 
express differing responses to drug-associated learning. In order to address these 
issues two changes are needed to experimental design. The injection paradigms 
used for morphine need to be more carefully designed to control for the effects of 
tolerance and withdrawal, and higher resolution techniques need to be routinely 
employed. 
1.10  Actions of morphine in CA1. 
Morphine is an opiate that can be isolated as the main active ingredient of papaver 
somniferum. It acts on a class of GPCRs known as opioid receptors. There are 
three major types of opioid receptor, given the Greek letters µ, δ, and κ. Morphine 
has higher affinity and efficacy at the µ-subtype and the reinforcing actions of 
morphine in the VTA are thought to be dependent on µ receptors (Contarino et al. 
2002). µ receptors are expressed on the soma and presynaptic nerve terminals of 
GABAergic interneurones of the VTA. Activation of somatic µ receptors by 
morphine can hyperpolarise GABA neurones through actions on G-protein 
activated inwardly rectifying potassium channels (GIRKs), whereas the major 
effect at nerve terminals is thought to be inhibition of voltage-gated calcium 
channels and/or direct inhibition of the SNARE pathway (Yoon et al. 2007). This 
disinhibition of VTA dopamine neurones can increase the extracellular 
concentration of dopamine in all VTA target regions including the ventral portion of 
CA1.  
In the CA1 region of the hippocampus µ receptors are also expressed on the 
GABAergic interneurones and are known to decrease their rate of firing 
(presumably through activation of GIRK channels). Similar to the effect in the VTA, 
disinhibition of pyramidal cells is also observed (Pang and Rose, 1989). The 
effects of morphine in CA1 could therefore be the combined effect of increased 
dopamine and disinhibition of pyramidal neurones. Therefore the actions on 
hippocampal processing will undoubtedly be complex. One example of this 
complexity is the effect on the integration of inputs from CA3 and the entorhinal 
cortex. Prior activation of the perforant path from the entorhinal cortex can inhibit 
the EPSP induced by Schaffer collateral stimulation in a temporally restricted 
manner. This is thought to be due to GABAB activity (Dvorak-Carbone and 
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Schuman, 1999). Morphine administration can prevent this inhibition of CA3 input 
by the entorhinal cortex (McQuiston, 2011). The expected effect of this mechanism 
would be positive summation of those inputs that would normally counteract one 
another. Combined with the increased dopamine due to disinhibition of the VTA 
this could lead to plasticity and association of those normally contrary inputs. 
Morphine will also undoubtedly have other indirect effects on hippocampal function 
(above is just one example) due to its effects on other brain regions with either 
direct or indirect projections to CA1 such as the GABAergic projection from the 
septal nuclei. 
1.11  Hippocampal synaptic plasticity as a possible therapeutic target 
for the treatment of drug addiction 
As already discussed the hippocampus is a brain structure thought to be intimately 
involved in the processing of information regarding environments surrounding the 
animal (the context) and possibly many other mnemonic functions. The 
presentation of a drug-paired context has been shown to result in behavioural 
changes in response to the context, as well as gating the influence of discrete cue-
drug associations. These behavioural changes are dependent on the normal 
physiological functions of the hippocampus. Synaptic plasticity in the hippocampus 
(and many other regions) occurs in response to addictive substances and 
therefore the prevention or reversal of synaptic plasticity may prevent drug seeking 
behaviours.  
A possible therapeutic mechanism comes from studies concerning the 
'reconsolidation' of memories. In psychology, memories once formed undergo a 
consolidation process to convert from short-term to long-term memories. This 
consolidation process has startling similarities to early and late forms of LTP. 
Protein synthesis inhibition disrupts L-LTP and long-term memory while leaving E-
LTP and short-term memory intact. Protein synthesis inhibition only appears to be 
effective during a short period following learning so would be unsuitable for 
targeting long held memories such as those presumably present in drug addicts. 
Reactivation of these memories however may render them again susceptible to 
disruption (Morris et al. 2006).  
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Milekic et al. (2006) first trained rats to express CPP for morphine using similar 
methods to those described in the Methods section below. They then showed that 
1 week after CPP had been expressed in these rats, CPP could be persistently 
disrupted, or reversed, by injections of protein synthesis inhibitors. The success of 
this treatment depended on a conditioning trial (involving both the injection of the 
drug and exposure to the drug-paired context) immediately preceding protein 
synthesis inhibition. This effect was not seen if the animals were re-exposed to the 
drug-paired context or drug alone, and was dependent on protein synthesis 
inhibition in the amygdala, hippocampus and nucleus accumbens but not the VTA. 
This effect seemed very persistent, as it was both long lasting (more than 4 weeks) 
and resistant to drug-primed reinstatement (Milekic et al. 2006). These results 
have been replicated by numerous authors using a wide variety of inhibitors of 
NMDAR-LTP, for an up to date and comprehensive review on this field see Sorg 
(2012). The major advantage of this approach is that it would presumably be 
specific for the reactivated memory. Reactivation of such memories in humans 
however may be more problematic than in rodents, as the failure of exposure 
therapy demonstrated (previously discussed, Marissen et al. 2007). Whatever the 
potential these therapies hold in human addicts, these studies lend further support 
to idea that synaptic plasticity processes within the hippocampus are critical in 
initiating at least some forms of drug seeking behaviour.  
One other obvious method of retrograde alteration of drug related LTP in the 
hippocampus would be the disputed inhibitor of PKMζ, ZIP. There do not appear to 
be any studies specifically aimed at the effects of ZIP in the hippocampus following 
CPP or any other drug related learning task however. One of the obvious 
disadvantages of using ZIP compared to the disruption of reconsolidation would be 
that ZIPs action would be non-specific throughout the locus of injection and so 
potentially could have wide ranging effects on memory stored in that area. 
Further work is needed to identify specific functional changes in the hippocampus 
that are correlated with the formation of drug seeking behaviours and relapse. The 
identification of such changes should hopefully lead to novel approaches to 
treatment, or the development of more specific drugs to retroactively target these 
changes.   
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1.12  Rationale for Experimental Design 
In this Introduction, the idea that drug addiction arises from a substance’s ability to 
usurp the brain’s mechanism for learning and memory has been introduced. One 
of the greatest unmet needs in the treatment of drug addiction is the prevention of 
relapse. This process is fundamentally dependent on the brain’s identification of 
drug-predictive cues through associative learning processes. The hippocampus 
has been shown to be intimately involved in these processes. Particularly involved 
in spatial and contextual processing in rodents, the hippocampus also plays a 
more general role in other higher forms of memory and cognition (at least in 
humans, but probably in rodents too). The reason for this apparent divide could be 
as simple as the lack of appropriate models to study these forms of memory in 
rodents.   
Previous studies have demonstrated functional changes in hippocampal synaptic 
transmission after the administration of non-contingent morphine (eg. Billa et al. 
2010) however it is unclear what these changes mean on a functional level. It is 
possible that these changes simply occur as a result of the pharmacological action 
of morphine, or morphine withdrawal, and do not encode any specific information. 
In order to elucidate fully the role of hippocampal synaptic plasticity in encoding 
associative addiction-related memories, it is essential to study such changes 
following contingent administration of drugs of abuse. Therefore the aim of this 
study was to determine the nature of synaptic changes occurring as a result of the 
formation of context-drug associations. In order to do this, comparisons where 
made between the effects of morphine when administered contingently on 
presentation of a particular environment, or non-contingently. The aim of this 
paradigm was to induce behavioural adaptations of relevance to addiction that 
where dependent on associative learning processes.   
The conditioned place preference model was chosen as it was ideally suited to this 
aim. Relatively young mice could be trained to exhibit CPP, reducing the technical 
problems associated with whole cell patch clamp recordings in older mice. Another 
requirement of the model was that it should use the minimum dose possible to 
induce CPP, as the effects of withdrawal/dependence could mask any potentially 
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important changes. The CPP model again was suitable for inducing behavioural 
plasticity with relatively low doses of drug.  
A combination of fEPSP recordings and whole cell patch clamp was used. fEPSP 
experiments, while useful for studying the function of populations of neurones 
under more physiological conditions and technically easier provide less definitive 
results and so these where performed first. Whole cell patch clamp became 
necessary in order to further investigate the observed effects in fEPSP 
experiments.  
1.13 Aims of the project 
To induce addiction relevant behaviours in mice that are dependent on 
associative learning processes. This was achieved by demonstrating CPP to 
morphine. 
To identify the modifications in synaptic transmission that occur specifically 
in response to the induction of these behavioural changes. This was achieved 
by using a range of electrophysiological studies in ex vivo brain slices, taken from 













2.1  Introduction 
This project utilised a combination of in vivo behavioural experiments and ex vivo 
electrophysiological experiments. The behavioural methods are described first, 
and then the electrophysiological methods. The contents of all the solutions used 
can be found in a section 2.5.  
2.2  Behavioural methods 
2.2.1  Animals used 
Male C57BL/6J mice were weaned at P21 and separated into cages containing 4 
animals per cage. The cages where then moved to a holding room adjacent to the 
room where behavioural experiments were to be performed. Mice were maintained 
on a 12 hour light/dark cycle (lights on at 6am) and were allowed access to food 
and water ad libitum. 
2.2.2  Handling/identification 
Mice were identified by means of an ear clip that was performed at the time of 
weaning. After being allowed to become accustomed to the holding room for 
between one and three days, the animals were handled twice per day (separate 
sessions approximately 30mins apart). Handling consisted of repeatedly picking 
the mouse up, stroking and 'scruffing' the mouse. This handling was performed on 
consecutive days for between 2 and 7 days, by the end of this period mice showed 
no visible signs of distress upon being handled. The day following the last day of 
handling the mice entered the behavioural experiment (see following section).  
2.2.3  Experimental protocol: conditioned place preference (biased)  
The apparatus was a three-chambered box, consisting of two 15cm x 30cm 
chambers (one with white walls, the other with black walls) separated by a middle 
compartment (15cm x 15cm) with yellow walls. The room containing the apparatus 
was illuminated using red light so as to reduce the natural aversion the mice may 
have had to the white chamber. Both the black and yellow chambers had a smooth 
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plastic floors whereas the white chamber had a stainless steel mesh floor. Each of 
the chambers was connected by small (4cm x 6cm) openings that where blocked 
during conditioning trials. All experiments were performed during the lights off 
period when the mice were expected to be most active. 
Day 1: Pre-test. Mice were placed into the middle (yellow) chamber of the 
apparatus with free access to all three compartments. The animals’ movements 
were recorded using an overhead camera for 15 minutes. Using this 
environmental configuration ensured that there was a significant inherent 
preference for the black walled (saline-paired) chamber during the day 1 pre-test. 
These experiments were performed in parallel so while each mouse had its own 
CPP apparatus, all mice from a particular cage (four mice per cage) were being 
tested in the same room at the same time.  
Day 2+3: Handling. Mice were handled twice per day for approximately 5 minutes 
during which the mice would be repeatedly picked up and 'scruffed'.  
Day 4-7: Conditioning. Mice were injected once per day with either saline or 
alternate injections of saline (10ml kg-1 i.p.) and morphine (10ml kg-1, 10mg kg-1 
i.p.) (the first injection day was always saline) before being confined to their 
assigned compartments for 30 minutes. During this time the subjects had no 
access to the small middle compartment. Each animal received either 4 saline 
injections over 4 days (SAL CPP) or 2 saline and 2 morphine injections over 4 
days (MOR CPP). It is worth emphasising that SAL CPP group had two injections 
of saline in the normally morphine paired black side of the apparatus (a kind of 
sham morphine injection). 
Day 8: Test. Mice were placed into the middle compartment with free access to 
both sides. The subjects’ movements were recorded by an overhead camera for 
15 minutes. Following the test phase animals were replaced in their home cage 
(for between 15mins and 4 days) before being taken in an insulated container to 
be anaesthetised prior to decapitation for the purpose of making brain slices.  
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2.2.4  Experimental protocol: conditioned place preference (unbiased) 
The method used for CPP induction was changed between making the fEPSP 
recordings (Chapter 3) and the whole-cell patch clamp recordings (Chapter 4). 
This was due to methodological issues discussed in further detail in the Appendix.  
The apparatus was a two-chambered box consisting of two equally sized 15cm x 
16cm chambers separated by a removable guillotine door (Ugo Basile, catalogue 
number 42503). One chamber had plain black walls, the other had stripy black and 
white walls and were further distinguished by different floor textures. Each 
conditioning apparatus was contained in a separate sound attenuation box (MED 
Associates, UK). Drug-paired chambers were pseudo-randomly selected but 
counterbalanced so an equal number of subjects were conditioned to each 
chamber. All experiments were performed during the lights off period when the 
mice were expected to be most active. 
Day 1: Pre-test. Mice were placed into a pseudo random side of the apparatus 
with free access to both compartments. The animals movements were recorded 
using an overhead camera for 30 minutes. Again, four experiments were run in 
parallel but this time the start date of each experiment was staggered (See Figure 
2.1). 
Day 2+3: Handling. Mice were handled twice per day for approximately 5 minutes 
during which the mice would be repeatedly picked up and 'scruffed'. 
Day 4-7: Conditioning. Mice were injected once per day with either saline or 
alternate injections of saline and morphine (just as in the previous CPP 
experiment. 10mg kg-1 i.p.) (the first injection day was always saline) before being 
confined to their assigned compartments for 30 minutes. Each animal received 
either 4 saline injections over 4 days (SAL CPP) or 2 saline and 2 morphine 
injections over 4 days (MOR CPP). 
Day 8: Test. Mice were placed into a pseudo-random side of the apparatus with 
free access to both sides, the animals’ movements were recorded by an overhead 
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camera for 30 minutes. Immediately following the test phase animals were placed 
in insulated container and taken to be anaesthetised prior to decapitation for the 
purpose of making brain slices.  
2.2.5  Experimental protocol: non-contingent administrations 
Non-contingent groups (both saline and morphine) had exactly the same handling 
and pre-experimental experiences as those animals undergoing conditioned place 
preference. Instead of the pre-test session (day 1) each subject was briefly picked 
up and replaced in the home cage. All animals received 4 daily injections (days 4-
7: either 4 saline or 2 saline + 2 morphine) but were placed directly into the home 
cage immediately following injections. On the final day (day 8) mice were placed 
directly into the insulated container for transport to the electrophysiology 
laboratory. 
2.2.6  Drugs used 
All morphine was purchased from MacFarlan Smith (Edinburgh, UK) and kept 
frozen in solution until immediately before use when it was thoroughly defrosted at 
room temperature. The morphine solution contained 1mg ml-1 morphine sulphate 
in 0.9% saline. All injections were given intraperitoneally at a dose volume of 10ml 
kg-1, giving a final dose of 10mg kg-1 (unless otherwise stated). 
0.9% Saline solution was purchased from national vet supplies Dechra (UK) and 
stored at 5ºC in sealed vials that where opened immediately before use. All 
injections were given intraperitoneally at a dose volume of 10ml kg-1. 
The movement of all animals was recorded using a video camera connected 
directly to a PC and analysed in real time using Noldus XT® software. The time 
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Figure 2.1 A table showing the handling and treatment performed on a cage 
of four mice undergoing conditioned place preference.  
Each column represents a day, each row a separate mouse in the same cage. 
Blue areas represent handling days , green areas represent test days and red 
areas represent conditioning days(Sal and Mor represent saline and morphine 
injections respectively). 
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2.3  Electrophysiology methods 
2.3.1  Brain slice preparation 
Mice were first anaesthetised using a solution of 160mg kg-1 ketamine and 20mg 
kg-1 xylazine and once under general anaesthesia were decapitated. The brain 
was immediately removed and placed in ice-cold cutting solution saturated with 
95% oxygen/5% carbon dioxide. Transverse brain slices containing the ventral 
hippocampus were cut at a setting of 275 or 350µm using a DTK-1000 vibratome 
(DSK). The cut slices were placed into an incubating chamber containing ACSF 
saturated with 95% oxygen/5% carbon dioxide at 30ºC and allowed to slowly cool 
to room temperature for 30min before being warmed back up to 31ºC for a further 
30min. In all electrophysiology experiments, no more than one cell per slice was 
recorded from. No more than two cells per animal was recorded from. 
2.3.2  Extracellular field recordings 
Brain slices cut at a setting of 350µm were transferred to a recording chamber 
where they were held at the interface of humidified 95% oxygen/5% carbon 
dioxide and aCSF saturated with 95% oxygen/5% carbon dioxide (continuously 
perfused at a flow rate of 1.5 – 2 ml min-1) at a temperature of 35°C. The position 
of the slice at the interface meant that the lower half of the slice was submerged in 
the aCSF with the upper surface exposed to humidified 95% oxygen/5% carbon 
dioxide.  
The hippocampus was identified by the morphology of the dentate gyrus and 
Ammon's horn and the CA1 area as the region furthest away from the dentate 
gyrus along the cell body layer. A teflon coated bipolar stimulating electrode (tip 
separation 150μm) was placed in the stratum radiatum on the CA3 side of the 
recording electrode. The recording electrode consisted of a pulled glass pipette 
with an electrical resistance of 3-6 MΩ and was filled with aCSF. The recording 
electrode was then placed on the striatum radiatum side of the CA1 pyramidal cell 
body layer (see Figure 2.2, next page).  
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The stimulation consisted of a square wave of 100µs duration at a frequency of 
0.05Hz and continued for the duration of the experiment. Stimuli were generated 
either using a MASTER-8 (A.M.P.I.) pulse generator or were computer-generated 
with WinEDR software (University of Strathclyde) via a constant-current stimulation 
isolation unit (DS2A, Digitimer).  
Evoked field EPSPs (fEPSPs) were amplified using an Axoclamp-2A amplifier 
(Axon Instruments), run through a 1 kHz low pass filter (NL 106, Digitimer) and 
50Hz noise eliminator (Hum Bug, Quest Scientific) before being digitized at a 
sampling rate of 10 kHz (CED Micro 1401 analogue-digital converter). All analysis 
was by WinEDR or WinWCP software (University of Strathclyde). The slope of the 
fEPSP was calculated by fitting a straight line between 20% and 80% of the 
maximum amplitude. A stimulation intensity that gave 50% of the maximum slope 
was first found and then this chosen stimulation intensity was unchanged for the 
remainder of the recording session.  
 
Figure 2.2 A schematic representation of the hippocampus showing the 
approximate location of the recording and stimulating electrodes during 
fEPSP recordings. 
Dashed line represents the cell bodies of the pyramidal cell layer. DG - dentate 
gyrus. 
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To induce stimulus-induced long-term potentiation (LTP), theta burst stimulation 
was applied. This consisted of 4 bursts with a 15 second inter-burst interval. Each 
burst (see Figure 2.3) consisted of 10 trains of 5 pulses at 100Hz with an inter-
train interval of 0.25 seconds. To induce stimulus-induced long-term depression 
(LTD), low frequency stimulation (LFS) was applied. This consisted of single 
pulses delivered at 2 Hz for 10 minutes (a total of 1200 pulses). To measure 
paired-pulse facilitation, twin pulses (50ms inter-pulse interval) were delivered at 
0.1Hz. 
 
Figure 2.3 A schematic representation of the theta burst protocol.  
Time is represented by the x-axis and vertical lines represent single square wave 
stimulations of 100µs duration. This diagram represents one of the four bursts 
used to induce LTP during the fEPSP recordings. 
fEPSPs were recorded for at least 20 minutes or until a stable baseline was 
recorded, prior to theta-burst or LFS stimulation. 6 consecutive fEPSP responses 
were averaged and the slope of fEPSPs measured. Data are presented as 
percentage of baseline, taking the final 5 measurements of pre-theta-burst or pre-
LFS stimulation as baseline responses. For paired-pulse data analysis, 10 
consecutive paired-pulse fEPSPs were recorded and averaged, the paired-pulse 
ratio was measured as the slope of the second fEPSP response as a function of 
the slope of the first fEPSP. A maximum of one recording per slice was taken. A 
maximum of two recordings per animal were performed.  
2.3.3  Whole-cell patch clamp electrophysiology 
A brain slice (cut at a setting of 275µm) was transferred to an Olympus BX51WI 
upright microscope and cells visualised using oblique optics. The recording 
chamber in the microscope was continuously perfused with ACSF saturated with 
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95% oxygen/5% carbon dioxide at a flow rate of 3ml min-1. The slice was 
submerged completely in ACSF at 31°C.  
The hippocampus was identified by the morphology of the dentate gyrus and 
Ammon's horn and the CA1 area as the region furthest away from the dentate 
gyrus along the cell body layer. Pyramidal cells were identified by their general cell 
morphology and their presence within the cell body layer of the CA1.  
For evoked responses, a Teflon coated bipolar stimulating electrode (tip separation 
150μm) was placed in the stratum radiatum on the CA3 side of the recording 
electrode. The stimulation consisted of a square wave of 150µs duration at a 
frequency of 0.1Hz. Stimuli were generated using WinEDR software via a 
constant-current stimulation isolation unit (DS2A, Digitimer).  For paired-pulse 
recordings, twin pulses (inter-pulse interval: 50 ms) were applied. 
The recording electrode consisted of a pulled glass pipette with an electrical 
resistance of 3-4 MΩ and filled with intracellular solution A or B. Evoked EPSCs 
were recorded using intracellular solution A, which contained fluoride ions to block 
GABAA receptors (Kay, 1992). Miniature EPSCs (mEPSCs) and miniature IPSCs 
(mIPSCs) were recorded using intracellular solution B, and 1 μM tetrodotoxin 
(Ascent Scientific) was continually present in the ACSF. To record mEPSCs, cells 
were voltage-clamped at -70mV (approximate Cl- reversal potential) To record 
mIPSCs, cells were voltage-clamped at 0mV (approximate reversal potential of 
AMPARs).  
Some cell somata were cleaned using a flow of ACSF from a broken pipette prior 
to attachment. Cells were voltage-clamped (apart from when stated, holding 
potential was -70mV). Data were amplified and filtered at 2 kHz (Axopatch 200A 
amplifier, Axon Instruments), passed through a 50Hz noise eliminator (Hum Bug, 
Quest Scientific) before being digitized at a sampling rate of 10 kHz (Digidata 1440 
A analogue/digital converter, Axon Instruments). All data were saved to computer 
using WinEDR software. The liquid junction potentials (~10mV) were calculated 
using Axon™ pCLAMP® software and compensated for during the experiments.  
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At the start of each recording, a measurement of series resistance was made 
following a 5mV, 50 ms voltage step. Whole-cell capacitance was also measured 
using the same 5mV, 50 ms voltage step generated by the Axopatch 200A 
amplifier. The whole cell capacitance and series resistance transients were 
compensated for manually using the controls on the amplifier. Any cell that showed 
a change in series resistance during the course of the recording of more than 25% 
was excluded from analysis. A stimulus-response curve was then generated to find 
the maximum response, and a stimulation value (constant current) that gave a 
response equal to ~75% of the maximum was used for the duration of the 
experiments. Any cell that had a maximum EPSC amplitude of less than 135pA 
was discarded.  
All recordings were stored on computer using WinEDR software and analysed 
either with WinEDR or WinWCP software (University of Strathclyde). Evoked 
EPSC amplitudes were measured by averaging 5 individual traces.  
Paired pulse ratios were calculated by dividing the peak current measurement of 
the second EPSC by the peak current measurement of the first EPSC (average of 
10 individual stimulations).  
AMPA:NMDA were calculated by dividing the peak current measurement at 5ms 
post-stimulation (at which time the current was shown to be predominantly AMPA-
mediated) by the current measurement at 50ms post-stimulation (at which time the 
current was shown to be predominantly NMDA-mediated). An average of 5 
individual stimulations was used for each measurement. AMPARs and NMDARs 
display very different channel kinetics as can be seen in Figure 2.4. Such a 
difference in kinetics means that a measure of the AMPA and NMDA components 
is possible through simply measuring the compound EPSC at the correct time 
points. These time points were selected using data obtained by adding 50µM D-
APV to the bathing solution for at least 5 minutes to block NMDAR mediated 
currents. The dashed lines in Figure A.16 show the two selected time points of 
7ms post stimulation and 55ms post stimulation. Using this approach to measuring 
AMPA:NMDA has the distinct advantage that both the AMPA and NMDA 
components are measured at exactly the same time. This is important as it means 
that the cell only has to be held at +40mV for short periods of time. This means 
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that any intracellular process triggered by such a strong, sustained depolarising 
signal will have a minimal effect (unlike the D-APV subtraction method, where data 
are reliant on no intrinsic changes to the recording taking place in the time during 
which D-APV treatment takes place – cells are held at +40mV for >10 minutes).. 
This approach also eliminates variation in the results due to changes in series 
resistance or recording stability when switching between -60mV and +40mV. On 
the other hand this approach has the disadvantage of not being able to separate 
the effects of changes in peak amplitude from changes in channel kinetics (such 
as would be predicted to happen due to changes in sub-unit composition).  




















Figure 2.4 Selection of time points for the measurement of AMPA:NMDA.  
A single experiment used in the calculation of time points for AMPA and NMDA 
measurements. Time zero in this graph is the time of stimulation. Dotted lines 
along the x-axis at 7 and 55 ms post stimulation represent the chosen times to 
measure AMPA and NMDA currents respectively. The black line (compound 
AMPAR/NMDAR-mediated current) is the recorded current at +40mV. The red line 
(AMPAR-mediated current) is the resulting current also at +40mV after 10 minutes 
in 50µM D-APV. The blue line (the NMDAR-mediated current) was calculated by 
subtraction of the red line from the black line. All recordings made in slices taken 
from naive C57BL/6J mice and stimulated to produce 50% of the maximum 
amplitude EPSC. 
Figure 2.4 shows a representative trace of 4 recordings used to derive the 
parameters from which time-points for AMPA and NMDA components of the EPSC 
were derived. This approach was therefore taken for all AMPA:NMDA 
measurements shown in Chapter 4 Figure 4.2.  
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Miniature EPSCs (mEPSCs) and miniature IPSCs (mIPSCs) were recorded by 
continuous recordings for at least 30 seconds. They were identified by their 
general waveform, a very fast rise time (approx 3ms) followed by a much slower 
exponential decay time (approx 10ms), and with an amplitude of at least 5pA. All 
mEPSC and mIPSC rise times were taken as time taken between 10% and 90% of 
event peak. Only those events that did not overlap with other events were 
recorded both for event amplitude and event rise time quantification. mEPSC 
decay times were measured as time taken for event to decay to 10% of peak 
response. Only those events where a 2nd event did not overlay onto the decay of 
the first were quantified. mIPSC were measured as time taken for event to decay 
to 50% of peak response. Only those events where a 2nd event did not overlay 
onto the decay of the first were quantified (time taken to decay to 10% was not 
feasible for mIPSCs for because of this, as the frequency of events was too high). 
Comparisons of mIPSCs and mEPSCs between groups were made by using 
Kolmogorov-Smirnov tests. Within each treatment group, the same number of 
events recorded from each neurone was pooled to avoid data being skewed 
towards neurones with the highest mEPSC or mIPSC frequencies.  
2.4  Drugs 
All drugs used were dissolved in either water or DMSO at 1000 times their 
required final concentration and frozen before storage. Before use all drugs were 
thoroughly thawed for at least one hour at room temperature before being diluted 
in ACSF to their required concentrations. CNQX and APV were purchased from 
Tocris, tetrodotoxin was purchased from Ascent Scientific and all other compounds 
and salts were purchased from Sigma-Aldrich 
2.5  Solutions 
Artificial Cerebrospinal Fluid (ACSF) 
125 mM  Sodium Chloride 
2.5 mM  Potassium Chloride 
1.2 mM Monosodium Phosphate 
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1.2 mM  Magnesium Chloride 
2.4 mM  Calcium Chloride 
21.4 mM  Sodium Bicarbonate 
11.1 mM  D-Glucose 
0.1 mM  Ascorbic Acid 
Cutting Solution  
19 mM  Sodium Chloride 
2.5 mM  Potassium Chloride 
1.2 mM  Monosodium Phosphate 
7 mM   Magnesium Chloride 
0.5 mM  Calcium Chloride 
15 mM  Sodium Bicarbonate 
6.2 mM  D-Glucose 
21 mM  Sucrose 
Intracellular Solution A 
63 mM  Caesium Fluoride  
56 mM  Caesium Methanesulphonate 
8.3 mM  Sodium Chloride 
8.4 mM  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
0.5 mM  Ethyline glycol tetraaceitic acid (EGTA) 
5 mM   N-(2,6-Dimethylphenylcarbamoylmethyl)triethylammonium  
  bromide (QX314) 
CsOH was then added to the solution until it reached a pH of 7.3.  
This gave a solution of osmolarity ~285 mOsM  
Intracellular Solution B 
120 mM  Caesium Methanesulphonate 
10 mM  Sodium Chloride 
2 mM   Magnesium Chloride 
10 mM  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
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0.5 mM  Ethyline glycol tetraaceitic acid (EGTA) 
5 mM   N-(2,6-Dimethylphenylcarbamoylmethyl)triethylammonium  
  bromide (QX314) 
2 mM   Mg-ATP 
0.25 mM  Na-GTP 
CsOH was then added to the solution until it reached a pH of 7.3.  





Chapter 3: Investigating the 
Effects of Morphine and 
Morphine-induced Place 
Preference on the Functioning of 
Hippocampal CA1 Synaptic 
Transmission using Field 
Recordings.  
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3.1   Introduction 
The overall aim of this thesis is to investigate synaptic plasticity changes in the 
hippocampus that are induced by or underlie addiction-related behaviour. Initially, 
experiments were performed to investigate potential changes in ex vivo stimulus-
induced LTP and LTD after the demonstration of drug seeking behaviour.  
Animals were first treated with morphine (administered either non-contingently or 
during place preference training), then killed and slices prepared. The ability of 
stimulus-induced LTP and LTD to be induced in slices taken from these animals 
was measured using field recordings. Comparing the effects of these treatments 
relative to their appropriate vehicle controls allowed for the investigation of 
changes in synaptic function that were unique to the drug-induced behavioural 
change. 
There are conflicting reports concerning the effects of non-contingent morphine on 
stimulus-induced LTP. Studies either report an attenuation (Pu et al. 2002; Bao et 
al. 2007 ; Lu et al. 2010; Xia et al. 2011) no change (Salmanzadeh et al. 2003; 
Billa et al. 2010) or an augmentation (Mansouri et al. 1999). There are a number of 
possible reasons for these contradictory findings. The injection paradigms used in 
many of these studies were sufficient to produce tolerance and withdrawal, these 
processes may interfere with the induction of LTP. Another possibility is that 
depending on precise details of the injection procedure, environmental cues may 
have become predictive of morphine administration. In this case, associative 
learning processes dependent on the hippocampus may have effects on the 
subsequent induction of LTP. While Xia et al. (2011) did attempt to control for this, 
their injection paradigm was more intense than the current paradigm and the 
subject was killed 90 minutes after the last injection of morphine.  
To date only limited data exists for the specific effects of morphine-induced place 
preference in the hippocampus. While none of it demonstrates any functional 
adaptations, AMPA surface expression may be increased after morphine CPP but 
not morphine administered non-contingently (Moron et al. 2010). This finding 
suggests that the associative learning processes may induce LTP mechanisms in 
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the hippocampus. Prior in vivo LTP induction (such as the insertion of AMPARs 
suggested above) may occlude further stimulus-induced LTP through saturation of 
these expression mechanisms (Pu et al. 2002). The observed effect of prior in vivo 
LTP induction on stimulus-induced LTP would therefore be one of attenuation. For 
more detail on this hypothesis see section 3.3 and Figure 3.17. 
Changes in stimulus-induced LTP can have alternative explanations to the one 
outlined above however, such as metaplastic changes. Metaplasticity is an 
adaptation in the state of the synapse that, while not effecting the probability of 
transmission, does affect the induction of plasticity. For example, the observed 
attenuation in stimulus-induced LTP (Pu et al. 2002; Bao et al. 2007 ; Lu et al. 
2010; Xia et al. 2011) could equally be due to a reduction in the prior in vivo 
activation of group I mGluR receptors, as prior activation of these receptors may 
be an induction requirement of LTP (Bashir et al. 1993 and see section 1.7.1). 
Therefore changes in stimulus-induced LTP between treatment groups may have 
more than one interpretation and further evidence is needed to support one 
hypothesis over the other. 
The initial aim of the following experiments was to demonstrate an effective 
method for stimulus-induced synaptic plasticity. After this a method for the 
induction of conditioned place preference to morphine also had to be developed. 
Then the effects of the two treatment paradigms, non-contingent morphine and 
morphine-induced place preference could be compared. The results presented 
below suggest that similar but subtly different processes occur in CA1 in response 
to morphine treatment when to used to induce place preference compared to non-
contingent administration.  
3.2   Results  
Field EPSPs were recorded from the dendritic layer of CA1 hippocampal slices 
following stimulation of Schaffer collateral afferent fibres. Care was taken to 
standardise the placement of both stimulating and recording electrodes in each 
slice (see section 2.3.2). Initially, input-output curves were generated, to derive a 
stimulus intensity that produced a 50% maximal fEPSP slope. This was then used 
for the ensuing recording.  
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3.2.1 Stimulus-induced long-term potentiation (LTP) and long-term depression 
(LTD) 
In control, untreated slices, both long-term depression (LTD) and long-term 
potentiation were induced. First, a 20-minute baseline recording was performed 
(0.05Hz stimulation). Immediately after this 20-minute period fEPSP slopes were 
analysed. If the baseline period was unstable (defined as a standard deviation less 
than 5% and no obvious continuous increase or decline in fEPSP slope within 20 
consecutive minutes), then this was repeated until a stable baseline was achieved. 
Then, either LTD was induced by low-frequency stimulation (LFS) or LTP was 
induced by theta-burst stimulation. Immediately following LFS or theta-burst, the 
fEPSP slope was recorded at 0.05 Hz for a further 60 minutes. 
Figure 3.1 shows data (n=7) from theta-burst stimulation, and Figure 3.2 shows 
data from LFS stimulation. While the LTP induced by theta-burst stimulation was 
robust with a reasonable degree of variation (mean fEPSP slope at 70 minutes: 
64% above baseline (standard deviation: 29%)), LTD induced by LFS was small, 
with a high degree of variability. Indeed, although noticeable LTD could be 
recorded in around half of the slices tested (4 of 7 slices), no LTD was produced in 
the others (3 of 7 slices), overall, there was no significant LTD induced (mean 
fEPSP slope at 70 minutes: 0% below baseline (standard deviation: 24%)). For 
this reason, only stimulus-induced LTP was used for the rest of the experiments 







































































Figure 3.1 Stimulus-induced long-term potentiation (LTP).  
fEPSPs were recorded from the dendritic layer of the CA1 hippocampal region, 
following Schaffer Collateral stimulation. Stimulus intensity was set at 50% 
maximum throughout. Following a 20 minute baseline period a theta-burst 
stimulation was applied that resulted in LTP in 9/9 slices. All data shown as 
normalised to field EPSP slope during baseline period. (A). Scatter plot showing all 
recordings, (B) averaged data (Mean ± S.E.M; n = 9), also included is a 
representative trace showing fEPSP recording before and 20 minutes after the 
theta-burst stimulation protocol. Calibration bars are set to 5ms and 2mV. 
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Figure 3.2 Stimulus-induced long-term depression (LTD).  
fEPSPs were recorded from the dendritic layer of the CA1 hippocampal region, 
following Schaffer Collateral stimulation. Stimulus intensity was set at 50% 
maximum throughout. Following a 20 minute baseline period a low-frequency 
stimulation was applied. In 4 out of 7 slices, this resulted in LTD, but no LTD was 
observed in 3 out of 7 slices. All data shown as normalised to field EPSP slope 
during baseline period. (A). Scatter plot showing all recordings (B) averaged data 
(Mean ± S.E.M; n = 7) (C) Trace showing successful LTD induction of fEPSP 
slope. Recording taken before and 20 minutes after the low frequency stimulation 
(LFS) protocol. Calibration bars are set to 5ms and 0.5mV. 
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3.2.2 Morphine-induced conditioned place preference (MOR CPP) 
In order to investigate the effects of drug-context associations on stimulus-induced 
LTP in CA1, the place preference model was selected. This was due to the need 
for young animals and low drug doses (see Introduction; section 1.12). After 
optimisation (see appendix, section A.1) a biased, unbalanced protocol was 
arrived at. There are a number of theoretical issues with this type of place 
preference protocol (Bardo and Bevins, 2000), something that is discussed in 
more detail in the Appendix. MOR CPP is a well established phenomenon however 
and the only objective here was to demonstrate that the mice had learnt an 
association between the drug and one specific environment.    
Figure 3.3 shows the demonstration of a morphine-induced place preference in 
C57BL/6J mice. The preference score was calculated by subtracting the total time 
spent in the saline paired environment from the total time spent in the morphine 
paired compartment. A positive value therefore indicates a preference for the drug-
paired compartment whereas a negative value represents a preference for the 
saline paired compartment. A 2-way ANOVA comparing the effects of training and 
drug with Bonferroni post tests revealed the MOR CPP group had a significant 
increase in preference for the drug-paired compartment on the test day compared 
to the pre-test day (P<0.01) whereas the SAL CPP group did not (P>0.05). This 
was also true when tested again 3 days later (P<0.05). After 7 days a further test 
suggested the MOR CPP group still spent longer in the drug-paired compartment 
compared to the pre-test, although this effect was not significant (t-test, P=0.2, 
n=8). One possible reason for this was the large variation observed in the +7 days 
MOR CPP group (SD of 173 seconds at +7 days compared to 59 seconds at pre-
test). Another possible reason for the general decreasing trend in preference over 
repeated testing was the process of extinction. CPP has been previously shown to 
be long lasting (at least 12 weeks, Mueller et al., 2002) but progressively declines 
following repeated exposure to the CPP environments in the absence of 
contingent drug administration, a process known as extinction (Mueller and 
Stewart, 2000). Slices were therefore taken from animals on the test day, and 3-, 













































Figure 3.3 Morphine-induced conditioned place preference (CPP).  
Mice were exposed to the conditioned place preference apparatus and baseline 
preference measured (pre-test). Mice were then were assigned to treatment 
groups, No saline-induced CPP was observed, but morphine-induced CPP was 
seen as a significant increase in preference score (time spent in morphine-paired 
environment on test-day minus time spent in the saline paired environment) 
compared to SAL CPP. Upon retesting for preference, animals still showed 
significant morphine-induced CPP preference 3 days after training, with a non-
significant trend at 7 days. Saline-treated animals were unchanged. Data is 
presented as mean +/- S.E.M. **=P<0.01, *=P<0.05 compared to pre-test score, 2-
way ANOVA with Bonferroni post-tests. n = 8 per treatment group. 
3.2.3 Effects of morphine treatment and morphine CPP training on stimulus-
induced LTP 
Next, animals were treated in vivo with 4 different regimens, prior to slices being 
taken and stimulus-induced LTP measured. Treatment groups were: SAL (animals 
were administered 4 daily injections of saline and confined to home cage), MOR 
(animals were given 2 injections of morphine (10 mg kg-1) and 2 injections of saline 
(10 ml kg-1) alternately over 4 days and confined to home cage), SAL CPP animals 
were administered the same injections as the ‘saline’ group but were exposed to 
the conditioned place preference boxes immediately after injections, MOR CPP 
animals were trained to demonstrate morphine conditioned place preference and 
so received the same injections as the MOR group, but with exposure to the 
conditioned place preference boxes. Thus there were both contingent and non-
contingent morphine treatments with vehicle controls. 
108 
Figure 3.4 shows that non-contingent morphine leads to a reduction in stimulus-
induced LTP at time points more than 22 minutes after LTP induction (by repeated 
t-tests, P<0.05). Although various conflicting effects of non-contingent in vivo 
morphine treatments on ex vivo LTP induction have been demonstrated (see 
section 3.1), the finding that in vivo morphine treatments can result in a decrease 
in stimulus-induced LTP has been previously demonstrated by some groups (see 
Xia et al. 2011; Pu et al. 2002; Lu et al. 2010; Bao et al. 2007).  


























Figure 3.4 Effect of non-contingent morphine on stimulus-induced LTP  
Mice were treated with MOR or SAL. Slices were taken 24 hours after last injection 
and stimulus-induced LTP was recorded following theta-burst stimulation. All data 
shown as normalised to fEPSP slope during baseline period. Symbols show mean 
values, dotted lines represent S. E. M. n = 12-16. Repeated unpaired t-tests 
revealed that fEPSP slopes at each time-point between 24 and 60 minutes were 
significantly different (P < 0.05). Arrow represents time of theta-burst induction. 
When the same morphine injections were administered in the context of MOR CPP 
training, this difference was no longer apparent, with no significant difference 
between SAL and MOR CPP treatment groups (Figure 3.5). Figures 3.4 and 3.5 
suggest that while non-contingent morphine treatment led to a reduction in the 
ability of theta-burst stimulation to induce LTP, the same drug injections given in 
the context of CPP training had no effect.  
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Figure 3.5 Effect of morphine-induced conditioned place preference training 
on stimulus-induced LTP  
Mice were trained to demonstrate MOR CPP or treated with SAL. Slices were 
taken and stimulus-induced LTP was recorded following theta-burst stimulation. All 
data shown as normalised to field EPSP slope during baseline period. Symbols 
show mean values, dotted lines represent S. E. M. n = 16-17. Unpaired t-test 
revealed that fEPSP slopes were not significantly different at any time-point (P > 
0.05) although a significant difference in variance between groups invalidated this 
test. Arrow represents time of theta-burst induction. 
A number of possible reasons could account for these differences seen between 
contingent and non-contingent morphine. One possibility was that morphine given 
in a specific context (MOR CPP) could trigger different mechanisms when 
compared to morphine given in the absence of any specific cue (MOR). Another 
possibility was that the CPP training had its own effects that were either masking 
or reversing the effects of morphine. To further investigate these hypotheses the 
effects of SAL CPP were examined.   
3.2.4 Effects of conditioned place preference training with saline injections on 
stimulus-induced LTP 
Figure 3.6 shows that, surprisingly, SAL CPP increases stimulus-induced LTP 
compared to SAL treatment alone. This suggests that conditioned place 
preference training itself induces changes in synaptic function, regardless of any 
drugs used to induce a preference. T-tests revealed that SAL CPP training (which 
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in itself did not induce any evident conditioned place preference behaviour, see 
Fig. 3.3) resulted in a significant increase in stimulus-induced LTP (P<0.05). 
Considering only figures 3.4 and 3.5, it appears that although non-contingent 
morphine induces a persistent deficit in the ability of theta-burst stimulation to 
induce LTP, when the same morphine/saline injections are given in the context of 
conditioned place preference training, this difference is no longer evident. This was 
a somewhat surprising finding, but did suggest that the failure to observe a change 
in stimulus-induced LTP in other studies (Salmanzadeh et al. 2003; Billa et al. 
2010) could have been due to unintended associative learning processes. 
Comparing the effects of MOR and MOR CPP to their appropriate controls (SAL 
and SAL CPP respectively, Figure 3.7) reveals that morphine reduces stimulus-
induced LTP in both situations (SAL vs MOR, P<0.05 between 26 and 60 minutes 
post LTP induction; SAL CPP vs MOR CPP, P<0.05 between 20 and 56 minutes 































Figure 3.6. Effect of CPP training in the absence of morphine administration 
on stimulus-induced LTP.  
Mice underwent either SAL or SAL CPP treatment before LTP induction. All data 
shown as normalised to field EPSP slope during baseline period. Symbols show 
mean values, dotted lines represent S. E. M. This graph shows a clear increase in 
stimulus-induced LTP following SAL CPP compared to SAL (P<0.05 for all times 
post stimulation) although again an increase in variance invalidated this result. 
Another problem with this interpretation is the duplication of the SAL treatment 
group in figures 3.4 and 3.5. While this method increases the chances of type I 
errors, there is a clear difference between these two groups (see below for a 

































Figure 3.7 Overall effects of morphine and conditioned place preference 
training on stimulus-induced LTP.  
Slices were taken and stimulus-induced LTP was recorded following theta-burst 
stimulation. Arrow represents time of theta-burst induction. All data shown as 
normalised to field EPSP slope during baseline period. Symbols show mean 
values, dotted lines represent S. E. M. n = 12-17. Arrow represents time of theta-
burst induction.  
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The data presented above utilises repeated t-tests to search for potential 
differences between defined groups. While within each graph each data point is 
only involved in one t-test, further comparisons lead to individual data points being 
used for more than one t-test. Using the same data for more than one t-test 
increases the chances of type 1 errors (the detection of a difference where there is 
none). One way around this is to use ANOVAs to make multiple comparisons 
between groups. Doing this however does reduce the power of the tests to detect 
differences (increasing the chances of a type II error). One of the validation 
procedures for one way ANOVAs is to use Bartlett's test to confirm that the 
variation amongst the different populations being compared is the same (Bartlett, 
1937). Choosing 50 minutes post theta burst as an example time point, Bartlett's 
test produces a P value of <0.0001. This low value invalidates the use of ANOVAs 
or students' t-tests to compare means. The data shown in Figures 3.4 – 3.7 were 
displayed in the conventional manner of plotting mean ± S.E.M. As the standard 
error of the mean generally decreases as sample size increases (S.E.M. = 
standard deviation divided by the square root of the sample size) then this 
variation is harder to see. Figure 3.8 highlights this, by plotting all data points (at 
time 50 minutes) as a scatter plot with mean and standard deviation values (rather 
than S.E.M.) shown. Here, it can clearly be seen that the variability of the data 
derived from morphine CPP- and saline CPP-treated animals was distinctly higher 
than data derived from non-contingently-treated animals. Indeed, the Fisher-
Snedecor distribution-test (F-test) can be used to assess whether the variance and 
standard deviation of two datasets are significantly different from each other. 
Performing this test reveals the MOR CPP data is significantly more variable than 
the MOR data (MOR: variance = 215, standard deviation = 15; MOR CPP: 
variance = 1602, standard deviation = 40. F-test = 0.002). Similarly, there is a 
significant difference between SAL and SAL CPP (non-contingent saline: variance 
= 154, standard deviation = 12; saline CPP: variance = 818, standard deviation = 
29. F-test = 0.003). There was no significant difference in variability between the 
SAL and MOR groups (F-test = 0.54) or the SAL CPP and MOR CPP groups (F-
test = 0.24).   
An apparent increase in variability could be caused by the presence of outliers in 
the dataset. Therefore Grubb’s test was used to examine whether there was a 
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statistically-significant outlier which may result in an apparent increase in 













































Figure 3.8 Increased variability of stimulus-induced LTP following 
conditioned place preference training  
Mice received in vivo treatments: non-contingent saline (‘saline’), non-contingent 
morphine (‘morphine’), morphine conditioned place preference (‘morphine CPP’) 
or saline conditioned place preference (‘saline CPP’) and stimulus-induced LTP 
was measured. Data show scatter plot of stimulus-induced LTP 50 minutes post-
theta-burst. All data shown as normalised to field EPSP slope during baseline 
period. Red central line represents mean values, error bars are standard deviation. 
F-test shows significantly increased variability in both the morphine CPP groups 
and saline CPP groups when compared to MOR and SAL respectively. ** = P < 
0.01, F-test for equal variance. 
A Student’s t-test with Welch’s correction can be used to analyse potential 
differences between the means of two populations with different variances (Welch, 
1947), such as the MOR and MOR CPP groups. Figure 3.9 shows that there is 
indeed a significant increase in the ability of theta-burst stimulation to induce LTP 
in the MOR CPP group compared with the MOR group using Welch’s correction 
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(which is the correct form of statistical analysis when 2 data-sets have significantly 
different variances) between 12 and 24 minutes post-theta-burst. There was a 
non-significant trend at the other time points (for example, P = 0.053 at 56 minutes 
post-theta-burst (time = 76 minutes)). Similarly, when the SAL and SAL CPP 
groups were reanalysed using Welch’s correction, the significant increase in LTP 
induction in the saline CPP group compared with the non-contingent saline group 
(see Figure 3.6) was still evident (P<0.05 at times 0-60 minutes). 
























Figure 3.9 Comparison of stimulus-induced LTP following MOR and MOR 
CPP.  
Stimulus-induced LTP was measured by administering a theta-burst at time zero. 
Data shown as mean ± S.E.M. n=16-19. Vertical dashed lines and * indicate time 
period within which groups were statistically different using t-test with Welch’s 
correction (P<0.05, 12-24 minutes post LTP induction). Arrow indicates time of 
theta-burst induction. Overall, morphine treatment, whether administered in the 
context of CPP or in the absence of any specific cue results in a significant 
decrease in the ability of theta-burst stimulation to induce LTP. Whereas CPP 
training itself (whether morphine is administered or not) results in a significant 
increase in the ability of a theta-burst to induce LTP. Also, there is a significant 
increase in the variability of stimulus-induced LTP in slices taken from animals that 
had undergone conditioned place preference training (whether saline or morphine 
was administered) when compared with animals that had undergone identical 
injection regimens but were confined to their home cage. 
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As mentioned in the introduction to this chapter, changes in stimulus-induced LTP 
can have more than one interpretation. It was therefore necessary to further 
investigate these changes using higher resolution techniques before any attempts 
were made to interpret these findings. These experiments are presented in 
Chapters 4 and 5. 
3.2.5 Investigating the mechanisms underlying increased variability of responses 
after morphine CPP 
Animals that had undergone conditioned place preference training were  exposed 
to a novel environment (the conditioned place preference equipment), and may 
therefore have had a more stressful experience than those that just received non-
contingent injections (or vice versa). Indeed, there is evidence that stress can 
cause subsequent changes in the amount of stimulus-induced LTP in ex vivo 
slices (Kim et al. 1996). Because of the constraints of the Home Office project 
licence it was not possible to deliberately induce stressful situations, therefore this 
hypothesis was tested by studying stimulus-induced LTP in completely separate 
group of animals. The two treatment groups were non-contingent saline animals 
(SAL treatment regime) and animals that were left completely unhandled before 
being killed. Figure 3.10 shows that although there is a trend to a decrease in 
stimulus-induced LTP in the saline group compared with the naïve group, this is 
not statistically significant (SAL vs Naive, P>0.05 at all time points following LTP 
induction using a unpaired t-test). If increased levels of stress were responsible for 
the apparent increase in stimulus-induced LTP in SAL CPP, then it would be 
expected that non-contingent saline would also cause an increase in stimulus-
induced LTP compared with untreated, naïve animals, which was not the case. 
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Figure 3.10 Comparison of stimulus-induced LTP following non-contingent 
saline treatment and untreated animals  
Mice were treated with saline ‘non-contingently’ over 4 days (‘saline’) or were left 
completely untreated and were not handled for the same length of time (‘naïve’). 
Slices were then taken and stimulus-induced LTP was recorded following theta-
burst stimulation at time = 20 minutes. All data shown as normalised to field EPSP 
slope during baseline period. Symbols show mean values, dotted lines represent 
S. E. M. n = 16-19. Unpaired t-test revealed that fEPSP slopes at each time-point 
were not significantly different from each other (P > 0.05) although SAL treatment 
did show a trend to increase fEPSP slopes post theta burst. 
In the data shown above (figures 3.4-3.9), animals were treated in vivo for 4 days, 
and then killed and slices taken from them either on the test day (1 day), or 4, 5, 6 
or 7 days after the last injection. We (Figure 3.3) and others have shown that 
conditioned place preference to morphine (and to other drugs of abuse) persists 
for at least 1 week, even as long as several months (Mueller et al., 2002). 
Assuming that these changes in behaviour are correlated to changes in synaptic 
transmission, then those changes may also persist for at least one week. Based 
on this assumption, no attempt was made to restrict recordings taken only from 
animals on the test day. There is evidence however, that information stored in the 
hippocampus is gradually consolidated to other brain regions over time (Debiec et 
al. 2002), and therefore perhaps this 'systems consolidation' could be responsible 
for the observed variability. To test this hypothesis, evidence for a correlation 
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between time since in vivo training and magnitude of LTP induction was examined. 
For example, perhaps those slices where a very high degree of stimulus-induced 
LTP was induced were taken from animals 6 days after cessation of behavioural 
treatment, whereas those exhibiting a low degree of stimulus-induced LTP may be 
from slices taken from animal on the test day (or vice versa). Figure 3.11 shows 
that this is not the case, as there is no correlation between the time after the end 
of behavioural training and slice preparation verses magnitude of stimulus-induced 
LTP. 


























Figure 3.11 Correlation plot of time-lag between end of behavioural treatment 
and ex vivo stimulus-induced LTP.  
All mice underwent morphine-induced conditioned place preference training, with 
the CPP test day on ‘day 1’, slices were taken from these animals on days 1, 4, 5 
or 6 and stimulus-induced LTP induced by theta-burst stimulation. Data plotted as 
fEPSP slope (normalised to baseline slope) at time = 12 minutes (ie. 12 minutes 
post-theta burst) (blue triangles) or at time = 60 minutes (ie. 60 minutes post-theta 
burst (red squares). Linear regression analysis was then performed; solid line is 
line of best-fit, dashed lines are 95% confidence band of regression line. There 
was no significant correlation between experimental day and magnitude of 
stimulus-induced LTP. At time = 12 minutes, r2 = 0.06, P = 0.31 for statistical 
deviance of line-of-best-fit from zero. At time = 60 minutes, r2 = 0.10, P = 0.26 for 
statistical deviance of line-of-best-fit from zero.  
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Alternatively, it is possible that the increased variability in stimulus-induced LTP in 
slices taken from animals that had undergone conditioned place preference 
training may be due to variability in the magnitude of conditioned place preference 
behaviour expressed by that animal, or how well that animal has learned the task. 
As animals that had undergone saline conditioned place preference expressed no 
overt change in behaviour (see Figure 3.3) we tested this hypothesis by examining 
a possible correlation between magnitude of stimulus-induced LTP and the 
magnitude of morphine-induced conditioned place preference behaviour (ie. 
magnitude of increase in time spent in morphine-conditioned environment). Figure 
3.12 clearly shows that there was no such correlation, nor significant deviation of 
the line of best-fit from zero, between conditioned place preference behaviour and 
magnitude of stimulus-induced LTP. Therefore, the variability in how well an animal 
learned the conditioned place preference task does not appear to underlie the 
variability in subsequent stimulus-induced LTP in slices taken from that animal.  
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Figure 3.12 Correlation plot of conditioned place preference behaviour and 
ex vivo stimulus-induced LTP.  
All mice underwent morphine-induced conditioned place preference training, 
Degree of expressed conditioned place preference behaviour is plotted on the x 
axis as the difference in time spent in the morphine-conditioned side on the post-
training day minus time spent in the morphine-conditioned side on the pre-training 
day (time in seconds). Y axis shows data plotted as field EPSP slope (normalised 
to baseline slope) at time = 12 minutes (ie. 12 minutes post-theta burst; blue 
triangles) or at time = 60 minutes (ie. 60 minutes post-theta burst; red squares). 
Linear regression analysis was then performed; solid line is line of best-fit, dashed 
lines are 95% confidence band of regression line. There was no significant 
correlation between experimental day and magnitude of stimulus-induced LTP. At 
time = 12 minutes, r2 = 0.06, P = 0.41 for statistical deviance of line-of-best-fit from 
zero. At time = 60 minutes, r2 = 0.06, P = 0.44 for statistical deviance of line-of-
best-fit from zero. 
Together, these data suggest that there is no correlation between the degree of 
expression of conditioned place preference behaviour and amount of stimulus-
induced LTP. Also there appears to be no correlation between the amount of 
stimulus-induced LTP, and how many days post-injection the electrophysiological 
recordings were taken. It is therefore unclear what mechanisms underlie the 
increased variability in both the CPP groups. 
The overall pattern of the above results (figures 3.4-3.12) is that morphine given in 
vivo (whether in a specific context or not) causes a decrease in the ability of 
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synapses to undergo ex vivo stimulus-induced LTP. Whereas prior training with the 
conditioned place preference behavioural paradigm, whether a rewarding 
substance (i.e. morphine) is used or not (i.e. saline) results in an increase in the 
ability of synapses to undergo stimulus-induced LTP although at this stage it is not 
possible to ascertain whether these changes oppose each other by being similar 
but opposite processes or are completely independent processes. 
3.2.6 Investigating pre-synaptic effects of MOR and MOR CPP treatments 
To further study the potential effects of in vivo conditioned place preference 
training and morphine on the CA3-CA1 synapses, paired pulse facilitation 
experiments were performed. The summation of presynaptic intracellular calcium 
concentration and voltage-gated calcium conductances combine to produce a 
processes known as facilitation (Zucker et al. 2002). The magnitude of facilitation 
has been demonstrated to be dependent on inter-pulse interval (the shorter the 
interval the greater the facilitation) and the release probability (Pr) of the 
presynaptic terminal (the lower the release probability the greater the facilitation) 
(Zucker et al. 2002).    
Figure 3.13 shows the paired-pulse ratios between the different treatment groups. 
No significant differences exist between MOR and SAL or between MOR CPP and 
SAL CPP using unpaired t-tests, although comparing SAL to MOR was close to 
significance (P=0.06). Paired pulse ratios were also measured 60 minutes after 
theta-burst induced LTP. As when paired-pulse facilitation was measured before 
stimulus-induced LTP occurred, there was no significant difference in paired-pulse 
ratio between SAL and MOR or between SAL CPP and MOR CPP (Figure 3.14, 
P>0.05 with unpaired t-tests). 
Using paired-pulse facilitation of fEPSPs as a measure of probability of transmitter 
release - none of the in vivo treatments produced a statistically-significant change 
when measured ex vivo. Further, unlike when stimulus-induced LTP was recorded, 
there was no significant change in variability between any of the treatment groups 











































Figure 3.13 Paired-pulse facilitation following different in vivo treatments.  
All mice underwent in vivo treatments (SAL, MOR, SAL CPP and MOR CPP). Two 
fEPSPs were evoked 50ms apart and the slopes of the ensuing fEPSPs were 
recorded. PPF ratios were calculated as the slope of the 2nd fEPSP divided by the 
slope of the 1st fEPSP. Scatter-plot shows all data points, red central line 
represents mean value with error bars of S.E.M. None of the in vivo treatments 
(MOR or MOR CPP) resulted in a significant change in paired pulse ratio when 
compared to their respective controls (unpaired t-tests, SAL vs MOR, P=0.06; SAL 








































Figure 3.14 Paired-pulse facilitation following different in vivo treatments 
after stimulus-induced LTP induction.  
All mice underwent in vivo treatments (non-contingent saline injections, non-
contingent morphine injections, saline CPP training or morphine CPP training). 
After a stable baseline LTP was induced by a theta-burst. 60 minutes later, two 
EPSPs were evoked 50ms apart and the slopes of the ensuing fEPSPs were 
recorded. PPF ratio is the slope of the 2nd fEPSP divided by the slope of the 1st 
fEPSP. Scatter-plot shows all data points, red central line represents mean value 
with error bars of S.E.M. None of the in vivo treatments (MOR or MOR CPP) 
resulted in a significant change in paired pulse ratio when compared to their 
respective controls (unpaired t-tests, SAL vs MOR, P=0.34; SAL CPP vs MOR 
CPP, P=0.48).  
3.2.7 Investigating a possible pre-synaptic component of stimulus-induced LTP 
As mentioned in the introduction, there has been considerable controversy as to 
whether LTP at the CA3-CA1 synapse has a presynaptic component, in addition to 
a postsynaptic component (Nicoll and Malenka, 1999). Combining the data from 
Figures 3.13 and 3.14 into a single analysis allows an attempt to be made to 
address this issue. Looking at Figure 3.15, an obvious decreasing trend in the 
paired ratio is apparent 60 minutes post-LTP induction. A two-way ANOVA 
comparing effects of treatment and LTP induction reveals no effect of treatment but 
a significant (P<0.005) effect of LTP induction. This suggests that regardless of 
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treatment, LTP induction causes a decrease in paired pulse ratios when measured 
60 minutes later, and so an increase in initial probability of release indicating a pre-











































Figure 3.15 Paired-pulse facilitation before and after stimulus-induced LTP 
induction following different in vivo treatments.  
All mice either underwent in vivo treatments (SAL, MOR, SAL CPP or MOR CPP), 
or were completely untreated (‘naïve’). After a stable baseline, two EPSPs were 
evoked 50ms apart and the slope of the ensuing fEPSPs were recorded. PPF ratio 
is the slope of the 2nd fEPSP divided by the slope of the 1st fEPSP. In each slice, 
LTP was then induced by theta-burst stimulation and paired-pulse ratio recording 
repeated 60 minutes later. Data are plotted as mean with error bars of S.E.M. A 
two-way ANOVA comparing effects of treatment and LTP induction revealed no 
treatment x LTP induction interaction but a significant (P<0.005) effect of LTP 
induction.   
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3.3 Summary 
The major findings of the fEPSP experiments were as follows 
 Theta-burst stimulations in the striatum radiatum of the CA1 hippocampal 
area result in a significant increase in fEPSP slope values. 
 This increase in fEPSP slope value is attenuated ex vivo by in vivo 
treatment with morphine  
 Exposure to the CPP apparatus alone is sufficient to augment the increase 
in fEPSP slope values ex vivo 
 Stimulus-induced increases in fEPSP slope values were associated with 
concurrent decreases in paired-pulse ratios. The finding that LTP induction 
decreases paired pulse ratios in CA1 has been shown previously 
(Kleschevnikov et al. 1997; Schulz et al. 1994) and adds further weight to 
the argument that a change in presynaptic neurotransmitter release may 
occur, at least during E-LTP in vitro. 
These results present clear evidence that morphine administration, whether non-
contingent or used to induce place preference did affect synaptic transmission in 
CA1. Another surprising finding was that exposure to the CPP apparatus alone 
(after only saline injections) was sufficient to augment stimulus-induced increases 
in fEPSP slope values. Using fEPSP recordings alone it was unclear as to whether 
CPP and morphine were having opposing effects on the same mechanism, or if 
they were acting via separate mechanisms. In fact it was unclear if morphine 
administration was causing this effect by inducing LTP in vivo (an occlusion effect) 
or if it was a 'metaplastic' effect. As discussed in the introduction to this chapter, 
there are two different possible interpretations of changes in stimulus-induced LTP, 
Figure 3.17 illustrates these two possible situations. As can be seen from the 
figure, potentiation of the AMPA response through or insertion of AMPARs into the 
postsynaptic membrane would be predicted to increase the relative amount of 
current flowing through AMPARs relative to NMDARs (Ungless et al. 2001). It may 
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therefore be possible to distinguish between these two situations through the 
measurement of these two currents. In order to make these measurements whole 




Figure 3.16 A cartoon to illustrate the two possible interpretations of a 
reduction in stimulus-induced LTP.  
Blue dots represent NMDARs, red dots represent AMPARs. In A, control LTP 
induction inserts AMPARs and so expresses normal LTP. In B, prior in vivo LTP 
prevents the induction of further LTP due to saturation of available AMPAR 
locations on the postsynaptic membrane. In C, metaplastic mechanisms reduce 
the insertion of AMPARs (and therefore the expression of LTP) through an 
undefined mechanism. The two situations B and C may be distinguished by 
measuring the relative amounts of current flow through AMPARs and NMDARs 








Chapter 4: Examination of Post-
Synaptic Changes in CA1 
caused by Morphine and 
Morphine-induced Place 
Preference Using Whole-Cell 
Patch Clamp 
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4.1  Introduction 
As mentioned above, the fEPSP data suggested a change in synaptic 
transmission had occurred in CA1. It was unclear what this change was however, 
and so whole cell patch clamp was utilised in an attempt to define a mechanism. 
One commonly used method of assessing in vivo modifications in ex vivo slices is 
the use of AMPA:NMDA values (in conjunction with a host of other 
measurements). While Billa et al. (2010a) found that non-contingent morphine had 
no effect on stimulus-induced LTP, they did show that AMPA:NMDA values were 
increased. They attributed this change to an increased insertion of GluR2 lacking 
AMPARs. Therefore it was important to discover if the observed effects in this 
study where due to changes in AMPA:NMDA and/or changes in the stoichiometry 
of AMPARs.  
Before these experiments were undertaken, further optimisation of the CPP 
paradigm resulted in a two-chambered, non-biased counter balanced design. This 
model of CPP is desirable as it has less theoretical concerns (see Appendix) and 
the demonstration of place preference can be done without saline controls (Bardo 
and Bevins 2002). The reasons for this change are discussed in more detail in the 
Appendix (section A.1).  
4.2 Results 
4.2.1  A new model of morphine-induced conditioned place preference. 
Due to the methodological concerns with the previous CPP model used in Figure 
3.3 (also see appendix section A.1), an unbiased, counterbalanced protocol was 
developed. Again conditioned place preference was expressed as a 'score' (time in 
morphine paired compartment minus time in saline paired compartment) and CPP 
was measured as a significant increase in this score after conditioning. While this 
model of CPP allows for the demonstration of preference independent of saline 
controls, these were still included as they were required for the 
electrophysiological comparisons. For all of the following experiments, 
electrophysiology was performed immediately after the test session. This version 
of the CPP model may be regarded as the 'ideal' amongst CPP models as it does 
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Figure 4.1 Morphine-induced conditioned place preference (CPP).  
Mice were exposed to the unbiased conditioned place preference apparatus (see 
methods section 2.2.4). The time spent in each compartment was recorded in 
order to calculate a preference score (time spent in drug-paired compartment 
minus time spent in saline paired compartment). Mice were then were assigned to 
one of two treatment groups (SAL CPP and MOR CPP). Following conditioned 
place preference training, animals were allowed free access in the CPP boxes and 
preference score on the test day was recorded. A two-way ANOVA comparing the 
effects of both conditioning and morphine treatment revealed a significant drug x 
conditioning interaction with no effect of conditioning but a significant effect of drug 
(P<0.005). Bonferroni post tests revealed MOR CPP group spent significantly 
longer in the drug-paired compartment on the test day compared to pre-test 
(P<0.001, n=14 for both groups) but with no significant difference in the SAL CPP 
group.. 
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4.2.2 AMPA:NMDA in CA1 neurones following MOR and MOR CPP treatment 
The previous chapter identified changes in ex vivo stimulus-induced LTP from 
animals that had undergone different specific in vivo treatment regimens. 
Specifically, MOR treatment caused a reduction in the ability of synapses to 
undergo stimulus-induced LTP, whereas SAL CPP training caused a potentiation in 
stimulus-induced LTP (Figure 3.7). Conditioned place preference training, but not 
morphine treatment, also caused a significant increase in the variability of this 
response. 
The two most likely explanations for the change in magnitude of stimulus-induced 
LTP is either that the in vivo treatment itself induces either LTP or LTD (occlusion 
effects) or that the in vivo treatments induce metaplastic changes. This could then 
affect the degree of stimulus-induced LTP expressed (this concept was discussed 
in more detail in section 3.3). As already discussed, one of the expressions of 
NMDAR-dependent LTP in CA1 is the insertion of AMPARs in the postsynaptic 
membrane. This could be predicted to increase the relative amounts of AMPAR-
mediated current compared to NMDAR-mediated current. Indeed this effect has 
been used previously by many authors as a way of measuring prior in vivo LTP in 
ex vivo experiments (Ungless et al. 2001). When expressed as the ratio 
AMPA:NMDA therefore, this value can be thought of as a measure of previous 
potentiation of the recorded synapses.   
In a attempt to reduce inter-subject variability, all animals were killed and slices 
taken immediately after conditioned place preference testing for MOR CPP and 




























Figure 4.2 AMPA:NMDA at CA3-CA1 synapses after contingent and non-
contingent morphine and saline treatments.  
 (A) All mice underwent in vivo treatments (SAL, MOR, SAL CPP or MOR CPP). 
Under voltage-clamp at +40mV, EPSCs were evoked and the AMPA and NMDA 
components measured as described in the Appendix. The ratio AMPA:NMDA is the 
magnitude of the AMPA component divided by the magnitude of the NMDA 
component, in each recorded neurone. While AMPA:NMDA was increased in MOR 
(n = 9 from 5 mice)  compared to SAL (n=11 from 6 mice, P<0.05, unpaired t-test). 
Comparing MOR CPP to SAL CPP was hindered due to the large  increase in 
variance in the MOR CPP (n=21 from 11 mice) compared to SAL CPP (n=16 from 
9 mice, F-test value=0.001, P=0.14 unpaired t-test with Welch's correction). (B) 
Representative traces showing single measurements of AMPA:NMDA in each test 

































Figure 4.2 shows that there was a significant increase in the AMPA:NMDA in 
animals that had undergone MOR treatments, compared to those that had 
undergone SAL treatments. This suggests that the decrease in magnitude in 
stimulus-induced LTP (see Chapter 3) could be because the in vivo morphine 
treatment has itself induced a form of LTP at these synapses. There was a similar 
but non-significant trend in the MOR CPP group compared to SAL CPP group, see 
Figure 4.2(A).  
The situation appears to be different concerning the augmentation of stimulus-
induced-LTP in the CPP groups. There were no obvious differences between the 
AMPA:NMDA for SAL and SAL CPP groups, this suggests that the increase in 
stimulus-induced-LTP seen after CPP training may not have been due to an 
occlusion effect. The observed changes in the CPP groups as seen in Chapter 3 is 
therefore more likely to be due to changes in metaplasticity.  
By showing AMPA:NMDA data as a scatter plot with means and standard 
deviations (rather than means and S.E.M.s) the increase in variability in the MOR 
CPP group is highlighted. The F-test can be used to compare variability of two 
samples, and showed that the MOR CPP data is significantly more variable than 
the data in each of the other treatment groups (P = 0.04 vs SAL; P = 0.006 vs. 
MOR; P = 0.011 vs. SAL CPP). Using Grubb’s test, there are no statistically-
significant outliers in any of the samples. It is worth noting that this change in 
variability seen in MOR CPP was not seen in SAL CPP as was the case in the 




































Figure 4.3 Variability of AMPA:NMDA at CA3-CA1 synapses.  
All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. Under 
voltage-clamp at +40mV, EPSCs were evoked and the AMPA and NMDA 
components recorded. AMPA:NMDA is the magnitude of the AMPA component 
divided by the magnitude of the NMDA component in each recorded neurone. 
Scatter plot shows all data (n = 9 – 21). ** = P < 0.01; F-test for equal variance 
(MOR CPP vs SAL CPP). 
4.2.2 Investigating whether AMPA:NMDA is correlated with magnitude of 
expression of conditioned place preference learning 
In an attempt to uncover the reason for this significantly increased variability, a 
correlation was again sought between the degree of conditioned place preference 
behaviour seen in vivo with the AMPA:NMDA value measured ex vivo. No 
significant correlation, nor deviation of the line of best-fit from zero, was observed 
(Figure 4.4). In Chapter 3, a possible interaction between the time between end of 
in vivo treatment and preparation of slices was investigated (but not found - Figure 
3.11). There can be no possible correlation in these data, as all slices were taken 1 
day following the final injection (or immediately after CPP test), to minimise this 
potential confounding variable. 
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Figure 4.3 does clearly show that there is an increase in variability in AMPA:NMDA 
in the morphine CPP group, but this is not correlated with the level of expression 
of conditioned place preference behaviour in animals from which slices were 
subsequently taken (Figure 4.4). Therefore, the increase in variability might be due 
to neurone-specific changes induced by morphine conditioned place preference. 
For example, it might be that only in a subset of neurones are LTP-like changes 
induced by morphine conditioned place preference training. Therefore, the next 
step was to search for correlations between different cell parameters that could 
identify subsets of CA1 hippocampal neurones that are affected differently by 
MOR CPP treatment. 

















Figure 4.4 Correlation plot of conditioned place preference behaviour and 
AMPA:NMDA.  
All mice are from MOR CPP group. Degree of expressed conditioned place 
preference behaviour is plotted on the x axis (the difference in time spent in the 
morphine-conditioned side on the post-training day minus time spent in the 
morphine-conditioned side on the pre-training day in seconds). Y axis shows 
AMPA:NMDA in a slice taken from that animal. Linear regression analysis was 
then performed, solid line is line of best-fit, dashed lines are 95% confidence band 
of regression line. There was no significant correlation between magnitude of 
expression of CPP behaviour and magnitude of AMPA:NMDA ratio. R2 = 0.001, P 
= 0.87 for statistical deviance of line-of-best-fit from zero. 
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4.2.3 Investigating possible subsets of CA1 neurones – relationship to 
AMPA:NMDA following MOR CPP training 
First of all the stimulus intensity that resulted in 75% of the maximum evoked 
EPSC was analysed. Figure 4.5 shows that there was no overall change in this 
value (effectively an input/output measure) between any of the in vivo treatment 
groups. Data are shown as stimulus intensity required to elicit 75% of the 
maximum EPSC. Unpaired t-tests failed to find any significant differences between 
any of the groups. Likewise F-tests did not detect any differences in the variability 




































































Figure 4.5 Stimulus intensity required to elicit 75% of max EPSC.  
All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. Input-
Output relationships were studied by changing stimulation intensity and recording 
evoked EPSC amplitude. Stimulation intensity required to evoke 75% maximum 
EPSC response was recorded and plotted. Data shown are mean ± S.E.M. 
Unpaired t-tests failed to find any significant difference between any of the groups 
n = 9-12. 
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Figure 4.6 also shows that there is no significant correlation, nor deviance of the 
line of best-fit from zero, when correlating stimulus intensity with AMPA:NMDA in 
the MOR CPP group. These data suggest that there is no sub-set of neurones that 
can be identified on the basis of stimulation intensity required to evoke 75% 
maximum EPSC (effectively an input/output measure). Also, the increase in 
variability of AMPA:NMDA in the morphine CPP treatment group is not by virtue of 
an artefact of these recordings being stimulated at more varied stimulation 
intensities compared with the other groups 
 

















Figure 4.6 Correlation plot of stimulation intensity and AMPA:NMDA in slices 
taken from mice that underwent MOR CPP treatment.  
All mice underwent morphine-induced conditioned place preference training. 
Stimulation intensity required to evoke EPSC at 75% maximum response is plotted 
on the x axis. Y axis shows data plotted as AMPA:NMDA in the same slice. Linear 
regression analysis was then performed; solid line is line of best-fit, dashed lines 
are 95% confidence band of regression line. There was no significant correlation 
between stimulation intensity applied and magnitude of AMPA:NMDA. R2 = 0.1, P 
= 0.41 for statistical deviance of line-of-best-fit from zero. 
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There were, however, changes observed in whole-cell capacitance between 
different treatment groups. Figure 4.7 demonstrates this, and shows that the 
whole-cell capacitance is significantly higher in the non-contingent morphine 
group, compared with saline, but not in the morphine CPP or saline CPP groups. 
There were no significant changes in the variability of capacitance measurements 













































Figure 4.7 Whole-cell capacitance.  
All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. Whole-
cell capacitance was measured during voltage-clamp recordings from CA1 
neurones. Data shown are mean ± S.E.M. n = 9-21. Unpaired t-test revealed MOR 
group had significantly increased whole cell capacitance compared to both SAL 
(P<0.05). 
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Figure 4.8 shows that there is no significant correlation, nor deviance of the line of 
best-fit from zero, when correlating stimulus intensity with AMPA:NMDA in the 
MOR CPP group. There was no correlation between whole cell capacitance and 
AMPA:NMDA in the MOR group also.  
 

















Figure 4.8 Correlation plot of whole-cell capacitance and AMPA:NMDA in 
slices taken from mice that underwent MOR CPP treatment.  
All mice underwent morphine-induced conditioned place preference training. 
Whole-cell capacitance (pF) is plotted on the x axis. Y axis shows data plotted as 
AMPA:NMDA in the same cell. Linear regression analysis was then performed; 
solid line is line of best-fit, dashed lines are 95% confidence band of regression 
line. There was no significant correlation between whole-cell capacitance and 
magnitude of AMPA:NMDA ratio. R2 = 0.04, P = 0.39 for statistical deviance of line-
of-best-fit from zero. 
Similarly, the magnitude of the EPSC itself was significantly higher in the non-














































Figure 4.9 Magnitude of evoked EPSC.  
(A) All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. 
EPSCs were evoked at 75% of max and amplitude recorded during voltage-clamp 
at -70mV. Data shown are mean ± S.E.M. SAL n=9 from 6 mice, MOR n=11 from 6 
mice, SAL CPP n=10 from 5 mice, MOR CPP n=21 from 11 mice. * = P<0.05; t-
test vs. SAL.(B) Representative traces for each of the test groups, calibration bars 


















































Figure 4.9 shows that in neurones recorded from animals that had MOR treatment, 
there was a significant increase in the magnitude of evoked EPSC. This was 
parallel to the increase in whole-cell capacitance already shown (Figure 4.7). 
Although there was no change in this measure in neurones taken from slices in the 
MOR CPP group a correlation between this parameter and AMPA:NMDA for MOR 
CPP was still drawn. Figure 4.10 shows that there is no relationship however. 
 

















Figure 4.10 Correlation plot of 75% of max EPSC amplitude and AMPA:NMDA 
in slices taken from mice that underwent MOR CPP treatment.  
All mice underwent morphine-induced conditioned place preference training. 
EPSC amplitude (pA) is plotted on the x axis. Y axis shows AMPA:NMDA in the 
same neurone. Linear regression analysis was then performed; solid line is line of 
best-fit, dashed lines are 95% confidence band of regression line. There was no 
significant correlation between EPSC amplitude and magnitude of AMPA:NMDA. 
R2 = 0.06, P = 0.46 for statistical deviance of line-of-best-fit from zero. 
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4.2.4 Investigating the change in EPSC amplitude after non-contingent MOR 
treatment 
EPSC amplitude was surprisingly increased in non-contingent MOR treated 
animals but not in the MOR CPP treated animals (Figure 4.9). EPSC amplitude 
when voltage clamped at -70mV is a general measure of the total number of 
AMPARs being stimulated (or the sensitivity of the AMPARs in question). 
Therefore one might suggest that if an increase in AMPA:NMDA was due to the 
insertion of AMPARs (or an increase in their sensitivity), then the EPSC amplitude 
would also increase. There was however, no apparent correlation between the 
EPSC amplitude and AMPA:NMDA in individual neurones for MOR treated group 
(R2=0.06, P=0.43, graph not shown). This suggests that the increase in EPSC 
amplitude and the increase in AMPA:NMDA may occur via different mechanisms 
(possibly a pre-synaptic mechanism).  
An increase in EPSC amplitude could be caused by an increase in the total 
number of synapses being stimulated. A larger cell with more synapses would 
have a larger surface area and therefore an increased whole cell capacitance. 
Indeed, whole cell capacitance, generally seen as an indicator of neuronal cell 
size, was positively correlated with EPSC amplitude when all treatment groups 
were pooled together (R2=0.25, P=0.001, graph not shown). Whole cell 
capacitance was also increased in the MOR treatment group compared to saline 
(Figure 4.7) and when EPSC amplitude is corrected for by cell capacitance there is 
no longer a significant difference between EPSC amplitudes across treatment 
groups (Figure 4.11). This suggests that the increase in EPSC amplitude in MOR 
treated animals may be due to an increase in the number of synapses.  
To summarise these findings, EPSC amplitudes and cell size appeared to be 
increased after MOR treatment, but not MOR CPP treatment. EPSC amplitudes 
depend on both pre- and postsynaptic mechanisms and therefore interpreting the 
results is difficult. The whole cell capacitance data however suggests that the locus 
of change at least involves a postsynaptic component. No evidence was found for 


































































Figure 4.11 Magnitude of evoked EPSC normalised to whole-cell 
capacitance.  
All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. EPSCs 
were evoked, whole-cell capacitance (pF) and 75% of max EPSC amplitude (pA) 
were measured. For each recorded neuron, 75% of max EPSC amplitude was 
then divided by whole-cell capacitance value (pA/pF). Data shown are mean ± 
S.E.M. n = 9-11. 
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4.2.5 Investigating the relationship between AMPA:NMDA and holding current 
The final cellular parameter that was measured was the holding current at -70mV. 
Here, there was no overall change in average holding potential between treatment 
groups (Figure 4.12). Although there was no apparent change between the 
different treatment groups, there was a significant positive correlation between 
holding current and AMPA:NMDA in the MOR CPP group (Figure 4.13).  
The initial purpose of investigating these correlations was to ascertain whether 
there was a correlation between a certain cellular parameter and AMPA:NMDA in 
the MOR CPP group of animals that might explain the significant increase in 
variability of AMPA:NMDA seen in that treatment group. Figure 4.13 suggests that 
the holding current of a neurone is a predictor of whether an individual neurone 
displays high or low AMPA:NMDA following MOR CPP treatment. However, for this 
to explain the increase in overall variability of AMPA:NMDA in the MOR CPP 
group, this correlation would have to be specific to that treatment group, not to the 
other treatment groups. 
Figure 4.14 shows a correlation plot between AMPA:NMDA and holding current for 
each cell from each treatment group (SAL, MOR, SAL CPP and MOR CPP) 
collated together. As with the MOR CPP group alone, there is a relatively weak 
overall correlation (r2 = 0.16), but there is a highly significant deviation of the line of 
best-fit away from zero (P = 0.003). 
Therefore, although there appears to be a correlation between holding current and 















































Figure 4.12 Holding current at -70mV across treatment groups.  
All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. 
Neurones were voltage-clamped at -70mV and the holding current measured. Data 
shown are mean ± S.E.M. n = 9-21.Unpaired t-tests failed to find any significant 























Figure 4.13 Correlation plot of holding current at -70mV and AMPA:NMDA in 
slices taken from mice that underwent MOR CPP treatment.  
All mice underwent morphine-induced conditioned place preference training. 
Holding current (pA) is plotted on the x axis. Y axis shows data plotted as 
AMPA:NMDA in the same neurone. Linear regression analysis was then 
performed; solid line is line of best-fit, dashed lines are 95% confidence band of 
regression line. There was a significant deviance of the line of best-fit from zero, 
showing that there is a correlation between holding current and AMPA:NMDA. R2 = 






















Figure 4.14 Correlation plot of holding current at -70mV and AMPA:NMDA.  
All mice underwent SAL, MOR, SAL CPP or MOR CPP treatment. Neurones were 
voltage-clamped at -70mV and holding current and AMPA:NMDA of evoked 
EPSCs recorded. Holding current (pA) is plotted on the x-axis. Y axis shows data 
plotted as AMPA:NMDA in the same neurone. Linear regression analysis was then 
performed; solid line is line of best-fit, dashed lines are 95% confidence band of 
regression line. There was a weak but significant deviance of the line of best-fit 
from zero, showing that there is a correlation between holding current and 
AMPA:NMDA. R2 = 0.16, P = 0.003 for statistical deviance of line-of-best-fit from 
zero. 
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4.2.6 Investigating the mechanism by which holding current and AMPA:NMDA are 
correlated 
The observation that there is a general correlation between holding current and 
AMPA:NMDA is interesting and has not been previously described. The potential 
explanation for this was explored further. There are two possible reasons for why 
the holding current might change from neurone to neurone. One is that the resting 
membrane potential might be different, and the other is that the input resistance 
might be different, as the holding current is formed by a combination of how far 
away from the resting membrane potential the neurone is voltage-clamped at, as 
well as the input resistance of that neurone. Although the resting membrane 
potential and input resistances were not empirically measured in these 
experiments, during the recordings, a further holding current was measured when 
the cell was voltage-clamped at +40mV. If the predominant reason for a change in 
holding current from neurone to neurone was because of input resistance rather 
than a change in resting membrane potential, then there would be a strong 
correlation between holding current at -70mV and holding current at +40mV. This 
was indeed the case (see Figure 4.15). 
An increase in input resistance is often seen as an indicator of neuronal size, 
where smaller neurones have higher input resistance. This could also be reflected 
in another indicator of neuronal size: whole-cell capacitance. In other words, if the 
holding potential of the neurone at -70mV is more negative because it is a cell with 
lower input resistance, rather than because it is a cell with a less negative resting 
membrane potential, then there should be a correlation between holding current 
and whole-cell capacitance, which there is, as seen in Figure 4.16. Although the 
deviation of the line of best fit from zero is highly significant (P < 0.01), the 
correlation was between holding current and whole-cell capacitance was quite 
weak (R2=0.12), suggesting that other mechanisms may also be responsible for 
changes in holding current.  
Therefore, although there is no indication of a neuronal marker that might explain 
the high variability seen in the AMPA:NMDA in the MOR CPP group, it appears 
that the AMPA:NMDA is correlated with input resistance, potentially meaning that 
larger cells, or perhaps those with more complex dendritic arborisations tend to 
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have higher AMPA:NMDA (Andrasfalvy & Magee (2001). Another explanation and 
one that could potentially fit the cell capacitance data better, is that the high 
AMPA:NDMA expressing cells in the MOR CPP group could show an increased 
number of conductances at the resting membrane potential. The potential 
implications of these mechanisms are discussed in more detail at the end of this 
chapter and in Chapter 6.   

































Figure 4.15 Correlation plot of holding current at -70mV and holding current 
at +40mV.  
All mice underwent SAL, MOR, SAL CPP or MOR CPP treatment. Neurones were 
voltage-clamped and holding current at both -70mV and +40mV recorded. Holding 
current at -70mV  (pA) is plotted on the x axis. Y axis shows holding current at 
+40mV (pA). Linear regression analysis was then performed; solid line is line of 
best-fit, dashed lines are 95% confidence band of regression line. There was a 
significant deviance of the line of best-fit from zero, showing that there is a 
correlation between holding current at -70mV and holding current at +40mV. R2 = 



































Figure 4.16 Correlation plot of holding current at -70mV and whole-cell 
capacitance.  
All mice underwent SAL, MOR, SAL CPP or MOR CPP treatment. Neurones were 
voltage-clamped at -70mV and then holding current and whole-cell capacitance 
recorded. Holding current at -70mV  (pA) is plotted on the x axis. Y axis shows 
whole-cell capacitance (pF) in the same neurone. Linear regression analysis was 
then performed; solid line is line of best-fit, dashed lines are 95% confidence band 
of regression line. There was a significant deviance of the line of best-fit from zero, 
showing that there is a correlation between holding current and whole-cell 
capacitance. R2 = 0.12, P = 0.009 for statistical deviance of line-of-best-fit from 
zero. 
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4.2.7 Investigating the surface expression and subunit composition of AMPA 
receptors following in vivo treatments 
At the start of this section (4.2) changes in AMPA:NMDA between MOR and SAL 
and between MOR CPP and SAL CPP were demonstrated. That the fact that little 
variation in synaptic NMDAR content is observed in CA1 neurones (Racca et al. 
2000) means that it is often assumed that such changes are an indication that 
AMPAR number or function are increased. If an increase in AMPA:NMDA  was 
purely due to an increase in postsynaptic AMPA receptors, then perhaps the 
response to bath-applied AMPA could be expected to be increased. This was 
examined in Figure 4.17. Here, slices were prepared from animals that received in 
vivo treatments as before, and 1 µM AMPA was bath-applied for 30 seconds in the 
presence of 100 µM cyclothiazide (to inhibit rapid desensitization of AMPA 
receptors (Fucile et al. 2006)). There was no significant difference in AMPA-






























































Figure 4.17 Effects of bath-applied AMPA following contingent and non-
contingent in vivo morphine treatments.  
(A) All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. Neurones 
were voltage-clamped at -70mV and AMPA (1 µM) in the presence of cyclothiazide (100 
µM) was washed over the slice for 30 seconds. Data shown are mean ± S.E.M. SAL n=6 
from 3 mice, MOR n=6 from 4 mice, SAL CPP n=5 from 3 mice, MOR CPP n=4 from 3 
mice. (B) Representative traces for each test group showing the effects of 30 seconds of 











































These data perhaps suggest that the alteration in AMPA:NMDA seen following in 
vivo morphine treatment (Figure 4.2) may not be due to induction of LTP at these 
synapses. These experiments are far from conclusive however, particularly 
because the variability in the bath-applied AMPA data was very high. Furthermore, 
bath-applied AMPA is far more likely to activate extra-synaptic AMPARs compared 
to evoked EPSCs. Thus, in these bath-applied experiments non-synaptic AMPARs 
could produce most of the observed current. If this was the case then any changes 
in synaptic AMPA current could be masked by the relatively large non-synaptic 
current.  
A number of studies have demonstrated that LTP induction in the CA1 region (and 
other brain regions) occurs coincidently with changes in the subunit composition of 
synaptic AMPARs as well as an overall increase in postsynaptic AMPAR density 
(Malenka and Bear, 2004). Specifically, LTP has been suggested to occur through 
the insertion of GluR2-lacking receptors. GluR2-containing and GluR2-lacking 
AMPA receptors have different electrophysiological characteristics that can often 
be measured by a change in rectification of the current flowing through the open 
channel (as has already been observed in the dorsal hippocampus after morphine 
treatment, see Billa et al. 2010). However, in order to observe rectification of these 
channels, spermine needs to be present in the patch solution. This was 
unfortunately not possible with a fluoride-containing pipette solution (see 
Appendix). Therefore, we used the selective GluR2-lacking AMPA receptor 
antagonist, Joro Spider toxin (JSTx, 500 nM) to assess whether it inhibited evoked 
EPSCs in neurones taken from animals that had received different in vivo 


























































Figure 4.18 Effect of Joro Spider Toxin (JSTx) on evoked EPSCs following in 
vivo treatments.  
All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. Evoked 
EPSCs were recorded and inhibition by bath-applied JSTx (500 nM for 10min) was 
measured. Data normalised to EPSC amplitude immediately prior to JSTx 
application. Data shown are mean ± S.E.M. n = 3 from 3 mice for each group. 
4.3 Summary 
In this chapter evidence is presented that AMPA:NMDA in MOR treated animals is 
increased compared to SAL treated animals. In MOR CPP treated animals there 
was no overall increase in AMPA:NMDA observed (unlike in the non-contingent 
MOR group). There was however, a highly significant increase in the variability of 
the AMPA:NMDA measure in the MOR CPP group (F-test P = 0.001 vs SAL CPP 
group). This finding suggests that the effects of MOR CPP on AMPA:NMDA may 
be neuron-specific, implicating different effects on different neuronal subsets. 
Further discussion on this possibility is explored in the General Discussion (section 
6). Efforts were made to examine whether such subsets of neurones could be 
identified by general electrophysiological parameters (eg. whole-cell capacitance, 
input resistance) but none was found. 
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Irrespective of in vivo treatment, increased AMPA:NMDA values did appear to 
occur alongside decreases in input resistance (input resistance is dependent on 
both cell size and membrane conductivity at -70mV). Recordings of whole cell 
capacitance suggest that cell size is not correlated to AMPA:NMDA (Figure 4.8) 
and therefore changes in membrane conductivity at -70mV may underlie this 
correlation. Further support for this idea comes from the fact that holding currents 
at -70mV were correlated to AMPA:NMDA values (Figure 4.14) but were not 
correlated at +40mV (R2=0.008, P=0.96). While this is an interesting general 
observation, it did not appear to be a specific mechanism for any changes 
observed in the MOR CPP group, and so did not help elucidate the mechanism 
involved in the increased variability in  AMPA:NMDA values for this group.   
In contrast to what was found in slices taken from MOR CPP treated animals, 
there was a significant increase in AMPA:NMDA in the MOR group (cf. Billa et al., 
2001), with no increase in variability. This is consistent with the hypothesis 
described in Chapter 4 (Figure 3.16) that morphine treatment itself induces an 
LTP-like change that can be seen as an increase in AMPA:NMDA during patch-
clamp recordings, and as a decrease in the ability of those synapses to display 
further stimulus-induced LTP. Although no change in AMPAR subunit composition 
was detected, this does not contradict the LTP hypothesis, as this effect is not 
consistently seen in other studies (see Introduction). Potentially, this effect could 
also involve increased dendritic arborisations, as an increase in whole-cell 
capacitance was seen in the non-contingent MOR group.  
A further implication of these results concerns the increase in stimulus-induced 
LTP seen after exposure to the CPP environment (Chapter 3). As no change in 
AMPA:NMDA values were seen between SAL and SAL CPP groups, this suggests 
that the mechanism underlying the increase in stimulus-induced LTP measured 
during field recordings in Chapter 3 is likely to be via a different mechanism to the 
one underlying the decrease seen after morphine treatment. The mechanism for 
the change after CPP exposure was not investigated further, although possible 






Chapter 5: Examination of 
Presynaptic Changes in CA1 
caused by Morphine and 
Morphine-induced Place 
Preference Using Whole-Cell 
Patch Clamp 
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5.1  Introduction 
In addition to post-synaptic changes LTP in the hippocampal CA1 area may have a 
pre-synaptic component (see introduction and Chapter 3). The possibility that 
MOR CPP training may induce presynaptic changes is further investigated in the 
following chapter, by studying paired pulse facilitation and miniature EPSCs.  
5.2 Results  
5.2.1 Paired-pulse facilitation of EPSCs following MOR and MOR CPP treatments 
As previously mentioned (Chapter 3), one technique that can be used to assess 
probability of transmitter release is paired-pulse facilitation. An increase in paired-
pulse facilitation (PPF) indicates a decrease in initial probability of transmitter 
release. In field recordings, there was no apparent change in PPF between the 
treatment groups, but there was a slight but significant reduction after stimulus-
induced LTP. One disadvantage of the field recordings (Chapter 3) was that the 
recordings are of many postsynaptic neurones combined, and so the resolution is 
much lower than in patch-clamp recordings, where only a single neurone is 
recorded from. We therefore repeated the paired-pulse facilitation experiments 
using whole cell patch clamp. 
Figure 5.1 demonstrates that when recorded in the patch-clamp configuration (so 
responses are only recorded from a single neuron) there is a strong and significant 
increase in PPF in the MOR treatment group, but not in the MOR CPP group. 
As with other measured variables including AMPA:NMDA and stimulus-induced 
LTP, MOR treatment surprisingly gave the most robust effect, and the addition of 
CPP training with morphine treatment appeared to counteract or prevent the effect 
of morphine itself. Unlike the postsynaptic changes (see Chapters 3 and 4) there 
was no significant increase in variability in any of the treatment groups (F-tests: 
MOR vs. SAL P=0.87; SAL CPP vs. SAL P=0.53; MOR CPP vs SAL CPP P=0.32).   
Although there was no significant increase in variance of PPF in the MOR CPP 
group, in a further attempt to try and identify potential subsets of neuronal 
responses to MOR CPP, a correlation was plotted between PPF value and 
AMPA:NMDA in the MOR CPP group. Figure 5.2 shows that there was no 
significant correlation between the two values. 
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Figure 5.1 Paired pulse ratio at Schaffer-Collateral-CA1 synapses after 
contingent and non-contingent morphine and saline treatments in vivo.  
(A) All mice underwent in vivo treatments; SAL,MOR, SAL CPP or MOR CPP. 
Under voltage-clamp at -70mV, EPSCs were evoked 50ms apart and EPSC 
amplitude of each measured. ‘Paired Pulse Ratio’ value is the amplitude of second 
stimulated EPSC divided by the first stimulated EPSC. Data plotted as means ± 
S.E.M. SAL n=7 from 6 mice, MOR n=11 from 6 mice, SAL CPP n=9 from 8 mice, 
MOR CPP n=9 from 7 mice.  ** = P < 0.01; t-test vs. respective SAL controls. Inset 
trace from a single MOR subject to demonstrate paired pulse facilitation.(B) 





























































Figure 5.2 Correlation plot of Paired Pulse Ratio and AMPA:NMDA ratios.  
All mice underwent MOR CPP treatment. Paired pulse ratio (ratio of amplitude of 
2nd EPSC / 1st EPSC, 50 ms apart) is plotted on the x axis. Y axis shows data 
plotted as AMPA:NMDA in a slice taken from the same neurone. Linear regression 
analysis was then performed; solid line is line of best-fit, dashed lines are 95% 
confidence band of regression line. There was no significant correlation between 
the paired pulse ratio and AMPA:NMDA. R2 = 0.006, P = 0.84 for statistical 
deviance of line-of-best-fit from zero. 
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5.2.2 Miniature excitatory post-synaptic currents following contingent and non-
contingent in vivo morphine treatments 
A further, more powerful way to investigate presynaptic release probability is to 
record miniature synaptic events. These events were recorded by a continuous 
measurement of holding current for at least 30 seconds in the presence of 1μM 
TTX. Figure 5.3 shows that there is a significant increase in inter-event interval of 
mEPSCs in the MOR treatment group, meaning that there is a significant decrease 
in the frequency of mEPSCs. There is also a similar but non-significant trend 
(P=0.06) in the MOR CPP vs. SAL CPP comparison. To derive the data shown in 
Figure 5.3 it is necessary first to take an average of the mEPSC inter-event 
interval in each individual neurone, then take the mean of those average values. It 
is usual to plot these types of data as cumulative frequency plots however, 
whereby the relative distributions of the data can be analysed and thus decrease 
the chance of a type II error. When drawing cumulative frequency graphs, it is 
important to ensure that equivalent numbers of events from each neurone (rather 
than equivalent time of duration of recording) are plotted. This is so that the 
cumulative frequency is not skewed by neurones with higher frequencies that 
would inevitably contribute more to the overall number of events.  
Figure 5.4 shows the cumulative frequency plot of mEPSCs taken from slices from 
animals that had undergone either MOR or SAL treatments. The shift to the right in 
the plot of the MOR group is symptomatic of an overall increase in inter-event 
interval, and therefore an overall decrease in mEPSC frequency. The Kolmogorov-
Smirnov test (K-S test) can be used to assess whether there is a significant 
difference between the relative distributions of cumulative frequency plots. Using 
this statistical test gives P <0.001 suggesting a highly significant decrease in 
mEPSC frequency in neurones taken from animals that had undergone non-
contingent morphine in vivo. This is in agreement with the mean mEPSC analysis 
(Figure 5.3) 
In contrast to SAL and MOR treatments, there was no significant difference (P = 
0.07; K-S test) in mEPSC frequency between animals that had undergone SAL 



























































Figure 5.3 Miniature EPSC frequency at Schaffer-Collateral-CA1 synapses 
after contingent and non-contingent morphine and saline treatments.  
(A) A representative example of a mEPSC recording. The addition of CNQX 
(50µM) and D-AP5 (50µM) abolished all detected events demonstrating all events 
where of glutamatergic origin. (B) All mice underwent in vivo treatments; SAL, 
MOR, SAL CPP or MOR CPP. mEPSCs were recorded and inter-event intervals 
measured. For each neurone the mean inter-event interval was taken, those 
values were then averaged and plotted (means ± S.E.M.). SAL n=5 from 5 mice, 
MOR n=4 from 4 mice, SAL CPP n=5 from 5 mice, MOR CPP n=4 from 4 mice.     







































Figure 5.4 Miniature EPSC frequency at Schaffer-Collateral-CA1 synapses 
after SAL or MOR treatments. 
(A) Mice underwent either SAL (n=5) or MOR (n=4) treatments. mEPSCs were 
recorded and inter-event intervals measured. Each event was ranked and plotted 
as a cumulative frequency plot.(B) Representative sample (1 second) of each test 
group. Calibration bars are set to 200ms and 10pA.  

































































Figure 5.5 Miniature EPSC frequency at Schaffer-Collateral-CA1 synapses 
after conditioned place preference.  
(A) Mice underwent either SAL CPP (n=5) or MOR CPP (n=4) treatments.  
mEPSCs were recorded and inter-event intervals measured. Each event was 
ranked and plotted as a cumulative frequency plot. (B) Representative sample (1 
second) of each test group. Calibration bars are set to 200ms and 10pA.  
 


































































As well as frequency, the amplitude of mEPSCs was measured. It is generally 
assumed that a decrease in mEPSC frequency (see Figure 5.4) is indicative of a 
decrease in probability of glutamate release, although further support is often 
provided by studying mEPSC amplitudes. 
Plotting the average mEPSC amplitudes within each neurone revealed there were 
no significant differences between treatment groups. As already mentioned above 
however, this approach can lead to an increase in type II errors. The data were 
therefore plotted as cumulative frequency plots. Figures 5.7 and 5.8 clearly show 
that there is no significant difference in mEPSC amplitudes between the different 
in vivo treatment groups. Therefore the significant decrease in mEPSC frequency 
after MOR shown above (Figure 5.3) is likely to be caused by a decrease in 
glutamate release probability at nerve terminals making synapses onto CA1 
neurones in the striatum radiatum. This idea is further supported by the findings of 



















Figure 5.6 Miniature EPSC amplitude at Schaffer-Collateral-CA1 synapses 
after different in vivo treatments.  
All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. 
mEPSCs were recorded and amplitudes measured. For each neurone the mean 
mEPSC amplitude was taken, those values were then averaged and plotted as the 
































Figure 5.7 Miniature EPSC amplitude at Schaffer-Collateral-CA1 synapses 
after MOR or SAL treatments.  
Mice underwent either SAL or MOR treatment. mEPSCs were recorded and 
amplitudes measured in pA. Each event was ranked and plotted as a cumulative 































Figure 5.8 Miniature EPSC amplitude at Schaffer-Collateral-CA1 synapses 
after conditioned place preference.  
Mice underwent either SAL CPP or MOR CPP treatment.  mEPSCs were recorded 
and amplitudes in pA measured. Each event was ranked and plotted as a 




5.2.3 Properties of miniature excitatory post-synaptic currents following contingent 
and non-contingent in vivo morphine treatments 
In addition to providing information about release probability, miniature EPSCs can 
also provide information about the nature of synapses in neurones from which the 
events are recorded. Specifically, the rise times of events are generally seen as an 
indicator of how far away from the recording site the events occur (Smith et al. 
2003; Gonzales-Burgos et al. 2009; Han et al. 2013). For example, with whole-cell 
patch-clamp recordings, where the recording itself is taken from the cell soma, if a 
mEPSC occurs at a distal dendrite the rise time is longer (ie. slower) than if the 
event occurred at a proximal dendrite. Therefore, rise times can give an indication 
of either the level of dendritic arborisation in an individual neuron, or of the relative 
distribution of synapses along a neurone. Therefore, mEPSC rise times were 
analysed (for means see Figure 5.9, cumulative frequency plots 5.10 and 5.11). 
Unpaired t-tests failed to find any significant differences between the groups 
(P>0.05 for both SAL vs. MOR and SAL CPP vs. MOR CPP comparisons). K-S 
tests also failed to find any differences between the relative distributions of 
mEPSC rise times for SAL vs. MOR (P=0.46). There was a non-significant trend 
toward longer rise times in the MOR CPP group compared to SAL CPP however 
(P=0.09). It would interesting to know if this increase in mEPSC rise time is 
correlated in any way to AMPA:NMDA in individual cells, however these two 
measurements were never taken from the same cell due to technical issues (see 
Appendix).    
While rise times are an indicator of proximity of synapses from recording site, there 
is generally no correlation between decay times and rise times of miniature events, 
and decay times are thought of as an indicator of subunit composition (McBain & 
Dingledine, 1992; Okada et al., 2000; Smith et al., 2003). Analysis of mEPSC 
decay times revealed that there was no significant change in decay times between 
the different in vivo treatment groups (Figures 5.12 – 5.14).This supports the 
finding of earlier experiments (Figure 4.18) that suggested no change in AMPAR 








































Figure 5.9 Miniature EPSC rise times at Schaffer-Collateral-CA1 synapses 
after in vivo treatments.  
All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. 
mEPSCs were recorded and rise times in milliseconds (ms) measured. For each 
neurone the mean mEPSC rise time was taken, those values were then averaged 
and plotted as mean ± S.E.M. n = 4-5 per treatment group. Unpaired t-tests for 


































Figure 5.10 Miniature EPSC rise times at Schaffer-Collateral-CA1 synapses 
after SAL or MOR  treatments.  
Mice underwent either SAL or MOR treatment. mEPSCs were recorded and rise 
times measured (ms). Each event was ranked and plotted as a cumulative 



































Figure 5.11 Miniature EPSC rise times at Schaffer-Collateral-CA1 synapses 
after conditioned place preference.  
Mice underwent either SAL CPP or MOR CPP treatment.  mEPSCs were recorded 
and rise times (ms) measured. Each event was ranked and plotted as a 










































Figure 5.12 Miniature EPSC decay times at Schaffer-Collateral-CA1 synapses 
after in vivo treatments.  
All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. 
mEPSCs were recorded and decay times in milliseconds (ms) measured. For each 
neurone the mean mEPSC decay times (ms) was taken, those values were then 

































Figure 5.13 Miniature EPSC decay times at Schaffer-Collateral-CA1 synapses 
after SAL or MOR treatments.  
Mice underwent either SAL or MOR treatments. mEPSCs were recorded and 
decay times measured (ms). Each event was ranked and plotted as a cumulative 
frequency plot.  n = 4-5 neurones per treatment group. P = 0.2; K-S test. 
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Figure 5.14 Miniature EPSC decay times at Schaffer-Collateral-CA1 synapses 
after conditioned place preference.  
Mice underwent either SAL CPP or MOR CPP treatment.  mEPSCs were recorded 
and decay times (ms) measured. Each event was ranked and plotted as a 
cumulative frequency plot.  n = 4-5 neurones per treatment group. P = 0.3; K-S 
test.  
Summarising the results from Chapter 5 so far, it appears that MOR treatment may 
decrease glutamate release probability in CA1, whereas MOR CPP has less clear 
effects. This finding is based on the evidence that MOR treatment both increases 
paired pulse facilitation (Figure 5.1) and decreases the frequency of mEPSCs 
(Figure 5.4) whilst leaving the amplitude and decay times of mEPSCs unaffected 
(Figures 5.7 and 5.13). The effects of MOR CPP treatment seem much less clear, 
paired pulse facilitation is unaffected (Figure 5.1), mEPSC frequency is not 
affected significantly (although shows a decreasing trend, Figure 5.5), and 
amplitude and decay times are unaffected (Figures 5.8 and 5.14). It is worth noting 
that the possible decrease in mEPSC frequency in the MOR CPP group is not 
supported by the paired pulse facilitation data. This could suggest that mEPSC 
frequency measurements as an indicator of probability of glutamate release is a 
more sensitive measure, or more likely, that the trend to a decrease in mEPSC 
frequency suggested by the K-S test (p=0.06) is really due to chance.  
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As already mentioned in the Introduction, glutamate is not the only 
neurotransmitter in the CA1 area, numerous GABAergic interneurones as well as 
direct GABAergic projections from the septal nuclei also exist. During the 
recording of mEPSCs, the glutamate miniature synaptic events were isolated by 
clamping the membrane potential close to the equilibrium potential (Veq) of chloride 
ions. This reduced GABAA mediated currents to undetectable levels (see Figure 
5.3(A)).  It was possible therefore to also study miniature synaptic GABAergic 
events by clamping the membrane potential close to the reversal potential for the 
glutamate mediated current (see below).    
5.2.4 Miniature inhibitory post-synaptic currents following in vivo treatments 
In addition to measuring release of glutamate onto CA1 neurones, release of 
GABA was assessed by recording miniature IPSCs (mIPSCs). Figures 5.15 – 5.17 
show that there was a significant increase in mIPSC inter-event interval, and so a 
significant decrease in mIPSC frequency, both in the MOR and MOR CPP groups. 
Although when data were averaged and analysed using unpaired t-tests (Figure 
5.15) there was only a non-significant trend, there was a clear increase when 
cumulative frequency plots were analysed using the Kolmogorov-Smirnov 
statistical test (Figures 5.16-5.17). 
These data suggest that there was a significant decrease in probability of GABA 
release onto CA1 neurones in brain slices taken either from MOR or MOR CPP 
treated animals. As with mEPSCs, to confirm that a decrease in mIPSC frequency 
is truly a reflection of decreased probability of transmitter release, it is important to 
ascertain that mIPSC amplitude is not affected. Figures 5.18 – 5.20 show that prior 







































Figure 5.15 Miniature IPSC frequency at Schaffer-Collateral-CA1 synapses 
after in vivo treatments.  
(A) A representative example of a mIPSC recording. The addition of the GABAA 
antagonist picrotoxin (50µM) abolished all detected events, demonstrating all 
events where of GABAergic origin. (B) All mice underwent in vivo treatments; SAL 
(n=4 from 4 mice), MOR (n=3 from 3 mice),SAL CPP (n=4 from 4 mice), or MOR 
CPP(n=3 from 3 mice). mIPSCs were recorded and inter-event intervals 
measured. For each neurone the mean inter-event interval was taken, those 



































































Figure 5.16 Miniature IPSC frequency at Schaffer-Collateral-CA1 synapses 
after MOR or SAL treatments.  
(A) Mice underwent either SAL or MOR treatments. mIPSCs were recorded and 
inter-event intervals measured. Each event was ranked and plotted as a 
cumulative frequency plot. SAL vs. MOR, P = 0.004 in K-S test. (B) Representative 
sample (1 second) of each test group. Calibration bars are set to 200ms and 
10pA. 













































Figure 5.17 Miniature IPSC frequency at Schaffer-Collateral-CA1 synapses 
after conditioned place preference.  
(A) Mice underwent either SAL CPP or MOR CPP treatment.  mIPSCs were 
recorded and inter-event intervals measured. Each event was ranked and plotted 
as a cumulative frequency plot.  n = 3-4 neurones per treatment group. P <0.001; 
K-S test. (B) Representative sample (1 second) of each test group. Calibration 
bars are set to 200ms and 10pA. 





































































Figure 5.18 Miniature IPSC amplitude at Schaffer-Collateral-CA1 synapses 
after in vivo treatments.  
All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. 
mIPSCs were recorded and amplitudes measured. For each neurone the mean 
mIPSC amplitude was taken, those values were then averaged and plotted as 

































Figure 5.19 Miniature IPSC amplitude at Schaffer-Collateral-CA1 synapses 
after SAL or MOR treatments.  
Mice underwent either SAL or MOR treatment. mIPSCs were recorded and 
amplitudes measured (pA). Each event was ranked and plotted as a cumulative 

































Figure 5.20 Miniature IPSC amplitude at Schaffer-Collateral-CA1 synapses 
after conditioned place preference.  
Mice underwent either SAL CPP or MOR CPP treatment.  mIPSCs were recorded 
and amplitudes (pA) measured. Each event was ranked and plotted as a 




5.2.5 Properties of miniature inhibitory post-synaptic currents following in vivo 
morphine treatments 
As with mEPSCs, additional synaptic information can be gathered by the analysis 
of mIPSC events by analysing rise times and decay times. Figures 5.21 – 5.23 
show that there was an apparent increase in the mIPSC rise time in the MOR 
treated group, but not in the MOR CPP group. Although there was a non-
significant trend when rise times were averaged, when the cumulative frequency 
plot was analysed with the Kolmogorov-Smirnov test, the difference between rise 
times in the SAL and MOR groups was highly significant. 
Unlike with rise times, there was no significant difference in mIPSC decay times 
between each treatment group (Figures 5.24 to 5.26). 
Put together, these data from mIPSC recordings suggest that morphine, whether 
administered in a specific context or not, results in an overall decrease in 
probability of GABA release onto CA1 neurones (assuming GABAA currents are 
representative of neurone wide GABA activity). Furthermore, the significant 
increase in rise times only in the MOR treatment group suggests that a greater 
proportion of GABAergic synapses are now at more distal dendritic locations. 
There are two possible explanations for this. The first explanation also considers 
the decrease in GABAergic release probability, concluding that the reduction may 
have occurred selectively at proximally located GABAergic synapses. A problem 
with this argument is that it fails to explain why in the MOR CPP group no increase 
in rise times are seen but a decrease in GABAergic release probability is. The 
second explanation is that the creation of more GABAergic synapses at distal 
locations is coupled with a global decrease in release probability. This argument is 
also supported by evidence from Figure 4.7 that suggested that whole cell 
capacitance is selectively increased in the MOR treated group. Perhaps therefore 
this increase in whole cell capacitance is due to the formation of new distally 















































Figure 5.21 Miniature IPSC rise times at Schaffer-Collateral-CA1 synapses 
after contingent and non-contingent morphine and saline treatments.  
All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. 
mIPSCs were recorded and rise times in milliseconds (ms) measured. For each 
neurone the mean mIPSC amplitude was taken, those values were then averaged 


































Figure 5.22 Miniature IPSC rise times at Schaffer-Collateral-CA1 synapses 
after SAL or MOR treatments.  
Mice underwent either SAL or MOR in vivo treatments. mIPSCs were recorded 
and rise times measured (ms). Each event was ranked and plotted as a 

































Figure 5.23 Miniature IPSC rise times at Schaffer-Collateral-CA1 synapses 
after conditioned place preference.  
Mice underwent either SAL CPP or MOR CPP treatment.  mIPSCs were recorded 
and rise times (ms) measured. Each event was ranked and plotted as a 


















































Figure 5.24 Miniature IPSC decay times at Schaffer-Collateral-CA1 synapses 
after in vivo treatments.  
All mice underwent in vivo treatments; SAL, MOR, SAL CPP or MOR CPP. 
mIPSCs were recorded and decay times in milliseconds (ms) measured. For each 
neurone the mean mIPSC decay time was taken, those values were then 
































Figure 5.25 Miniature IPSC decay times at Schaffer-Collateral-CA1 synapses 
after SAL or MOR treatment.  
Mice underwent either SAL or MOR treatment.  mIPSCs were recorded and decay 
times measured (ms). Each event was ranked and plotted as a cumulative 


































Figure 5.26 Miniature IPSC decay times at Schaffer-Collateral-CA1 synapses 
after conditioned place preference.  
Mice underwent either SAL CPP or MOR CPP. mIPSCs were recorded and decay 
times (ms) measured. Each event was ranked and plotted as a cumulative 
frequency plot.  n = 3-4 neurones per treatment group. P = 0.3; K-S test.  
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5.3  Summary 
In this chapter the presynaptic properties of synapses on CA1 pyramidal cell 
dendrites were examined. The major findings were that non-contingent morphine 
(MOR) treatment appeared to reduce neurotransmitter release probability at both 
glutamatergic and GABAergic synapses. On the other hand, MOR CPP treatment 
appeared to either mask or prevent the decrease in glutamatergic release 
probability whilst GABAergic release probability remained reduced. In the MOR 
group, but not in the MOR CPP group, there was also an increase in rise times of 
miniature IPSCs, indicative of proportionally more GABAergic events coming from 
more distal dendritic synapses. Together with the finding that miniature IPSC 
frequency was decreased in this group this suggests that non-contingent MOR 
treatment selectively prunes GABAergic input at more proximal synapses in these 
neurones. This effect was seemingly absent in the MOR CPP treated animals. 
While this result would undoubtedly be an interesting one, the shape of the curves 
in Figure 5.22 suggests that more experiments are needed to confirm this result.  
This chapter concludes the Results section of this work. In the following chapter 
these results are discussed in the context of current literature and implications of 







Chapter 6: General Discussion 
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6.1  Introduction 
In this chapter, the results from Chapters 3, 4 and 5 are discussed. The chapter 
will begin with a discussion of the conditioned place preference protocol and its 
implications for the interpretation of the electrophysiological data. Next, the effects 
of morphine and morphine-induced CPP on stimulus-induced LTP are interpreted, 
first separately and then together in an attempt to identify any specific effects of 
drug related learning. This pattern (treating the four experimental groups first as 
two individual experiments (SAL vs. MOR and SAL CPP vs. MOR CPP) then 
together as one experiment), is then repeated in further sections considering the 
likely location and mechanism of these changes. 
6.2  Morphine-induced conditioned place preference 
In both Figure 3.3 and Figure 4.1 subjects in the MOR CPP group spent 
significantly more time in the drug-paired compartment on the test day compared 
to the pre-test day. The purpose of demonstrating CPP prior to electrophysiological 
analysis was in order to study the effects of drug-induced, addiction-related 
behaviour in the hippocampus. The main aim of this experiment was therefore to 
demonstrate the formation of a place preference to morphine, the expression of 
which must depend on the formation of drug-environment associations.  
The CPP paradigm is perhaps the most widely used model of drug seeking 
behaviour in use today. Despite its popularity, consensus is yet to be reached 
regarding what particular behavioural construct of addiction it actually measures 
(Bardo and Bevins, 2000). As previously discussed, rodent models of a complex 
human behaviour such as drug addiction are likely never to be wholly adequate 
representations of the condition. Particular isolated aspects of the behaviour 
(constructs) are therefore often modelled in rodents in an attempt to produce 
relatively simple, reproducible tests with predictive validity in humans. Whatever 
particular behavioural construct CPP actually models, it has proven to be reliable 
in predicting the efficacy of several approved treatments for relapse prevention 
(such as naltrexone, a treatment approved for the treatment of opiate and alcohol 
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dependence). For an up to date overview of the successes of CPP in this context 
see Napier et al. 2013.   
There exists some subtle differences between reported CPP methods in this study 
and those used by other laboratories, generally each laboratory has its own 
optimal conditions for demonstrating CPP. The most obvious division in the choice 
of apparatus is that between two and three chamber designs. The three-chamber 
design, with a small middle chamber that is paired to neither the vehicle or drug, is 
perhaps the most commonly used apparatus in the literature for three main 
reasons. Firstly, it provides a start compartment for the pre and post-conditioning 
trials. This prevents the experimenter introducing bias into the experiment by 
placing the animal in either one of the conditioning compartments, a 'forced choice' 
(Parker, 1992). Secondly, it also allows for the control of any confounding novelty 
driven preference to the drug-paired environment. Scoles and Siegel (1986) first 
argued that a rodent’s innate preference for a novel environment could be 
expressed in the post-conditioning trial, based on the assumption that a drug’s 
effect was to attenuate the habituation to the drug-paired environment (Scoles and 
Siegel, 1986). This issue was largely addressed by Parker (1992) and is solved by 
the presence of a third compartment that the animal will have experienced in a 
drug free state only once (the same number of times that the drug-paired 
environment would have been experienced in a drug-free state). In this study, no 
significant changes in the time spent in the middle compartment was observed for 
any of the experimental groups, supporting the suggestion that under these 
conditions novelty was not a significant factor influencing CPP scores. Thirdly, the 
three chamber design allows for the dissociation between preference for the drug, 
and aversion for the vehicle. Any aversion for the vehicle would be presumably 
expressed equally between the middle and drug-paired compartments. The fact 
that no change in the time spent in the middle compartment was detected supports 
the conclusion that vehicle aversion was not a significant factor under these 
conditions (data not shown). The two chambered model does have advantages 
however, for instance there seems to be no standard way of dealing with the time 
spent in the third compartment (Cunningham et al. 2003). For the fEPSP 
recordings a three chambered design was used. After optimisation during 
preparation of the patch clamp experiments, the design was switched to a two 
chambered design. The reasons for this were due to both variability in the control 
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animals behaviour, and the simplicity of the analysis. The two chambered model 
may represent a simpler choice for the animal, particularly important when 
attempting to optimise the reproducibility of any such CPP experiment. The 
reasons underlying this change in experimental protocol are discussed in further 
detail in the Appendix (Section A.1).  
Another important contrast in apparatus design is whether or not the subjects have 
any innate preference for one environment over the other. Apparatus that results in 
the expression of this innate preference for one particular environment (apparatus 
bias) is known as a biased design and has important implications for interpretation 
of the experiment. Biased designs were once the favoured method in CPP studies, 
although this has now become less popular (Schechter, 1998). Cunningham et al. 
(2003) did an extensive study on the role of apparatus bias on place conditioning 
in mice. They found that when using apparatus that resulted in strong initial 
preferences, then place preference was only expressed if the drug-paired 
compartment was assigned as the initially least preferred side (Cunningham et al. 
2003). One possible criticism of the biased design is that it is possible that the 
apparent initial preference was in fact the expression of an aversion for the least 
preferred side. If this was the case, then any anxiolytic effect of conditioning could 
be interpreted as preference (Carr, 1989). In fact this conclusion had been 
reached in a very early paper investigating the effects of heroin on place 
preference (Schenk, 1985). Cunningham et al. (2003) argued this anxiolytic effect 
was unlikely to account for all the observed changes in their experiment, as 
exactly the same experimental method produced CPP in an unbiased apparatus. 
The exact same argument could be applied to the data presented here, the 
effectiveness of the protocol for inducing CPP in the two chambered design 
(Figure 4.1) validates the previously performed three chambered experiment 
(Figure 3.3). The three chambered apparatus was an innately biased apparatus, 
one side being black while the other was white. The demonstration of place 
preference was expressed as an increase in the preference score on the test day 
compared to the pre-conditioning preference score. While during initial 
optimisation of the experiment this biased method gave the largest effect, the mice 
did not actually show a absolute preference for the drug-paired compartment. Due 
to concerns over the validity of such a model (see Appendix Section A.1) an 
unbiased design was chosen during the second round of optimisation when the 
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patch clamp experiments were being set up. One rather surprising fact is that 
although generally more highly regarded, the unbiased design has no standard 
definition. It is often difficult to tell apart studies that use a truly unbiased apparatus 
and studies that use a biased apparatus combined with the counterbalanced 
selection of drug-paired contexts (often reported as unbiased). The way in which 
the data are presented often hides any initial apparatus bias, if present 
(Cunningham et al. 2003). In the two chambered design (Figure 4.1), no significant 
preference in the pre-test score was detected (defined according to their 
environmental cues) and can therefore be defined as truly non-biased.  
The two chambered experiment (Figure 4.1) was truly non-biased, and the drug-
paired compartment randomly split between the two environmental contexts. The 
development of preference therefore can only be due to the drug-context pairing or 
aversion to the vehicle, as these were the only constant factors across subjects. 
Aversion for the vehicle is indistinguishable from preference for the drug in the two 
chambered design. Using a three chambered design however, aversion for the 
vehicle may be expressed as an increase in both the drug-paired and neutral 
middle compartments. As already mentioned, no change in the amount of time 
spent in the middle compartment was observed in this design; therefore it is 
unlikely that exactly the same vehicle injections would cause an aversion in the 
two chambered design (Figure 4.1)  
The induction and expression of CPP bears the hallmarks of a Pavlovian learning 
process, requiring temporal contiguity of the unconditioned and conditioned stimuli 
as well as being subject to latent inhibition (where familiarity with the CS 
attenuates the subsequent development of US-CS associations), extinction and 
recovery. There are significant differences between classical Pavlovian 
conditioning and CPP however. One such example is that the conditioned 
response (the approach behaviour underlying CPP) cannot be exhibited during 
conditioning due to the animal being confined to one particular compartment. 
Further support for the idea that CPP may be more complex than simple Pavlovian 
conditioning comes from the finding that restraining rats during conditioning does 
not prevent the induction of CPP (Carr et al. 1988). CPP is therefore not predicted 
by the model of primary Pavlovian conditioning. Bardo and Bevins (2000) 
attempted to address this and other issues surrounding CPP, concluding that it 
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may be the expression of second order Pavlovian conditioning. As already 
mentioned in the Introduction, second order Pavlovian conditioning is where a 
normally neutral stimulus (CS) acquires the reinforcing properties of an 
unconditioned stimulus (US) through repeated contiguous pairings. In the case of 
CPP, the CS is presumed to be the features unique to (or context of) the drug-
paired side of the CPP apparatus. A significant prediction of this hypothesis is that 
an increase in the probability of behaviour(s) underlying CPP would be seen 
during the test session, due to the reinforcement of the preference behaviour by 
the drug-paired context (secondary reinforcement). To the author’s knowledge, 
four studies have addressed this issue (Bardo et al. 1984; Bozarth 1987; Mueller 
and Stewart, 2000; German and Fields, 2006) however none of these studies 
found any evidence that preference increases as the test session continues. In 
support of these findings, there was no apparent difference in subject behaviour 
during the initial or final 15 minutes of the test session in this study (data not 
shown).  
A popular hypothesis is that CPP may be the expression of a conditioned 
approach response (CR) learnt through primary Pavlovian learning processes, 
similar to so called auto-shaping (Robbins and Everitt, 2002). This hypothesis 
states that CPP is the result of context-reward associations (presumably learnt 
through primary Pavlovian conditioning) influencing some sort of other exploratory 
behaviour. German and Fields (2006) proposed that the expression of CPP was 
due to an increased probability of the subject (a rat in their case) choosing to enter 
the drug-paired context. They arrived at this hypothesis after measuring two major 
behavioural parameters in their model of CPP, visit duration and visit frequency. 
Firstly they observed that while mean visit duration in the morphine-paired 
environment did not increase, visit frequency did. Secondly, the visit duration 
distribution of the morphine-paired environment suggested a constant exit 
probability (an exponential decrease in frequency of increasing visit durations) 
rather than a change in intended visit duration (presumably resulting in shift in a 
Gaussian distribution of visit durations around the intended visit duration value). 
This result is important as it suggests that two separate processes could be at 
work in CPP, the learning of Pavlovian drug-context associations, and the 
expression of CPP through the influence of these learnt associations on natural 
exploratory behaviour.  
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Despite the unresolved theoretical issues surrounding CPP, there is general 
agreement that some form of Pavlovian learning of drug-context associations 
occurs during CPP. It could be expected therefore, that the hippocampus 
(generally regarded as the location for encoding aspects of contextual and spatial 
information, as well as playing a wider role in the development of addiction-related 
behaviour) would play a role in CPP behaviours. Indeed lesions of the 
hippocampus can prevent the development of CPP (Ferbinteanu and Mcdonald, 
2001), and the administration of morphine locally in to the hippocampus may even 
be sufficient to induce CPP (Corrigall and Linseman, 1988). Despite this fact, no 
demonstration of functional changes in hippocampal synaptic transmission after 
CPP have ever been published, these changes form the basis for the remaining 
discussion.  
6.3  Effects of morphine treatment on fEPSP recordings 
Extracellular field EPSP recordings (fEPSPs) revealed that non-contingent MOR 
treatment attenuated stimulus-induced LTP at Schaffer collateral-CA1 synapses 
(Figure 3.4). The effects of chronic morphine treatments on stimulus-induced LTP 
in CA1 have been addressed by numerous previous studies (Pu et al. 2002; 
Salmanzadeh et al. 2003; Bao et al. 2007, Lu et al. 2010; Xia et al. 2011). In many 
of these studies chronic courses of morphine impair the extent of any 
experimentally-induced LTP - in agreement with this study (although see Mansouri, 
1999; Billa et al. 2010). The reasons given for this decrease in inducible LTP are 
varied. Pu et al. (2002) suggest that increased PKA activity in response to opiate 
withdrawal may over activate CaMKII (a key mediator of NMDAR-LTP, see 
Introduction), causing a saturation of LTP. This could result in an apparent 
decrease in inducible LTP. Bao et al. (2007) also conclude that this attenuation of 
induced LTP is due to PKA over activation. PKA overactivation is a hallmark of 
opiate withdrawal, produced by the result of a homeostatic response to the chronic 
inhibition of PKA by the Gi/o coupled µ opioid receptor. In both these studies very 
intense courses of morphine treatment were utilised (18 injections of 10mg kg-1, 
each injection separated by 12 hours, Bao et al. 2007; 20 injections of 10mg kg-1, 
each injection separated by 12 hours, Pu et al. 2002). The authors make clear that 
they presume the observed effects are due to withdrawal. Although their 
observations are consistent with those of the present study, the morphine 
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treatments used here (2 injections of 10mg kg-1, each injection separated by 48 
hours and with preparation of slices performed at least 48 hours after the final 
morphine injection), are much less likely to induce dependence and withdrawal.  
Lu et al. (2010) attempted to observe the effects of morphine treatment that were 
not due to withdrawal. They showed that increased extracellular adenosine 
induced by morphine treatment is not correlated with behavioural signs of 
withdrawal, and that re-exposure of brain slices to morphine does not reduce this 
adenosine concentration. However the injection paradigm they used (a total of 14 
injections, injection interval 12 hours, dose increasing from 20 mg kg-1 on day one 
to 100 mg kg-1 on day 7) is not well suited to looking at effects of morphine 
independent from withdrawal. Despite this fact they propose that these increases 
in extracellular adenosine act to reduce stimulus-induced LTP through an A1 
receptor dependent mechanism. Adenosine A1 receptors are expressed both pre 
and post synaptically in the hippocampus and reduce pre-synaptic transmitter 
release as well as inhibiting NMDAR currents. If the effects observed by Lu et al. 
(2010) were indeed the same as those seen in the present study, then both a 
reduction in transmitter release as well as a reduction in NMDAR-meditated 
current should have been observed in the patch clamp studies, indeed this 
hypothesis could fit the patch clamp data (discussed later, see Figures 4.2, 5.1 and 
5.19).    
Salmanzadeh et al. (2003) observed a slightly different effect of morphine to those 
papers already discussed (Lu, 2010; Bao, 2007; Pu, 2002). Slices taken from 
morphine treated animals showed an attenuated LTP when the slices were 
maintained in a solution containing morphine. Slices from naive animals kept in the 
same morphine solution exhibited normal LTP, as did slices from morphine treated 
animals kept in morphine free solution. There are a number of possible reasons for 
the differences between this study and those that have already been discussed 
(Lu, 2010; Bao, 2007; Pu, 2002). Firstly, Salmanzadeh et al. used morphine added 
to the drinking water, whereas all other studies mentioned (including the present 
one) used experimenter administered bolus injections of morphine. There are two 
possible interpretations of this difference. The first explanation is that while 
experimenter administered morphine represents a completely passive model of 
morphine administration (with no Pavlovian learning occurring), morphine added to 
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the drinking water could be seen as a model of non-operant self-administration. 
The second possibility is that while morphine added to the drinking water 
represents a passive model of morphine administration, experimenter 
administered morphine is actually a model of Pavlovian learning where certain 
elements of the protocol are learnt to predict the arrival of the morphine. There is 
evidence that experimenter administered morphine and morphine delivered by a 
computer controlled cannula (with no predictive cues) do in fact differentially affect 
AMPA:NMDA in the dopaminergic neurones of the ventral tegmental area (Chen et 
al. 2008). In this study, comparing the effects of an inappropriate vehicle control 
(SAL) to a model of drug-environment learning (MOR CPP) masked the 
attenuation in stimulus-induced LTP normally induced by morphine (see Figures 
3.4 and 3.5). This result suggests that the combined effects of drug-environment 
learning and pharmacological actions of morphine could have combined in the 
Salmanzadeh et al. study to mask each other. This argument could equally be 
applied to the findings of Billa et al. (2010a) although potential drug-predictive 
cues would be harder to identify.  
An alternative explanation often given for contradictory results in experiments such 
as these is that the stimulation protocols used where different. The Salmanzadeh 
study induced LTP using primed burst stimulation, an induction method that makes 
use of the oscillatory nature of hippocampal activity (see Introduction). If changes 
in GABA activity during morphine treatment were responsible for the reduction in 
stimulus-induced LTP seen in other studies, then the Salmanzadeh study may not 
have detected those changes due to the GABAB mediated auto-inhibition (none of 
the previous studies already discussed blocked GABA activity during LTP 
induction). In the present study, a theta burst induction protocol was used. This 
induction protocol also utilises GABAB mediated auto-inhibition to increase the 
depolarisation of the post-synaptic neurone, although a reduction in stimulus-
induced LTP was observed (Figure 3.4). This finding suggests that changes in 
GABA activity after morphine treatment were not responsible for these 
discrepancies.  
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6.4  Effects of morphine-induced CPP on fEPSP Recordings 
MOR CPP induced no changes in stimulus-induced LTP that could not be 
explained by a combination of the effects of MOR treatment and the effects of SAL 
CPP treatment combined. The overall effect of morphine in MOR or MOR CPP 
treatment paradigms seemed to be indistinguishable - that is a attenuation in 
stimulus-induced LTP compared to appropriate vehicle controls (SAL or SAL CPP 
respectively Figure 3.7). The overall effect of exposure to the CPP apparatus 
appeared to be similar when comparing MOR to MOR CPP or SAL to SAL CPP - 
that is a augmentation in stimulus-induced LTP (Figure 3.7). The apparent lack of 
change when comparing SAL to MOR CPP therefore (as many studies do) may in 
reality be the effects of morphine and the separate effects of CPP training 
overlying and cancelling each other.  
The observation that SAL CPP treatment appeared to cause an increase in the 
magnitude of stimulus-induced LTP that was roughly equal in size to the reduction 
seen in the MOR group was surprising. This was particularly surprising as the 
major predicted confounding factor in this kind of behavioural protocol was stress 
induced by the exposure of the mice to novel environments or the injection 
protocol. Stress has a well documented role in the impairment of hippocampal 
stimulus-induced LTP (for a review see Kumar, 2011). So to confirm this effect was 
not due to stress, naive mice having received no handling or behavioural 
interventions whatsoever where compared with mice that had received SAL 
treatment. As expected SAL treatment caused a small but not statistically 
significant decrease in the magnitude of stimulus-induced LTP. One possibility for 
this surprising result is that entry into the CPP apparatus could represent a form of 
environmental enrichment (EE). EE has been shown to reverse the impairment in 
stimulus-induced LTP (Solinas et al. 2010) as well as reducing the expression of 
CPP to cocaine or even extinguishing it (Chauvet et al. 2008). The results 
presented here suggest that although EE (the CPP protocol in this case) can 
apparently reverse the reduction in inducible LTP in the hippocampus, this is not 
correlated to any reduction in drug seeking behaviour (measured using the CPP 
model) as the MOR CPP group expressed preference for the drug-paired side.    
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One other interesting effect noted in the Results section was a large increase in 
variability of the data from both MOR CPP and SAL CPP groups (Figure 3.8). 
Based on the hypothesis that stimulus-induced LTP is reduced if LTP has already 
taken place at those synapses in vivo, it was reasoned that perhaps this variability 
represented different 'amounts' of learning (meaning perhaps the amount of 
inducible LTP in the slice was correlated somehow to how familiar the subject had 
become with the place preference apparatus). A correlation plot was therefore 
drawn comparing preference score and magnitude of inducible LTP (Figure 3.12) 
although no significant relationship was found. This result does not necessarily 
suggest that there is no correlation between learning and LTP however, perhaps 
just the method of measuring the learning (behaviourally) was incorrect. As a 
deeper analysis of individual behaviour was not performed, there remains the 
possibility that some aspect of a subject’s behaviour would be predictive of the 
magnitude of inducible LTP. One interesting comparison that was not performed 
would be to compare the probability of drug-paired environment entry (as 
measured in German and Fields (2006)) with the magnitude of inducible LTP. 
Unfortunately this labour intensive analysis could not be performed due to time 
considerations. Another possible underlying cause of this increase in variability 
was the precise proximodistal/dorsoventral placement of the stimulating and 
recording electrodes. While every effort was made to standardise the placement of 
these electrodes some variability is unavoidable using current slicing and 
recording techniques. In a recent review Fanselow and Dong (2010) proposed the 
separation of each of the major hippocampal subfields (DG, CA3 and CA1) into 
three further structures, dorsal, intermediate and ventral for each subfield. This 
idea was based on the mounting behavioural and genetic data suggesting 
differences in these subfields along the dorsoventral axis. In the present study 
ventral hippocampal slices were prepared using a transverse slicing method, it 
was reasoned that the orientation of the dorsal hippocampus would prevent any 
slices being collected from this region. While this argument may be true, it is 
entirely possible that slices were collected from this intermediate zone as well as 
the ventral zone. The underlying cause of this variability therefore could be the fact 
that different dorsoventral portions of CA1 are affected differently by the CPP 
training, and that in this experiment the dorsoventral placement of electrodes was 
not sufficiently controlled. Regardless of the mechanism underlying this increased 
variability in the CPP groups, the fact that it was not unique to MOR CPP 
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suggested that this effect may not underlie the drug-induced behavioural 
adaptations seen in this group. 
Deducing a mechanism for the observed adaptations induced by morphine (when 
using fEPSP measurements as the only electrophysiological measurement) is 
complicated due to the numerous possible interpretations of this result. For 
example, morphine appears to reduce stimulus-induced LTP. It could be suggested 
that the observed reduction in stimulus-induced LTP could be due to prior in vivo 
LTP as a result of the drug treatment. The observed changes then would therefore 
be due to a kind of 'ceiling effect'. This possibility (and others) was discussed 
previously in Section 3.3. One possible way to investigate this using fEPSP 
measurements would be by the analysis of input output curves, but this would 
require a high number of repeats as the signal to noise ratio of such experiments is 
generally small. Another possibility is that some kind of other adaptation occurs in 
response to the pharmacological actions of the drug, such as a reduction in 
mGluR activation, or changes in extracellular adenosine concentrations. This 
explanation would therefore be that morphine reduces 'meta-plasticity' in CA1 
rather than inducing LTP itself. In an attempt to identify which of these scenarios 
was correct, and to further investigate the source of variation in both of the CPP 
groups, whole cell patch clamp was performed in the same hippocampal region 
using the same experimental groups.   
6.5  AMPA:NMDA is increased by morphine treatment 
The fEPSP recordings yielded two possible hypotheses surrounding the decrease 
in stimulus-induced LTP. The first was that prior in vivo LTP had occurred, the 
second was that metaplastic changes had occurred in vivo that affected 
subsequent ex vivo LTP (see Figure 3.16). In an attempt to further test these 
hypotheses whole cell patch clamp recordings were performed on individual 
hippocampal CA1 pyramidal cells whilst stimulating in the same location in the 
striatum radiatum. It was reasoned that if prior in vivo LTP had occurred (perhaps 
by NMDAR-LTP), then the ratio of current mediated by AMPARs should increase 
relative to the current mediated by NMDARs (as in Ungless et al. 2001). Indeed in 
this study, increased AMPA:NMDA in the non-contingent MOR group is consistent 
with the first hypothesis, that prior in vivo LTP had occurred (Figure 4.2). This 
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result comes with the caveat that if the decrease in stimulus-induced LTP was due 
to reduced NMDA then AMPA:NMDA could also have increased. Billa et al. 
(2010a) also studied the effects of experimenter administered morphine in CA1, 
using a combination of extracellular field recordings, patch clamp, and biochemical 
analysis. After repeated morphine administration they found increased 
AMPA:NMDA in agreement with this study (Billa et al. 2010). They also provided 
biochemical evidence to suggest that while AMPAR expression had increased, 
NMDAR expression remained unaffected. Therefore this study supports Billa et 
al's finding that experimenter administered morphine increases AMPA:NMDA 
through insertion of AMPARs in CA1 neurones, the extension of this argument is 
that in vivo an LTP-like mechanism occurs in response to the non-contingent 
morphine treatment.  
In contrast to this study, Billa et al. (2010a) did not observe any reduction in 
inducible LTP using extracellular field recordings. One possible reason for this 
result is that the high frequency stimulation protocol used in their study induced 
LTP via a different initial mechanism to the theta type stimulation utilised in this 
study. Differing patterns of presynaptic activity would be expected to produce 
different amounts of glutamate release from the presynaptic cell and may therefore 
activate unique combinations of receptors by spill over mechanisms. One 
hypothetical example of this situation could be that high frequency stimulation 
such as that used in Billa et al. (2x100Hz pulses of one second each) could 
activate the extrasynaptic mGluRs on the post-synaptic cell. If this were the case 
then any treatment that reduced mGluR activation in vivo would not be detected as 
a reduction in inducible LTP (mGluR activation may act as a molecular switch 
facilitating the induction of LTP for several hours after activation, see Introduction 
for more details). If theta-type stimulation such as that used in this study was 
dependent on prior mGluR activation in vivo then using this method would reveal 
the difference. This would suggest that morphine had metaplastic effects alongside 
insertion of AMPARs.  
Another possible way to reconcile these results is to assume that the injection 
paradigm used in Billa et al. (2010a) was in fact more akin to the MOR CPP group 
in this study. As the injection paradigm used did not include alternate saline 
injections, then many procedural aspects of the injection process will have been 
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predictive of imminent morphine reward, and therefore the effects of the drug may 
be confounded with the effects of reward related learning. This conclusion has 
been reached before, Chen et al. (2008) showed that cocaine induced increases in 
AMPA:NMDA in the VTA could be abolished by giving rats cocaine through a 
computerised cannula, rather than an experimenter administered ip injection. 
Comparing the SAL group (control) with the MOR CPP group (morphine plus a 
predictive cue) in this study would lead to the conclusion that morphine 
administration does not affect inducible LTP. In reality, the MOR CPP group result 
appears to be the combined effects of CPP (or in the case of Billa et al. some 
procedural aspect of the method) and MOR treatment (that does in fact attenuate 
inducible LTP in this study). This problem of separating pharmacological effects of 
a rewarding substance from unintended reward related learning (or more general 
learning as in the SAL CPP group) is common to many of the experimenter 
administered models in current literature. The results presented here suggest that 
the inclusion of alternate injections of saline may prevent procedural aspects of the 
method becoming predictive of reward, and therefore may prevent any adaptations 
related to learning. 
Evidence for an increase in absolute AMPAR function (and therefore synaptic 
efficacy) following any kind of treatment is difficult to observe as the natural 
variability in the number of functional synaptic connections, along with variations in 
the angle of cut when making the brain slices mean that synaptic responses have 
a large variability in amplitude. This variability is one of the problems that the use 
of AMPA:NMDA attempts to solve, and while it allows for the identification of a 
functional change in synaptic composition, it does less to inform as to the nature of 
the change. Ungless et al. (2001) when studying the VTA showed that this 
increase in AMPA:NMDA was accompanied by an increase in AMPA-induced 
current when AMPA was bath applied to the whole cell. In the current study no 
change in AMPA-induced current could be observed between MOR and SAL 
groups (Figure 4.17), this is in agreement with the Billa et al. (2010a) study also. It 
is possible this result is a false negative, as the significant variability in the data 
means that any change would have to be large. Reasons for this variability could 
include the natural variability in neurone size as well changes in drug availability at 
the receptors due to the changes in location and orientation of recorded neurones 
within the slice. The variability as a result of differences in availability could be 
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accounted for by using a longer drug application time (to allow equilibrium to be 
reached), this was attempted but after 12 minutes the AMPA-induced current had 
not reached a steady state and so the experiment was not repeated (data not 
shown). Alternatively, an increase in AMPA:NMDA could simply represent a shift of 
AMPARs from extra-synaptic sites to synaptic ones (and possibly reduce the 
current induced by brief applications of AMPA) this could further increase the 
chances of such a false negative result. To address this problem the total synaptic 
current amplitude at -70mV (and at 70% of max response) was analysed. As input-
output curves were generated at the beginning of each experiment, then total 
EPSC amplitude should be (theoretically) independent of stimulating electrode 
location. Therefore any increase in the mean value of EPSC amplitude could 
represent a greater number of synaptic AMPARs. Indeed the amplitude in MOR 
cells was significantly greater than the amplitude in SAL cells (Figure 4.9). One 
caveat of this measurement is that the number of AMPA receptors is dependent 
upon cell size (based on the assumption that a larger cell will have more 
synapses). In order to control for this possibility the amplitude of the EPSC can be 
divided by the measurement of whole cell capacitance. Whole cell capacitance 
arises as a result of the insulating properties of the lipid bilayer. The larger the cell 
surface area, the higher the capacitance. By normalising the results of the 
measured EPSC amplitudes by their respective whole cell capacitance the 
variability of cell size is controlled for, and the value becomes a measure of the 
density of synaptic AMPARs across the whole cell. After normalising by cell 
capacitance no significant difference in synaptic AMPAR density was observed 
(although the trend was still present, Figure 4.11). This suggests that an increase 
in the number of synapses (concurrent with an increase in cell size) was in fact 
responsible for the observed changes in EPSC amplitude between MOR and SAL. 
There appeared to be no correlation between cell size and AMPA:NMDA however, 
suggesting that the increase in AMPA:NMDA and the increase in EPSC amplitude 
were unrelated.   
In the present study, while AMPA:NMDA were increased (Figure 4.2), no evidence 
was found for either a change in subunit composition and only limited evidence of 
an increased overall AMPA function (Figures 4.9 and 4.11). While the AMPA:NMDA 
result is in agreement with previous reports (Billa et al. 2010), the present study 
failed to find evidence of an increase in GluR2 lacking AMPA receptors. One 
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possible reason for these discrepant findings is again differences in dosing 
patterns. Comparisons across studies using morphine as the addictive substance 
are frustratingly difficult to make as all too often the high doses given in quick 
succession mean the effects of drug withdrawal are inseparable from 
pharmacological actions or experience-dependent adaptations. In the case of Billa 
et al. (2010a), a rebounding over activation of PKA could be expected to increase 
phosphorylation of GluR1 and the insertion of GluR2-lacking AMPARs (Colledge et 
al. 2000). This would still not explain the observed increase in AMPA:NMDA 
common to both this study and Billa et al. (2010a) however, and this hypothesis 
must be treated with caution given the limited evidence of µ opioid receptors in 
hippocampal CA1 cells (Arvidsson et al. 1995).  
As this contradiction between this study and Billa et al. (2010a) was a little 
surprising, the possible reasons for a change in AMPA:NMDA were investigated 
using available literature. The possible reasons for an observed changes in 
AMPA:NMDA actually turn out to be many, as illustrated by the observations in 
other brain regions where measurements of AMPA:NMDA have been studied in 
more detail.  
The first observation of an addictive substance inducing a change in AMPA:NMDA 
was observed in the ventral-tegmental area (VTA) by Ungless et al. (2001). In the 
Ungless et al. (2001) paper the authors acknowledge that an increase in 
AMPA:NMDA alone does not provide strong evidence of an LTP-like change, as 
this change in AMPA:NMDA could also be due to changes in NMDA-mediated 
currents. Along with an increase in AMPA:NMDA therefore, Ungless et al. (2001) 
showed an increase in mEPSC frequency and amplitude, as well as an increase in 
the current induced by exogenously applied AMPA. In the same study the authors 
also studied AMPA:NMDA in the hippocampus although no change was observed 
following a single injection of cocaine. This increase in AMPA:NMDA was also 
observed in a later study by Saal et al. (2003) where they also showed that 
addictive substances with varying mechanisms of action (including morphine) 
increased AMPA:NMDA in VTA neurones. The mechanism of this increase in 
AMPA:NMDA has been extensively studied and may involve the insertion of GluR2 
lacking AMPARs (Dong et al. 2004, Engblom et al. 2008). This process has also 
been shown to be dependent upon both the NMDAR (Engblom et al. 2008; Zweifel 
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et al. 2008) and the D5 receptor (Argilli et al. 2008, Schilström et al. 2006). The 
necessary trigger for these adaptations seems to be the rise of dopamine within 
the VTA rather than any experience-dependent activity as in vitro application of 
cocaine on acute slices can also increase the AMPA:NMDA hours later (Argilli et 
al. 2008). The hippocampus receives a dopaminergic innervation from the VTA, 
and CA1 pyramidal neurones express D5 receptors and D1/5 activation can affect 
the induction of LTP and LTD in this area (Frey et al., 1991; Huang and Kandel, 
1995; Chen et al. 1996; Otmakhova and Lisman, 1996; Swanson-Park et al. 
1999). Dopamine release as a result of the pharmacological actions of an 
addictive substance may therefore affect LTP induction in the hippocampus. The 
idea is a compelling one, and suggests a mechanism by which in vivo morphine 
could have differing and indirect effects on hippocampal transmission.  
GluR2 lacking AMPARs are strongly inwardly rectifying, and so may contribute little 
to the AMPAR-mediated EPSC recorded at +40mV. Removal of NMDARs and 
insertion of calcium permeable AMPARs can have complex effects on the rules 
governing LTP induction in acute slices (Mameli et al. 2011), and could explain 
why researchers using different induction protocols see either an attenuation (Luu 
and Malenka, 2008) or augmentation (Liu et al. 2005) in inducible LTP. Although no 
evidence was found for a change in stoichiometry of AMPARs in this study, the 
data was far from conclusive. The data provided by Billa et al. (2010a) and Xia et 
al. (2011) suggest that GluR2 lacking AMPARs combined with differences in LTP 
induction protocol may have been responsible for the differences seen in stimulus-
induced LTP. One expected effect of changes in the sub-unit composition of AMPA 
receptors would be alterations in the decay times of mEPSCs. This is due to the 
fact that GluR2 lacking AMPARs display altered channel kinetics, including faster 
gating and higher single channel conductance (Liu and Cull-Candy, 2002). No 
evidence of changes in decay time could be observed in response to MOR 
treatment however (Figure 5.25), suggesting that no change in sub-unit 
composition occurred (although see Panicker et al. 2008). 
In the VTA there is also evidence that the insertion of AMPAR into the post-
synaptic membrane is coupled with a removal of NMDAR. This removal of the 
NMDAR would obviously increase any AMPA:NMDA measurement, and has been 
suggested to be the major contributory factor in any increase in AMPA:NMDA 
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(Mameli et al. 2011). Although attempts were made to directly measure NMDA-
mediated currents, seal instability at +40mV seemingly due to the presence of 
fluoride in the pipette solution prevented any consistent measurements.    
In the nucleus accumbens the picture appears to be much more complex. This 
complexity may in part, be due to the nucleus accumbens actually being a 
collection of functionally distinct structures tightly packed into a small space. The 
majority of neurones in the NAc are inhibitory GABAergic neurones known as 
medium spiny neurones (MSNs). These MSNs can be divided into two classes 
based on their function and receptor expression profile. The 'direct pathway' 
supposedly involved in the selection and initiation of movement contains Gs-
coupled D1 receptor expressing MSNs. The 'indirect pathway' is involved in the 
inhibition of movement and contains Gi-coupled D2 receptor expressing MSNs 
(Kreitzer and Malenka, 2008). As well as these two functionally distinct but 
physically intermingled pathways the NAc can be further divided into two sub-
regions the 'shell' and 'core' that may also have functionally distinct roles. 
Unfortunately nearly all the available literature studying the electrophysiological 
changes in the NAc following exposure to drugs of abuse uses cocaine as the test 
substance. Therefore there is no way of knowing whether these effects are due to 
the specific pharmacological properties of cocaine - or whether this is a common 
mechanism shared by all addictive substances. Repeated cocaine administration 
initially causes a decrease in AMPA:NMDA in the NAc shell (Thomas et al. 2001). 
This decrease was initially thought to be due to an LTD-like process occurring on 
the PFC input synapses (Thomas et al. 2001; Kourrich et al. 2007) although more 
recent evidence suggests that this decrease may be due to the production of silent 
synapses (Huang et al. 2009). Silent synapses are synapses with functional 
NMDARs but very little or no AMPARs (Malenka and Bear, 2004).  Acute cocaine 
administration is sufficient to increase dendritic spine density (Kolb et al. 2003) 
with more intense treatment regimens increasing the effect further. The hypothesis 
that this increase in spine density represents the formation of new synapses is 
supported by the finding that NR2B synaptic function is increased (Huang et al. 
2009). NR2B containing NMDA receptors are often used as a marker for immature 
synapses (Sheng et al. 1994). To further complicate matters - in cocaine withdrawn 
rats, a decrease in AMPA:NMDA is also seen (Kourrich et al. 2007) however this 
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time the effect is likely due to internalisation of AMPA receptors (Boudreau et al. 
2007).  
The increase in spine density following cocaine treatment in the nucleus 
accumbens could help explain the increased cell capacitance and EPSP amplitude 
seen in MOR treated mice in the present study (Figures 4.7 and 4.9). Cells with 
increased dendritic arborations may also exhibit higher AMPA:NMDA values 
(Andrasfalvy & Magee, 2001). Therefore one possible explanation for the above 
data is that MOR treatment increases the number of dendritic arborations. 
Presumably this would be due to the formation of new synaptic contacts, and so 
slices from MOR treated mice could be predicted to have an increased mEPSC 
frequency. The result of this experiment turns out to not be clear due to concurrent 
alterations in paired pulse facilitation (discussed later). Another way of observing 
possible increases in dendritic branching and synapse formation (that is 
independent of changes in release probability) is by studying the rise times of 
mEPSCs. Increased rise times may be associated with increased synapse-soma 
distances and therefore be a measure of dendritic growth (Smith et al. 2003; 
Gonzales-Burgos et al. 2009). Indeed increased rise times were observed for 
mIPSCs (Figure 5.22) and the trend was the same although not statistically 
significant for mEPSCs (Figure 5.10, P=0.1). Taken together, these findings 
suggest that creation of new synapses, particularly at distal dendrites, may play a 
part in the observed effects of MOR treatment. 
In summary then, the data shows AMPA:NMDA was increased in MOR compared 
to SAL. A detailed analysis of the literature reveals many possible mechanisms for 
increasing AMPA:NMDA but the precise mechanism at work here has not been 
conclusively identified. Regardless of the failure to find the precise mechanism for 
this increased AMPA:NMDA, this study provides good evidence that synaptic 
transmission in this region has been affected by morphine treatment. There also 
appears to be a related effect of MOR treatment in changing the cell morphology, 
this idea is supported by the increased whole cell capacitance, EPSC amplitude, 
and mIPSC rise times.  
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6.6  Morphine-induced CPP has complex effects on AMPA:NMDA  
Although no significant effects of MOR CPP on mean AMPA:NMDA values were 
seen when compared to SAL CPP (Figure 4.2), there was a similar increasing 
trend following MOR CPP as seen in the MOR/SAL comparison. What was 
immediately obvious looking at the data however, was the large increase in 
variability seen in the MOR CPP group. Some of the recordings appear to have 
very large AMPA:NMDA values while the majority express values similar to SAL 
CPP. The fact that this increase in variability was not seen in the MOR group 
suggests that the effect seen could not be attributable to differences in the 
biochemical response to morphine among sub-populations of cells. This suggests 
that there exists a sub-population of cells in the hippocampus that respond 
differently to morphine-induced CPP. A hypothesis was put forward that if LTP was 
a cellular correlate of memory, and AMPA:NMDA was a correlate of LTP; then 
perhaps the value of AMPA:NMDA was somehow correlated to the 'strength' of the 
memory. It was thought that perhaps those mice that had formed a stronger 
memory of the CPP apparatus would perform better in the CPP test. A correlation 
was drawn between AMPA:NMDA values and preference score (Figure 4.4) but no 
significant effect was detected. In fact, where more than one AMPA:NMDA value 
was taken from the same mouse, there appeared to be no difference between 
intra- and inter-subject variability (data not shown). This suggests that the 
AMPA:NMDA values between cells in CA1 for a single subject had become more 
variable, and so any correlation between any behavioural trait and AMPA:NMDA 
would be highly unlikely. It was reasoned that if this increase in AMPA:NMDA was 
due to increased dendritic arborisation (as may be the case in the nucleus 
accumbens) or some other mechanism (such as a decrease in the number of 
synapses proximal to the soma), then it was possible that changes in specific cell 
parameters could correlate with increased AMPA:NMDA in the MOR CPP group.   
In an attempt to look for any possible electrophysiological markers of those cells 
expressing high AMPA:NMDA values in the MOR CPP group, correlations were 
drawn for AMPA:NMDA values compared to each of the whole cell parameters 
measured. No correlations were observed between AMPA:NMDA and; the stimulus 
intensity required to elicit 75% EPSC (Figure 4.6), whole cell capacitance (Figure 
4.8), and the amplitude of 75% EPSC (Figure 4.10). There was a correlation 
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however, between AMPA:NMDA in MOR CPP and the holding current at -70mV 
(Figure 4.13). Although this correlation was quite weak (R2=0.24), it was 
reasonably significant (P=0.02, 95% confidence interval of r = 0.08 to 0.76). As 
mentioned in the results, holding current is determined by a function of both 
resting membrane potential and input resistance. This suggests that a small 
proportion of the variability seen in AMPA:NMDA was due to variation in cell size. 
This correlation was present across all treatment groups however, and there was 
no significant increase in variability seen in MOR CPP holding current values. This 
suggests that mechanisms other than changes in cell size were responsible for 
increasing the variability in the MOR CPP group.  
MOR CPP treatment had complex effects on AMPA:NMDA, with some neurones 
appearing to display very high AMPA:NMDA values while others appeared to be 
unchanged compared to SAL CPP or SAL. Assuming Billa et al. (2010a) were in 
fact observing a model of drug-induced learning, one could suggest that the 
insertion of GluR2-lacking AMPARs may be responsible for this increase. None of 
the above experiments provided evidence to support this conclusion however, 
under these conditions at least.  
It was not clear if this effect on AMPA:NMDA was the result of two overlapping 
processes, or if the different conditions experienced during morphine treatment 
induced a unique set of adaptations. At present the latter of these two explanations 
seems more likely as AMPA:NMDA values appeared to be unchanged in the SAL 
CPP group compared to SAL group. Again, no specific mechanism or 
electrophysiological marker unique to the adaptations seen in the MOR CPP group 
was identified, although in general it appeared that larger cells may express higher 
AMPA:NMDA values. This increase in AMPA:NMDA in larger cells has been 
previously reported (Andrasfalvy & Magee, 2001) and may represent a mechanism 
of distance-dependent scaling. Distance-dependent scaling is a mechanism that 
serves to balance the effects that proximal and distant EPSCs have over somatic 
membrane potential. One possibility therefore is that AMPA:NMDA could increase 
through increases in the relative amount of distal synapses (either the creation or 
destruction of synapses). The data presented here suggests that synapse creation 
could be the mechanism, as whole cell capacitance was increased in the MOR 
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group and input resistance appeared to decrease with increasing AMPA:NMDA 
across the groups.  
A marker often used for the detection of newly created synapses is the NR2B 
subunit of the NMDAR, with smaller less stable synapses expressing greater 
levels of NR2B. As already mentioned in the introduction NMDA receptors consist 
of tetrameric assemblies of NR1 and NR2 subunits. The NR1 subunit is a 
constructive subunit that is required for functional NMDARs. The NR2 subunits (A-
D) modulate the kinetics of the receptor. In the hippocampus NR2A and NR2B are 
the major subunit types, and the ratio NR2A:NR2B may modulate the induction of 
LTP (a metaplastic mechanism). It would be interesting to see if those cells 
expressing increased AMPA:NMDA also expressed greater sensitivity to NR2B 
subunit selective NMDAR antagonists, such as ifenprodil. It has already been 
demonstrated that NR2B expression is increased in the hippocampus after 
morphine-induced place preference but not after place preference induced by 
natural rewards such as novelty, social interaction or food (Ma et al. 2006). 
Ifenprodil has also been shown to be effective systemically in preventing the 
induction, expression and reinstatement of morphine-induced place preference 
(Ma et al. 2011). NR2B containing receptors have slower channel closing rates 
than NR2A containing NMDARs and therefore conduct more calcium per activation 
(Yashiro and Philpot, 2008). Lower NR2A:NR2B values may then lower the LTP 
induction threshold and provide a mechanism for the possible increase of in vivo 
LTP seen in both MOR and MOR CPP groups.       
6.7  Glutamate release is reduced by MOR treatment 
The paired pulse ratio, measured by comparing two stimulated EPSCs triggered in 
quick succession, is often used to give a measure of release probability in the pre-
synaptic terminal (Stevens, 1999). Paired pulse ratios were significantly increased 
in the non-contingent MOR group compared to SAL but remained unchanged in 
MOR CPP compared to SAL CPP (Figure 5.1). An increase in paired pulse ratio is 
often interpreted as a reduction in the probability of neurotransmitter release (Pr) 
from the presynaptic terminal, although there are alternative ways of interpreting 
the data. One possible interpretation of these data (that also accounts for the 
increased AMPA:NMDA seen in MOR) would be that postsynaptic 'unsilencing' of 
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synapses (insertion of AMPARs into synapses where there was previously none) 
could reveal a previously undetected population of presynaptic terminals with low 
Pr values. A prediction of this hypothesis would be that the frequency of mEPSCs 
would increase, as this value is a function of Pr and the total number of synapses. 
mEPSC frequency was in fact decreased in MOR treated subjects (Figure 5.4), 
supporting the hypothesis that the increased paired pulse ratio seen in MOR was 
in fact due to a decrease in Pr. While initially this decrease in Pr in the MOR group 
(a LTD-like change) seemed at odds with the rise in AMPA:NMDA (a LTP-like 
change) this finding does have support from the literature. Xu et al. (2004) showed 
that following a chronic course of morphine (and naloxone-precipitated withdrawal) 
the activity of SNAP-25 was reduced. SNAP-25 is a key mediator of calcium-
induced exocytosis and so neurotransmitter release would be predicted to be 
reduced. Marie-Claire et al. (2007) studied changes in gene expression after an 
extended CPP paradigm (training was 23 days long involving a total of 11 
morphine injections). They found 13 different genes were differentially expressed 
in the hippocampus compared to saline controls, and one of their major 
conclusions was a reduction in neurotransmitter release.   
As already mentioned in the introduction, the effects of in vivo morphine 
treatments on CA1 hippocampal neurones can be through network changes but 
also by morphine acting directly on the hippocampus through activation of µ-opioid 
receptors, although activation of other subtypes of receptors may play a role (Billa 
et al. 2010b). These Gi/o coupled receptors are thought to be located 
presynaptically on inhibitory GABAergic terminals. The expected actions of 
morphine would therefore be an increase in glutamatergic transmission through 
disinhibition. This classical model of the acute actions of morphine could be 
applied to the findings in this study where changes were seen long after cessation 
of in vivo morphine treatments. This suggests that the prolonged reduction in 
transmitter release seen here following morphine treatment could be some sort of 
homeostatic mechanism, in response to the over-activation of CA1 neurones. A 
prediction of this hypothesis is that high levels of activity in CA1 would be 
predicted to also cause a shift in the threshold of LTP (metaplasticity) making LTP 
induction less likely. This argument is supported by data from this study (Figure 
3.4) and others (Pu et al. 2002; Salmanzadeh et al. 2003; Bao et al. 2007, Lu et al. 
2010; Xia et al. 2011). In vivo however, acute (or chronic) administrations of 
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morphine appear to reduce extracellular concentrations of glutamate measured by 
microdialysis (Guo et al. 2005). The actions of morphine may therefore be radically 
different in vivo compared to in vitro, this finding suggests caution must be excised 
when attempting to predict the actions of a drug from in vitro studies.  
6.8  Glutamate release is unaffected by MOR CPP treatment 
The possible decrease in glutamate Pr discussed above was not present in 
comparisons between SAL CPP and MOR CPP (see Figures 5.1 and 5.5). This 
result is significant, as considered together with data from the AMPA:NMDA 
measurements (Figure 4.3) a unique set of adaptations is revealed. These effects 
appear not to be due to either the 'experience' of the CPP protocol or the 
pharmacological actions of morphine. Again, without identifying a specific 
mechanism for the reduction in transmitter release in the MOR group, it is difficult 
to say if the failure to detect a change in the MOR CPP group was down to two 
opposing processes cancelling each other out, or due to the CPP experience 
preventing the adaptations seen in MOR from occurring. A possible explanation for 
this effect emerges when considering the likely effects of the changes in 
AMPA:NMDA seen across the two groups.  
Widespread increases in AMPA:NMDA (assuming they resulted from the insertion 
of AMPARs) would be expected to have a large excitatory effect on the CA1 
network, and therefore could possibly induce some kind of homeostatic response. 
Isolated increases in AMPA:NMDA on the other hand, may not have such network 
wide effects on excitability, perhaps therefore not requiring the (most likely) 
heterosynaptic reduction in transmitter release seen in this study (Figures 5.1 and 
5.7). One study already mentioned (Marie-Claire et al. 2007) also used the CPP 
paradigm to study the effects of morphine-induced behavioural adaptations, and 
their conclusion that transmitter release after CPP induced by morphine was 
reduced initially seems to contradict the findings presented here. Marie-Claire et 
al. (2007) studied changes in gene expression throughout the hippocampus 
however, and therefore their findings are open to a number of possible reconciling 
interpretations, the simplest being that transmitter release was affected at a 
different hippocampal synapse (the mossy fibre-CA3  synapse for example is well 
known to express a presynaptic form of plasticity). Another possibility is that 
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transmitter release was down regulated at the inhibitory synapses in CA1, and 
therefore not detected by this experiment.  
To further investigate the possibility that GABAergic transmission could be reduced 
after morphine treatment, mIPSCs were also recorded. In both MOR and MOR 
CPP mIPSC frequency was reduced (Figures 5.16 and 5.17). This finding not only 
reconciles the Marie-Claire et al. (2007) findings with the present data but also 
suggests that the effect that they observed could be unrelated to the induction or 
expression of CPP. Rather a prolonged reduction in GABAergic Pr could result 
from in vivo administration of morphine regardless of context.   
6.9  Summary of major findings 
Before a further discussion of the likely implications of the observed changes, a 
brief summary of the major findings will be useful. The major aim of this work was 
to identify alterations in CA1 synaptic transmission that were related to morphine-
induced behavioural adaptation in the CPP paradigm. In order to do this, the 
effects of morphine and exposure to the CPP apparatus needed to be controlled 
for. While the SAL CPP group controlled for the exposure of the animal to the CPP 
apparatus and methodological procedures, controlling for the effects of morphine 
administration is more complex. The comparison of effects between non-
contingent SAL and non-contingent MOR and between SAL CPP and MOR CPP 
was an attempt to control for this variable. The previous paragraphs have dealt 
with the interpretation of the data and what kind of adaptations are likely to have 
occurred in response to the different treatments, they are summarised in the 
following table (Figure 6.1, next page).  
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Variable SAL MOR SAL CPP MOR CPP 
Inducible LTP 0 - + 0? (minus 
compared to 
SAL CPP) 




0 + 0 0 
Cell 
Capacitance 
0 + 0 0 
Paired Pulse 
Ratio 
0 + 0 0 
mEPSC  
frequency 
0 - 0 0 
mIPSC 
frequency 
0 - 0 - 
mIPSC rise 
time 
0 +? 0 0 
 
Figure 6.1 A table summarising major findings.  
Pluses signify an increase, minuses a decrease. MOR treatment appeared to 
decrease inducible LTP, increase AMPA:NMDA, increase cell size, decrease 
glutamate Pr and decrease GABA Pr. MOR treatment also appeared to increase 
mIPSC rise times although  more experiments would be needed to confirm this 
result (see Figure 5.22). MOR CPP treatment decreased inducible LTP, increased 
AMPA:NMDA in a subset of neurones and decreased GABA Pr.    
The reduction in inducible LTP seen in both MOR and MOR CPP  is likely to be 
due to a  metaplastic effect rather than a ceiling effect, as it was also seen in MOR 
CPP (where only a minority of cells expressed increased AMPA:NMDA). This 
effect may not be related to the morphine-induced behavioural change measured 
in this experiment as it occurs regardless of context. Reliable increases in 
AMPA:NMDA were observed in the non-contingent MOR group but not in the MOR 
CPP group. AMPA:NMDA appeared to be highly increased only in a minority of 
cells in the MOR CPP group. This effect was unique to the MOR CPP group and 
therefore may represent one of the neuroadaptations that underlie morphine-
induced behavioural change. The EPSC amplitude was increased in MOR 
suggesting that either the mechanism underlying this increase in AMPA:NMDA 
was due to the insertion of AMPARs, or that MOR treatment had increased cell 
size or morphology (and therefore the number or location of synapses). The data 
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from cell capacitance measurements suggested that this increase was due to an 
increase in cell size. Although mEPSC measurements disagreed with this 
interpretation, these data were made less compelling by concurrent increases in 
paired pulse ratios. None of these effects (increases in cell size, reductions in 
glutamate Pr) were seen in MOR CPP. The most likely explanation for this was that 
the administration of morphine in a specific context prevented these adaptations 
from occurring, perhaps due to the more specific potentiation of neurones within 
CA1 (seen in the AMPA:NMDA experiments). GABA Pr appeared to be reduced 
across both MOR and MOR CPP, suggesting the administration of morphine alone 
was responsible for this adaptation and therefore was probably not related to 
morphine-induced behavioural change seen in the MOR CPP group.   
6.10  Interpretation of results 
As mentioned in the introduction the aim of this work was to identify changes in 
synaptic transmission related to drug-induced behavioural adaptations. The results 
discussed above reveal a picture of complex and unique adaptations that occur 
after morphine-induced place preference. These adaptations in synaptic 
transmission appear not to just be a combination of SAL CPP and MOR treatment 
suggesting that they may underlie the behavioural adaptations that occur uniquely 
after MOR CPP treatment. One of the major criticisms that can be levelled at 
previous published work is the failure to correctly control for both the 'drug 
experience' as well as procedural aspects of the CPP procedure. The 'drug 
experience' control is critical as not only are in vivo effects of a drug often vastly 
different to those of in vitro applications, but there are also undoubtedly learning 
processes that occur purely as a result of the conscious experience of a morphine-
induced euphoria (assuming rodents do indeed experience such things). An 
example of the importance of including 'experience' controls can be seen when 
considering the effects of MOR CPP on glutamate Pr. While comparing SAL CPP 
to MOR CPP reveals no change in Pr, when considered together with the fact that 
normally morphine induces a reduction in Pr, this absence of a change becomes 
significant. This effect would not be detected without these 'experience' controls. It 
is not clear if this change in Pr occurs as a result of re-exposure to the drug-paired 
environment (during the test session) or if this adaptation in the MOR group is a 
result of the unpredictable administration of drug (presumably developing during 
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the injections). A way of investigating this effect would be to add a further 
treatment group that underwent MOR CPP training but were killed immediately 
before the CPP test. The addition of this treatment group would be useful for the 
study of all observed changes in synaptic function and could potentially identify 
changes that precede the induction of drug seeking behaviours.  
While Table 6.1 summarises the adaptations that occur in response to MOR CPP 
treatment, it makes no predictions as to the implications of such changes. One 
hypothesis is that the neurones with high AMPA:NMDA represent part of the 
memory trace encoding the availability of drugs in one particular place. Place cells 
within CA1 have already been discussed in the Introduction (section 1.5.3.2), and 
there is limited evidence that their firing may be modulated by motivational factors 
(Moita et al. 2004; Hollup et al. 2001). It is possible therefore that these highly 
potentiated neurones detected are the place cells encoding the location of the 
morphine paired side of the CPP apparatus. Place cells increase their firing rate 
when the animal enters a specific location in an environment. The large dopamine 
signal resulting from the actions of morphine in the VTA would be expected to 
facilitate the induction of LTP in the hippocampus (as discussed in the 
Introduction). So assuming the mice had 'remembered' that the morphine paired 
environment was in fact only one half of a  two chambered environment, then 
perhaps LTP was over induced in those place cells encoding the morphine paired  
environment. This hypothesis explains the widespread potentiation seen in the 
MOR group as during home cage injections the subject would have roamed 
throughout his environment, potentiating all place cells equally.  
An alternative hypothesis, not mutually exclusive from the previous one, considers 
a different function of the hippocampus. As already mentioned in the Introduction 
the hippocampus has extensive efferent connections to the nucleus accumbens, 
and may help select appropriate behaviours depending on previous experience in 
similar contexts (Sesack and Grace, 2010). The multimodal sensory inputs may 
combine with previous memory traces in the hippocampus to produce a readout to 
the nucleus accumbens that induces appropriate behavioural responses. The 
normal physiological function of this system could be (for example) the selection of 
either food or copulation seeking behaviours depending on the previous 
experience in similar contexts. It is tempting to speculate that the highly 
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potentiated neurones seen within the MOR CPP group combined with the reduced 
flexibility (LTP) seen in both MOR and MOR CPP could result in very different 
sensory inputs ending in excitation of the same highly potentiated neurones. 
Perhaps this mechanism could result in a 'drugs available' signal from the 
hippocampus in many different and inappropriate contexts. This could explain the 
gradual spread of drug seeking behaviours in different contexts that occurs during 
the development of addiction. This hypothesis could also explain the somewhat 
surprising results from Vorel et al. (2001) where non-specific electrical stimulation 
of the hippocampus appeared to produce a coherent signal within the animal that 
induced drug-seeking behaviours.  
6.11  Suggestions for further work and conclusion 
The most obvious target for further research would be to investigate the neurones 
expressing high AMPA:NMDA in the MOR CPP group. Not only does the nature of 
the change need to be further investigated but also the mechanism(s) that leads to 
specific neurones being affected. Koya et al. (2012) used a fluorescent form of the 
neuronal activity marker, Fos, to identify a sub-population of neurones within the 
nucleus accumbens that were strongly activated in response to context-specific 
cocaine sensitization and found profoundly different patterns of cocaine-induced 
changes in AMPA:NMDA and probability of transmitter release between those 
neurones that were activated by cocaine treatment (Fos-positive) and those that 
are not (Fos-negative). It would be useful to develop a similar such technique to 
identify those neurones expressing high AMPA:NMDA in the hippocampus. This 
would be particularly useful in an area such as the hippocampus with such well 
defined and highly organised topography, as even basic visualisation could give an 
insight into the function/connectivity of these neurones. Furthermore, the 
mechanism(s) responsible for increasing AMPA:NMDA would be much easier to 
study if patch-clamp targets could be identified prior to recordings being made.  
An alternative but similar approach follows a recent paper identifying sub-
populations of CA1 pyramidal neurones (Graves et al., 2012). In that study, two 
distinct sub-populations of CA1 pyramidal neurones, co-existing within the same 
sub-region of the hippocampus, were identified based on different 
electrophysiological and pharmacological characteristics and were also shown to 
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project to distinct brain regions, and to receive afferent input from distinct brain 
regions. Future work could be designed to investigate whether morphine CPP-
dependent changes in synaptic plasticity at CA1 neurones are specific to one cell 
type.  
Related to this there is evidence that the dorsal and ventral hippocampus are 
different both in terms of input and output and their physiological functions. The 
present study concentrated on investigating the ventral hippocampus but it would 
be interesting to also study possible changes in the dorsal hippocampus. In a 
similar vein, it would also be interesting the study synaptic modifications both up 
and down stream of CA1 (CA3 and the ventral subiculum respectively) to create a 
wider picture of how hippocampal processing is affected by MOR CPP treatment.  
Another important question arising from these results relates to the timing of these 
changes. Some of these changes appear to occur after morphine administration, 
increases in AMPA:NMDA for example also occur in the MOR group. It is therefore 
likely that those mechanisms occur sometime during or after the morphine 
administration (although their precise nature or location may be context specific). 
Other changes however are less clear, specifically the change in glutamatergic Pr 
seen in MOR but not MOR CPP. It is hard to imagine that following the first 
administration of morphine different mechanisms are induced, as neither of the 
environments are novel or at that stage predictive of morphine reward. Therefore 
perhaps this Pr reduction occurs immediately prior or following the CPP test 
session. This suggests that this adaptation could be a particularly suitable target 
for intervention and therefore may be one of the most significant results to come 
out of this work. It would also be interesting to see how these adaptations changed 
over extended periods of time, given the proposed time-limited nature of the 
hippocampus in memory storage and the long lasting behavioural effects of CPP 
training.  
Finally, the overlying objective of this study was not to study the effects of 
morphine specifically, but to study more general reward related learning 
processes. An important next step in verifying these findings therefore would be to 
repeat these observations using both natural rewards and other addictive 
substances. The hope would be that other addictive substances with varying 
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mechanisms of action but not natural rewards would induce some of these 
identified changes. A further logical extension would also be to repeat these 
findings in other strains of mice and ultimately other species. While this work never 
attempted or even aspired to create a 'magic bullet' for the treatment of addiction, 
perhaps one of these changes does represent a 'magic target' that one day will be 
utilised.   
In conclusion, this work provides a number of interesting and previously 
unobserved effects of both morphine and morphine related learning in the 
hippocampus of C57BL/6J mice. As with any scientific experiment many questions 
arise from this work that deserve further investigation in the hope of one day 











In this appendix are included some of the more significant technical issues 
encountered whilst developing methods for both the conditioned place preference 
experiments as well as the electrophysiology experiments.  
A.1  Conditioned place preference experiments. 
A.1.1  Introduction 
The place conditioning paradigm is a widely used in vivo method of measuring the 
rewarding or aversive effects of psychoactive substances (Tzschentke, 1998). 
Place conditioning relies on second order Pavlovian conditioning whereby the 
conditioned stimulus acquires the salient properties of the unconditioned stimulus 
through repeated pairings. As mentioned in the Introduction there were a number 
of constraining factors leading to the choice of this animal model: 
The behavioural model must involve the formation of drug-context 
associations. As this was the aim of the electrophysiological investigation.  
The animals must be (relatively) young. Patch-clamp recordings are generally 
performed with slices taken from young animals. This is likely to be due to 
increases in connective tissue and other biochemical changes with age, as well as 
the enhanced speed of dissection and cooling of younger, smaller, brains (Gibb & 
Edwards, 1994). This makes experiments on older animals more challenging. 
Given the amount of time invested into each experimental subject before 
electrophysiology was performed it was important to maximise the chances of 
successful recordings being obtained. 
The drug doses involved must be as low and as infrequent as possible. As 
one of the main aims of this work was to study the formation of drug-context 
associations any confounding factors such as drug withdrawal or the development 
of drug tolerance were to be avoided.  
Initially the model was loosely based on that of Orsini et al. (2005). Orsini et al. 
(2005) had shown that the C57BL/6J strain of mouse was more sensitive to the 
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rewarding effects of morphine in a CPP model than the DBA/2 mouse strain. The 
conditioned place preference and the conditioned place aversion models are well 
documented to be influenced by genetic background (Cunningham et al. 1992; 
Semenova et al. 1995; Orsini et al. 2005). The C57BL/6J strain is generally found 
to be the most sensitive to the rewarding effects of morphine, and therefore was 
selected as the strain of choice.  
There are three major methodological issues surrounding the design of 
conditioned place preference experiments:  
Two vs. Three chambered design of conditioning environment. There are a 
number of theoretical and methodological issues involved in this choice. 
The presence of apparatus bias in the place conditioning environment. The 
presence of apparatus bias can have an impact on the sensitivity of the 
experiment. 
The biased/counterbalanced assignment of drug-paired zones. The presence 
of apparatus bias can determine if a counterbalanced protocol can be used. 
The number of chambers in a place conditioning experiment has a significant 
effect on both technical and theoretical issues. A two-chambered design consists 
of just the drug-paired and saline-paired environment with a removable door 
directly connecting the two. A three-chambered design consists of the drug-paired 
and saline-paired environments connected via a smaller neutral compartment. 
Technically the two chambered design is preferred as this makes the analysis of 
time in each zone simple. Another advantage of the two chambered design is that 
it is relatively simple to avoid apparatus bias. The major theoretical criticism of the 
two chambered design is that during the test session the subject is forced to make 
the choice between the vehicle-paired compartment and the drug-paired 
compartment (Prus et al. 2009). This means that any aversion to the vehicle-
paired environment is very difficult to control for. With a three chambered design 
however, the time spent in the middle compartment can be assessed. Another 
criticism levelled at the two chambered design is that if the drug treatment were to 
prevent the familiarisation of the drug-paired context; then novelty could confound 
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the results (as rodents are exploratory creatures). For these reasons a three 
chambered design was initially selected for the CPP experiments.  
Apparatus bias describes the effects that different environmental contexts have on 
subject behaviour. For example, in rats (and most likely other rodents) a 
compartment with white walls is generally less preferable to a compartment exactly 
the same but with black walls (Roma and Riley, 2005). The presence of bias in the 
apparatus is to be avoided if possible due to a number of issues. Firstly, if the drug 
is paired to an initially preferred environment then CPP may be difficult to detect 
due to a ceiling effect. Secondly, any bias present may represent an aversion to 
one particular side. If this is true then any anxiolytic effect of the drug conditioning 
may increase the amount of time in the initially aversive compartment (Bardo and 
Bevins, 2000). This could have the effect of always either increasing or decreasing 
the value of the CPP. This is also true vice versa for anxiogenic treatments. At the 
very best this would have the effect of increasing the variability of the data (and 
therefore decreasing the power of subsequent statistical analysis). For these 
reasons the first objective was to develop three easily distinguishable 
environments that C57BL/6J mice did not show preference for (Figure A.1). The 
distinct environments were created by using various different floor textures 
(ranging from smooth plastic to stainless steel grid) and wall colours (white, grey, 
yellow and black).  
The third important methodological issue was whether or not to assign the drug-
paired compartments randomly or not (biased vs counterbalanced protocol). While 
this choice appears to matter little when there is no apparatus bias (Cunningham 
et al. 2003) if the apparatus is biased then there are a number of points to 
consider. When choosing drug-context pairings based on initial preferences, 
detection of CPP could be hindered if the drug-paired environment is initially 
strongly preferred due to ceiling effects (as well as regression to the mean in 
unbiased apparatus). If selecting the initially least preferred environment then any 
anxiogenic effects of drug treatment could be indistinguishable from the effects of 
CPP (as well as regression to the mean in unbiased apparatus). Using a pseudo-
random assignment of compartments would control for these factors, but in biased 
apparatus this could increase variability to the extent the detection of CPP would 
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be occluded. As this apparatus was thought to be unbiased then a pseudo-random 
















































Figure A.1 The effects of different environmental contexts on subject 
preference.  
The results from a single experiment using 24 x C57BL/6J mice (n=6 for each 
group). Mice were allowed to freely explore all compartments for 15 minutes and 
the total time spent in each compartment was recorded are presented as the mean 
+/- SEM. Stars indicate preference for one particular side over the other measured 
using a students' t-test. Each context differed from one another by different 
combinations of floor textures and wall colours in the same dimly lit room.  
Figure A.1 gives an example of the effect changing floor textures and wall colours 
can have on initial preference during the CPP pre-test in a single experiment. 
From these experiments, the combination of walls and floors that made up 
condition 4 was selected. 
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A.1.2  Dose-response curve. 
Although already reported by Orsini et al. (2005) and others, differences in subject 
age and contextual cues necessitated the dose-response relationship to be 
investigated. This was in order to achieve the demonstration of CPP whilst 
attempting to keep both the size and number of drug doses low, to avoid potential 
withdrawal effects. 23 x C57BL/6J mice were randomly assigned one of three 
doses of morphine (either 5, 10 or 20 mg kg-1). Mice received two injections per 
day in a random order, one dose of morphine and one saline. This gave a total of 4 
doses of morphine. As can be seen in Figure A.2, 10 mg kg-1 appeared to be the 






































Figure A.2 A graph to show the effect of morphine dose on the detection of 
place preference.  
23 x C57BL/6J mice were randomly split into one of three treatment groups to 
receive either 5, 10 or 20 mg kg-1 morphine place conditioning. n=7-8 in each 
group, two-way ANOVA revealed a significant effect of training but not of dose. 
Stars indicate significant difference (P<0.05) between time spent in the morphine 
paired zone on test day compared to pre-test result (Bonferroni post-test).  
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A.1.3  Single vs double injections  
Again, to further minimise the issue of drug withdrawal more attempts were made 
to reduce the amount of drug given to each subject. 16 x C57BL/6J mice were 
randomly split into two groups to both receive CPP training using 10 mg kg-1 
morphine. One group (double injections) received two injections per day, one of 
saline and one of morphine (as above) giving a total of four morphine doses. The 
other group (single injections) had one injection per day (alternating between 
saline and morphine) giving a total of two morphine doses. The most obvious 
result of this experiment (Figure A.3) was that it failed to demonstrate significant 
CPP in either group (although the alternate injection paradigm group showed a 





































Figure A.3 The effects of different injection paradigms on the expression of 
place preference.  
(A) 16 x C57BL/6J mice were randomly split into one of two injection paradigms, to 
receive either one or two injections per day. n=8 in each group, two-way ANOVA 
did not find any significant effect of training. (B) Time spent in each of the two 
compartments during the pre-test session. n=16 for each group, students' t-test 
revealed a significant preference for one side of the apparatus over the other 


















































































A.1.4  Further environmental changes 
Further analysis of the data from Figure A.3 revealed that a significant apparatus 
bias had developed (see Figure A.3, part B). Therefore further alterations in 
environmental context were performed and tested for preference. These 
experiments failed to produce a combination of environments that the mice 
preferred equally. A number of alterations were tested involving not only changes 
in tactile and visual cues but also involving smells and using masking (white) 
noise, an example of the data from one such experiment is given in Figure A.4. 
During this pre-test, masking smells and white noise were used. While this 
resulted in a balance of preferences, the environment was unsuitable as mice 
spent a large proportion of their time in the middle (smaller) compartment and 



























Figure A.4 Results of a pre-test during further environmental optimisation.  
16 x C57BL/6J mice were allowed to freely explore the whole of the environment 
for 15 minutes while the total amount of time spent in each compartment was 
recorded.  
A.1.5  The design of a biased experiment. 
Overall, after testing a wide variety of different changes in environment it was not 
possible to change the environment in such a way that apparatus bias was reliably 
eliminated. Based on this failure, a biased protocol was developed. The biased 
paradigm in CPP experiments is widely used (although less so recently as it does 
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have a number of specific problems that were discussed earlier). Of concern in the 
results of Figure A.5 is the finding that conditioning in both the morphine and saline 
groups increases time spent in the particular environment assigned to be paired 
with morphine.  
This makes it necessary to compare the behaviour of the morphine group against 
the saline control group. This can be done by generating a 'CPP score' that is 
equal to time spent in the morphine paired zone on the test day minus time spent 
in the morphine paired zone on the pre-test day. Comparing the CPP score of the 
morphine group with that of the saline group using a unpaired t-test results in no 
significant difference (P=0.34, data not shown), and therefore no significant 













































Figure A.5 An example of a biased morphine CPP experiment.  
12 x C57BL/6J mice were randomly assigned to receive either saline or morphine 
place preference training (saline n=4, morphine n=8). The assignment of morphine 
paired zones was biased so that each mouse received morphine in its initially least 
preferred zone. A two-way ANOVA revealed a significant effect of both conditioning 
and drug with no interaction. Bonferroni post-tests revealed the MOR CPP group 
spent significantly longer in the morphine paired zone on the test day compared to 
the pre-test whereas the SALCPP group did not.   
One possible reason for mice spending more time in the least preferred 
compartment after repeated saline treatments could be that habituation to an 
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initially aversive environment results in reduced aversion and so a shift toward this 
compartment on the test day. For this reason attempts were made to reduce 
possible sources of aversion from the environment whilst still keeping the zones 
distinct. One condition that was changed was to perform the same experiment as 
above but in red light rather than diffuse white light. This change resulted in visibly 
less stress for the animals something that is thought to impair the detection of CPP 
(Bechtholt et al. 2004). The most useful effect of using red light was in the 
behaviour of the saline controls. Under diffuse white light saline control subjects 
spend more time in the less preferred zone on the test day compared to the pre-
test day (Figure A.6). Under red lighting however, zone preference does not 
change during conditioning and the animals displayed very consistent behaviour 
throughout the duration of the test. At this point it was decided that a robust 

















































Figure A.6 Effects of red lighting on the behaviour of saline control CPP 
group.  
While the animals were visibly less stressed at the end of each test session, the 
saline control group (n=8) also displayed very consistent behaviour compared to 
the saline control group in Figure A.5. A two-way ANOVA revealed effects of drug 
but not of conditioning. This allowed detection of changes in preference (by 
Bonferroni post tests) in the morphine group (n=8) unconfounded by the shift in 
preference of the controls. This effect was still present when re-tested 3 days later. 
Stars indicate P<0.05 when compared to pre-test result.  
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A.1.6  Collection of fEPSP data 
Having found a protocol that demonstrated robust morphine-induced CPP and had 
seemingly stable control behaviour, fEPSP recordings were collected whilst the 
protocol remained unchanged. The results of these numerous experiments are 
presented in the main results section (Chapter 3).  
One flaw in the experimental design during this time was that saline control 
experiments were not performed along with the demonstration of morphine CPP. 
The reasons for this were that as the main aim of the study at this point was to 
investigate changes in synaptic plasticity in slices taken from animals that had 
been trained to exhibit morphine CPP, animal treatments were focussed on 
morphine CPP training rather than saline CPP training. Further, as CPP training 
takes 1 week per animal, in order to allow sufficient time for the 
electrophysiological investigation of each animal completing the CPP protocol (1 
animal per day), subject numbers per experiment had to be kept low (n=4 per 
experiment, ie. n=4 trained per week). Given the natural variability present in in 
vivo experiments it is not possible to demonstrate CPP in each individual 
experiment (ie. n=2 saline-treated vs. n=2 morphine-treated per week). Therefore, 
at least initially, all behaviourally trained mice subsequently used for brain slice 
field recordings were trained to exhibit morphine-induced CPP. As can be seen in 
Figure A.7 (A) the MOR CPP group continued to show a increase in the amount of 
time spent in the morphine paired compartment. After sufficient data had been 
collected, these SAL CPP experiments were gradually reintroduced. At this time it 
became apparent that the behaviour of the SAL CPP treated subjects had 
changed. Collating data from both periods for the SAL CPP group resulted in the 
occlusion of any effect present in the MOR CPP group (Figure A.7 B) 
As it was not possible to identify when this change in behaviour could have 
occurred, it was not possible to exclude specific fEPSP data without excluding it 
































Figure A.7 Collated saline- and morphine-induced CPP data from the period 
over which fEPSP experiments were being performed.  
(A) Comparing collated MOR CPP data (n=50) against saline controls performed 
at the start of the recording period (n=8) (B) Comparing collated MOR CPP data 
(n=50) against saline controls performed both at the start and toward the end of 
the recording period (n=16). All data analysed using a two-way ANOVAs with 
Bonferroni post-tests, stars indicate a significant difference in time spent in the 





























































































These results show that there was a consistent shift in preference toward the 
morphine paired environment in MOR CPP treated subjects (Figure A.7 A and B). 
In SAL CPP treated animals however, there was a change in behaviour at some 
point between the two recording periods. The effect of this change in behaviour 
was to mask any effect seen due to place preference in the MOR CPP group. It is 
impossible to tell from these results if this change in behaviour would have 
stopped the formation of drug-environment associations in the MOR CPP group.    
The decision to include any fEPSP data in the main text therefore was based on 
the following reasoning. The objective of the CPP experiment was not to study the 
expression of CPP per se, but to demonstrate the formation of drug-context 
associations. During the conditioning process the effects of the drug could 
potentially be paired with many environmental cues related to conditioning 
methods. Therefore the absence of CPP during this time does not necessarily 
suggest the lack of any drug context associations. It is entirely possible that the 
chosen method of measurement simply failed to detect them. Cunningham et al. 
(2003) studied the effects of bias during the assignment of drug-paired zones in 
their place conditioning protocol. Using biased apparatus they demonstrated that 
CPP was only expressed in the group of subjects conditioned to their initially least 
preferred side; no apparent change of preference occurred in the group whose 
initially most preferred side was chosen as the drug-paired zone. Repeating their 
experiment in a similar environment (but crucially, one that did not display 
significant apparatus bias) resulted in mice displaying increased preference for the 
drug-paired zone regardless of initial preference. Since the same protocol in only 
slightly different environments resulted in CPP, they concluded that the failure to 
detect CPP in the biased apparatus (and conditioned to their most preferred zone) 
was due to a ceiling effect. In this experiment, the failure to demonstrate CPP 
(Figure A.7 B) occurred using the same protocol and environment that previously 
resulted in a detectable CPP (Figure A.5). Considering the Cunningham et al. 
(2003) argument therefore, could lead to the conclusion that the change in 
behaviour of the saline controls was masking the CPP likely to be present in the 
MOR CPP group. Secondly, there were consistent and significant differences seen 
in the field recording experiments (see Chapter 3) between the MOR CPP and 
SAL CPP treatment groups. This again suggests that different neuronal changes 
were taking place in mice that had undergone MOR CPP compared with SAL CPP. 
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A.1.7  Redesign of CPP paradigm 
At the end of the fEPSP recording period the opportunity was taken to redesign the 
CPP paradigm to address some of the flaws present in the previous model. The 
major flaw identified above was that the demonstration of CPP was dependent on 
the behaviour of the SAL CPP group (due to the paradigm used), and that the 
behaviour of this group appeared to change over time. One way to overcome this 
problem is to use a counter-balanced design of experiment. In this method, equal 
amounts of animals are conditioned to each distinct environment (as opposed to 
the biased design used above where drug-conditioning is always to the initially 
least-preferred environment). Therefore, if innate preference to one particular 
environment develops over time, this would no longer have any effect on the post-
test preference data, as this environment would be drug-paired in half of the 
animals and saline-paired the other half. Thus, any morphine-induced CPP seen in 
a counter-balanced experiment must represent drug-induced preference 
(Cunningham et al., 2003). 
At the same time the apparatus was changed from a three-chambered design to a 
two-chambered design, and the length of the pre-test and test trials was increased 
from 15 to 30 minutes.    
The first stage in the development of the counter-balanced non-biased design was 
to create two equally preferred environments as was initially performed in Figure 
A.1, but this time continued monitoring of pre-test data confirmed no preference 
developed over time. The results of both the initial pre-test confirming the absence 
of apparatus bias (Figure A.7 A) as well as collated data taken over the whole 



























Figure A.8 Final environmental optimisation experiment comparing plain and 
stripy compartments.  
(A) A paired t-test comparing the time spent in each compartment found no 
significant difference (n=8, P=0.26) (B) Collated pre-test data from the period over 
which patch clamp data was collected. A paired t-test comparing the time spent in 
each compartment found no significant difference (n=28, P > 0.05) 
While the development of a counter-balanced design of CPP experiment negates 
the requirement for a saline CPP group, the electrophysiological experiments still 
required this. As can be seen in Figure A.9, as expected, saline-induced CPP was 
































































































Figure A.9 Saline- and morphine-induced CPP during the period that the 
patch clamp data was being collected.  
A two-way ANOVA revealed a significant effect of drug but not conditioning. It is 
highly unlikely that an effect of conditioning would be seen in a counterbalanced 
design of experiment such as this. Star indicates a significant difference in the time 
spent in the morphine paired zone on the test day compared to pre-test result 
(Bonferroni post test). This data was presented in a different for in Chapter 4 
(Figure 4.1). 
236 
A.2  Optimisation of patch clamp methods 
The main aim of the patch clamp electrophysiology experiments was to further 
investigate the functional changes in synaptic transmission that had been 
observed during the fEPSP recordings. A reduction in stimulus-induced LTP had 
been observed in response to morphine for both the non-contingent and place 
preference groups. It was reasoned that a reduction in stimulus-induced LTP could 
be due to either previous in vivo LTP induction or due to a reduction in meta-
plasticity. Each of these scenarios is presented graphically in Figure 3.16. As can 
be seen from the figure in vivo LTP (scenario 1) would have the result of 
increasing the value of AMPA:NMDA, as would a reduction in metaplasticity 
(scenario 2). Ungless et al. (2001) were the first to describe the change in 
AMPA:NMDA as a marker for previous in vivo LTP. Using 100µM picrotoxin to 
inhibit GABAA mediated current Ungless et al. (2001) voltage clamped neurones at 
+40mV to relieve to magnesium block on NMDA channels (see Introduction). They 
then compared stimulated EPSCs in the presence and absence of 50µM D-APV. 
Using subtraction of the AMPA-mediated current from the compound AMPA/NMDA 
current allowed them to measure both the size of the AMPAR-mediated and 
NMDAR-mediated currents.  
The Ungless et al. (2001) paper was chosen as a model in the development of the 
methods used in this study. A number of problems were encountered when 
attempting to measure AMPA:NMDA in this way - the most significant of these 
along with the solutions are described below.  
A.2.1  Isolation of the compound AMPA/NMDA current 
The first step was to confirm that that 100µM picrotoxin was indeed isolating the 
glutamate mediated current at -70mV. To achieve this, 10 minutes after the 
addition of 100µM picrotoxin, the 75% EPSC was measured. Then, 50µM D-APV 
with 50µM DNQX (an AMPA/Kainate antagonist) was added to the bathing solution 
and 10minutes later the 75% EPSC was once again measured (Figure A.10). 
Figure A.10 clearly shows a negligible EPSC following the addition of D-APV and 
DNQX suggesting that the observed EPSC at -70mV under these conditions was 
indeed mediated by glutamate.  
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Figure A.10 The recorded EPSC at -70mV in the presence of 100µM 
picrotoxin is mediated largely by glutamate. 
All recordings made in slices taken from naive C57BL/6J mice and stimulated to 
produce 75% of the maximum amplitude EPSC. Control (black) trace shows EPSC 
after the addition of 100µM picrotoxin, red trace shows the EPSC following the 
addition of the competitive antagonists D-APV and DNQX. This result suggests 
that the control (black) EPSC trace is mediate largely by glutamate. 
 Ungless et al. (2001) used 100µM picrotoxin in order to inhibit GABAAR-mediated 
current. Perhaps due to differences in the functioning of local inhibitory (GABA) 
circuits between brain regions, 100µM picrotoxin appeared to (occasionally and 
unpredictably) cause a large, long-lasting inward current in response to sub-
maximal stimulation. An example of this current is given below. 
As can be clearly seen in figure A.11, the presence of this current occluded 
measurement of the AMPA/NMDA current. This problem, occurring only in around 
5-10% of cells was initially ignored; cells displaying the current were excluded from 
analysis. Over time (days and weeks) however, the numbers of cells displaying 
this current increased (possibly due to the increasing health of the brain slices) 
until, before the method was changed, it was observed in 12 out of 21 recordings 
(>50%. Various approaches were taken to prevent the occurrence of this current, 
but efforts were largely unsuccessful. These approaches included; thorough 
dissection of CA1 from the surrounding tissue (following this, picrotoxin-induced 
current occurred in 5 out of 10 recordings), reducing stimulation intensity to 30% of 
maximal response (picrotoxin-induced current occurred in 6 out of 11 recordings), 
reducing the concentration of picrotoxin to 50µM (picrotoxin-induced current 
occurred in 3 out of 9 recordings), using bicuculline instead of picrotoxin as the 
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Figure A.11 Examples of variable effects of 100µM picrotoxin.  
All recordings made in slices taken from naive C57BL/6J mice and stimulated to 
produce 50% of the maximum amplitude EPSC. (A) An example of the large 
inward current induced by stimulation in the presence of 100µM picrotoxin (B) An 
example of a recording performed under the same conditions where the large 




Extracellular block of GABAA was more desirable than intracellular methods in this 
preparation as it was reasoned that local circuit GABA neurones contained within 
CA1 could potentially affect pre-synaptic glutamate release at the CA3-CA1 
synapse. Therefore without extracellular GABAA inhibition, any changes in this 
GABA modulation of glutamate release due to treatment could be indistinguishable 
from more direct effects on glutamate release. In order to address this argument, 
the effects of picrotoxin on paired pulse facilitation were examined (Figure A.12). 
As can be seen from Figure A.12 100µM picrotoxin caused a general decrease in 
paired pulse ratios when the inter-pulse interval was greater than 100ms. This 
result suggested that the paired pulse measurements taken at 50ms are 
independent of GABA activity. With this result in mind intracellular methods of 
inhibiting GABAA were explored.  






















Figure A.12 Effects of 100µM picrotoxin on paired pulse ratios in slices taken 
from naive mice.  
Paired pulse values at various inter-pulse intervals were first calculated, then 100 
µM picrotoxin was added for 10 minutes before calculating paired pulse ratios one 
more. Data are presented as mean +/- SEM. A two-way ANOVA revealed a 
significant effect of both inter-pulse interval and drug, Bonferroni post-tests found a 
significant difference between paired pulse ratios in the absence or presence of 
100 µM picrotoxin when measured with a 150 ms inter-pulse interval (P<0.05).   
Intracellular block of chloride conductance has also been demonstrated using 
picrotoxin in the intracellular solution (Akaike et al. 1985; Cupello et al. 1991; 
Inomata et al. 1998). In this preparation however, adding 50µM picrotoxin to the 
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intracellular solution appeared not to be effective within 30 minutes (data not 
shown). 4,4'-Dinitro-stilbene-2,2'-disulfonic acid (DNDS) has been shown to inhibit 
chloride conductance in cortical neurones (Dudek and Friedlander, 1996) therefore 
500µM DNDS was added to the intracellular solution. To test for the effectiveness 
of the DNDS stimulated IPSPs were recorded at 0mV (close to the reversal 
potential for the AMPAR-mediated current). As can been seen in Figure A.13 
(following page), stimulation whilst holding the membrane potential at 0mV results 
in a large hyperpolarising current (presumably an inward flow of chloride ions) that 
is completely inhibited by the addition of 50µM picrotoxin (part A). DNDS (500µM) 












Figure A.13 500µM DNDS fails to completely inhibit the picrotoxin sensitive 
current.  
All recordings made in slices taken from naive C57BL/6J mice and stimulated to 
produce 50% of the maximum amplitude EPSC. (A) Changing holding voltage to 
0mV (approximate reversal potential for the AMPA-mediated current resulted in a 
large upward current (likely to be inward flow of chloride ions through the GABAA 
receptor, which was inhibited by addition of picrotoxin (100 M). (B) The IPSC 
recorded at 0mV approximately 20 minutes after breaking through into the cell with 
DNDS present in the patch solution.   
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Another reported method of blocking chloride conductance is the inclusion of 
fluoride ions in the intracellular solution (Kay, 1992). Replacement of half of the 
methanesulphonate ions with Fl- ions appeared to result in complete inhibition of 
the IPSP recorded at 0mV within 10 minutes. Supporting this finding was the 
observation that the resulting current was not affected significantly by the 
subsequent addition of 50µM picrotoxin (see Figure A.14). A significant 
disadvantage of using either DNDS or fluoride ions in the intracellular solution was 
that both the spermine and ATP/GTP appeared to precipitate out of the solution. 
Spermine is a polyamine compound that allows the inward rectification of GluR2 -
lacking AMPARs to be observed (Isa et al. 1995). Removal of this compound 
therefore made it unlikely that changes in the sub-unit composition of AMPARs 
would be detected by measuring current-voltage relationships. ATP and GTP are 
necessary for many biochemical processes within neurones and therefore the 
major worry when removing these compounds would be that the functioning and/or 
health of the neurones could be significantly affected during the recordings. While 
this issue is difficult to resolve the stability of responses during a 60 minute 
































Figure A.14 The inclusion of fluoride ions into the pipette solution is 
effective in inhibiting IPSCs observed at 0mV.  
 
(A) Results of a single experiment. The control trace (black) is taken immediately 
after breaking though and calculating a stimulus response curve, then 10 minutes 
later (red) at the same holding potential and stimulus intensity. The addition of 
100µM picrotoxin resulted in a change in the kinetics of the revealed EPSC 
(possibly due to inhibition of pre-synaptic GABAARs) but had little effect on the 
IPSC (B) Averaged data (n=3) showing the effect of 100µM picrotoxin on the IPSP 
amplitude. All recordings made in slices taken from naive C57BL/6J mice and 
stimulated to produce 50% of the maximum amplitude EPSC.  
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A.2.2  Measurement of AMPA:NMDA values.  
Ungless et al. (2001) used 50µM D-APV to inhibit the NMDAR-mediated current, 
and thus observe the AMPAR-mediated current. In this preparation however 50µM 
D-APV appeared to have unpredictable effects. The results ranged from where D-
APV had a profound effect on the compound current, to no detectable effect. 
When D-APV appeared to have completely blocked NMDAR-mediated current 
(Figure A.14 C) the resulting analysis produced traces similar to those presented 
in Ungless et al. (2001). D-APV also produced traces that indicated that it had  
little or no effect however (see Figure A.14 A). The absence of any significant 
apparent NMDAR-mediated current in the thousands of synapses recorded from in 
a single cell was deemed unlikely. The ability of D-APV to inhibit the NMDAR-
mediated current was therefore identified as the likely cause of variation. Different 
batch numbers of D-APV were ordered as well as D-APV from alternative 


































Figure A.15 50µM D-APV has variable effects on EPSCs in CA1 pyramidal 
neurones.  
The result of adding 50 µM D-APV to the ACSF from three separate experiments. 
The traces have been chosen to demonstrate the variability of D-APV ranging from 
no or little effect (A and B respectively) to significant inhibition (C). All recordings 
made in slices taken from naive C57BL/6J mice and stimulated to produce 50% of 
the maximum amplitude EPSC.  
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As an alternative approach, (+)MK-801 (a non-competitive use-dependent NMDAR 
antagonist) was also used. As MK-801 is use-dependent, a short 'induction' 
protocol (200 pulses delivered at 5Hz) was used 5 minutes after adding the 
antagonist to the ACSF. Although this protocol bears a resemblance to protocols 
used for the experimental induction of LTD, there are a number of reasons why 
this was predicted not to occur. Firstly LTD is dependent on a wide variety of 
signalling mechanisms - many of which require ATP or GTP, in this pipette solution 
ATP and GTP were excluded. MK-801 inhibits NMDA receptors, and current 
through these channels is a induction requirement of many LTD processes. In 
support of this argument was the observation that the AMPAR-mediated EPSC 
recorded at -70mV was unchanged 10 minutes after the 'induction' protocol (see 
Figure A.16). As with the D-APV experiments mentioned above MK-801 seemed to 
have variable effects on EPSPs recorded at +40mV, sometimes appearing to 
achieve near complete block of NMDA (giving sharp AMPA responses that 
decayed within approximately 50ms) to having much less of an effect (data not 







































Figure A.16 MK-801 induction protocol does not result in LTD.  
EPSC peak amplitudes did not differ between the start of the experiment (Before 
Induction) and 10 minutes following the induction protocol (After Induction). All 
recordings made in slices taken from naive C57BL/6J mice and stimulated to 
produce 50% of the maximum amplitude EPSC (n=5). 
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Presuming that the D-APV and MK-801 were active in all experiments, it was 
reasoned that perhaps there was a problem with the availability of the antagonists 
at the receptor. D-APV is a small molecule readily dissolved to 50mM in water (the 
concentration of the stock solution) so precipitation issues were ruled out. The fact 
that it is a small molecule means that problems with diffusion into the synaptic cleft 
were unlikely, and picrotoxin (a larger molecule) seemed to exert close to its 
maximum effects within 5 minutes (Figure A.17). Another reason for a drug not 
being available at the receptor could be due to its solubility in fat, highly lipid 
soluble compounds can readily dissolve into the fatty tissue in brain slices and so 
reduce the concentration of the drug dissolved in water. Obviously this reduces the 
concentration of the drug at the receptor. The predicted Log P value for D-APV 
however is -3.54 whereas picrotoxin is -1.08 (meaning APV is more hydrophilic 
than picrotoxin). This suggested that availability of APV at the receptor would not 
be affected by the presence of fatty tissue in the slice any more than for picrotoxin. 
In further support of this argument was the observation that morphine (more 
lipophilic than picrotoxin or D-APV, predicted Log P = 0.9) also reached equilibrium 
within 10 minutes (see results Figure A.15) (all Log P predictions from 
www.chemicalize.org). in conclusion, the reason why D-APV gave inconsistent 
results is unclear, however, as I was unable to routinely isolate pure AMPAR-
mediated currents, alternative antagonist free methods of calculating AMPA:NMDA 





























Figure A.17 Picrotoxin reaches maximum effect in approximately 3 minutes.  
50 µM picrotoxin was added to the bathing solution at time zero and picrotoxin-
containing aCSF reached the slice chamber at approx t = 2 min. The neurone was 
held at 0mv and the resultant IPSC recorded. As can be seen from the graph, 
picrotoxin appeared to reach its maximum effect within approximately 3 minutes 
after reaching the slice chamber (n=4). All recordings made in slices taken from 
naive C57BL/6J mice and stimulated to produce 50% of the maximum amplitude 
EPSC. 
A.2.3 Investigating the variability observed in the stimulus-response relationship 
within different treatment groups. 
While it is entirely possible that the variability seen within treatment groups for the 
experiment presented in Figure 4.9 (effectively an input-output measure) is due to 
slight differences in the placement of the electrodes and connectivity of the 
patched neurone, other sources of experimental error were investigated. It was 
suggested that perhaps the current output of the stimulus isolation unit did not 
increase in a linear fashion as the control dial was turned. This could lead to errors 
in the plotting of the stimulus-response curve performed at the start of each 
experiment, and therefore not stimulating the cell to produce 75% of its maximum 
EPSC. To investigate this possibility, the stimulating electrode was first lowered 
into some ACSF. The potential difference between the positive and negative 
electrodes on the stimulating electrode was then monitored as the size of the 
stimulus was gradually increased throughout its range. As the resistance of this 
circuit should remain constant, the current delivered by the stimulating electrode 
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should be directly proportional to the voltage across it (as stated in Ohm's law). 
Figure A.18 shows the results of this experiment.  




































Figure A.18 A graph to show the current output of the stimulus isolation unit 
A stimulating electrode was lowered into a solution of ACSF. The dial on the 
stimulus isolation unit (current setting) was then gradually increased and the 
voltage across the stimulating electrode measured. n=3 for each point. A runs test 
for linearity failed to find any deviation from linearity (P=0.13).  
The runs test for linearity failed to find any deviation from a straight line (although 
clearly there is a small amount of variation in the current output). This result 
suggests that while the stimulus isolation unit may have been introducing some 
experimental error into the stimulus-response curves, this was unlikely to be 
significant, and some other source of variation may be needed to fully account for 
the variation seen in Figure 4.9. 
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